Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3046279	p-pct	ug/l (ug/l)	9981	19918	1.18%
3046279	s-pct	ug/l (ug/l)	2586	4303	0.00%
3046279	p-pct	— (—)	1710	2552	100.00%	Distribution not available
3046279	p-pct	ng/ml (ug/l)	839	1493	0.00%
3046279	s-pct	— (—)	581	1373	100.00%	Distribution not available
3046279	p-pctpika	ug/l (ug/l)	108	141	0.00%
3046279	p-pctpika	— (—)	36	37	100.00%	Distribution not available
3046279	p-pct-o	— (—)	13	15	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Solid cancers, helper endpoint

2675

6803

2.39

323.31

2.1

2.0

2.48

2.12

ug/l

0.57

2420

5940

Agranulocytosis

686

1424

5.48

318.20

2.6

1.9

1.55

2.33

ug/l

0.94

647

1269

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2293

9715

2.43

317.35

2.3

1.9

2.38

2.13

ug/l

0.37

2018

8527

Early onset COPD, excluding more controls

766

1734

4.69

312.79

2.3

1.7

1.90

2.52

ug/l

0.65

702

1536

Iron deficiency anaemia

1793

6839

2.72

311.69

2.2

1.9

3.50

2.16

ug/l

0.90

1582

5946

Insulin, intermediate and long-acting

2200

9094

2.46

310.86

2.2

2.0

2.36

2.21

ug/l

0.25

2009

7952

Lung cancer and mesothelioma

829

1672

4.56

308.18

2.0

1.7

1.75

2.71

ug/l

1.03

753

1461

ILD medications: immunosuppressive drugs

2565

7212

3.47

307.65

2.2

1.9

2.39

2.25

ug/l

0.09

2326

6356

ILD medications: prednisolone, methylprednisolone, prednisone

4337

8359

3.02

307.65

2.2

1.9

2.09

2.31

ug/l

0.47

3891

7296

Erysipelas

2762

5407

4.86

307.65

2.2

1.7

2.24

1.43

ug/l

3.19

2468

4578

Insulin, combination of fast acting with intermediate-acting or long-acting

2470

9680

2.43

307.65

2.2

1.9

2.28

2.19

ug/l

0.15

2259

8438

Bacterial pneumonia, not elsewhere classified

1900

3937

4.57

307.65

2.7

1.7

2.15

2.48

ug/l

0.44

1698

3401

Any reimbursement code in KELA

1357

1598

4.36

307.65

2.2

1.8

2.22

1.76

ug/l

0.66

1227

1334

Viral Sepsis

1317

2386

6.23

307.65

2.8

1.6

3.41

1.31

ug/l

1.13

1165

2051

Infections, IBD-co-morbidities

925

828

8.76

307.65

2.8

1.8

2.51

2.46

ug/l

0.02

845

741

Non-invasive ventilation

1452

1576

9.12

307.65

2.8

1.7

2.50

2.15

ug/l

0.29

1165

1405

Diseases of the respiratory system

1847

3128

3.04

307.65

2.0

1.7

2.06

2.65

ug/l

0.85

1650

2725

Malaise and fatigue

2223

4883

3.88

307.65

2.1

1.8

2.08

2.33

ug/l

0.43

1899

4260

All-cause Heart Failure

3046

6989

3.31

307.65

2.2

1.9

2.75

2.20

ug/l

0.52

2720

6087

Bacterial infection, other or unspecified

4979

5057

10.11

307.65

2.3

1.7

2.35

1.44

ug/l

2.09

4538

4264

Heart failure and coronary heart disease

2142

5334

3.05

307.65

2.2

1.9

2.22

2.33

ug/l

0.14

1938

4565

Explicit bacterial Sepsis

639

1173

6.13

307.65

2.4

1.6

4.10

1.66

ug/l

3.40

584

1011

Influenza and pneumonia

5718

7068

5.53

307.65

2.3

1.8

2.25

2.35

ug/l

0.12

5150

6155

Inflammatory bowel disease treatment related agents

4465

9128

2.84

307.65

2.1

1.9

1.97

2.32

ug/l

0.93

3998

7967

ILD medications

4353

8411

2.92

307.65

2.2

1.9

2.02

2.32

ug/l

0.70

3902

7342

Cardiovascular diseases (excluding rheumatic etc)

1606

2464

3.86

307.65

2.3

1.8

2.07

1.85

ug/l

0.28

1445

2178

COPD/asthma/ILD related infections

3830

5503

3.63

307.65

2.2

1.7

1.96

2.49

ug/l

1.39

3420

4801

Dialysis, with operation codes

891

1705

6.06

307.65

3.1

1.8

3.82

2.05

ug/l

1.94

844

1492

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4656

9559

3.56

307.65

2.3

1.9

2.63

2.03

ug/l

0.97

4208

8320

Other heart diseases

1559

2136

4.98

307.65

2.5

1.8

2.04

1.93

ug/l

0.14

1417

1901

Septicaemia

3588

4321

9.07

307.65

2.6

1.7

4.74

1.44

ug/l

19.75

3269

3628

Aplastic and other anaemias

2477

7490

3.32

307.65

2.3

1.9

3.19

2.12

ug/l

0.99

2224

6485

Insulin medication

2463

8128

2.67

307.65

2.2

2.0

2.28

2.16

ug/l

0.21

2252

7075

COPD (mode)

1324

2436

4.56

307.65

2.1

1.7

1.90

2.66

ug/l

1.23

1171

2126

Asthma

2268

3630

3.38

307.65

2.1

1.7

2.11

2.61

ug/l

0.79

2033

3176

Asthma (only as main-diagnosis)

1991

3630

3.27

307.65

2.1

1.7

1.98

2.61

ug/l

1.05

1763

3176

Asthma (only as main-diagnosis), excluding more controls

1910

3061

3.68

307.65

2.1

1.7

2.04

2.68

ug/l

0.94

1694

2676

Covid-19 confirmed case

2724

5404

5.74

307.65

2.2

1.9

1.51

2.40

ug/l

3.48

2383

4728

Complications of procedures, not elsewhere classified

3081

10370

2.56

307.65

2.3

1.9

2.27

2.29

ug/l

0.03

2732

9121

Metabolic disorders

3371

8668

2.46

307.65

2.2

1.9

2.19

2.32

ug/l

0.19

3022

7613

Anaemias

1021

428

16.70

307.65

2.6

1.6

3.43

1.71

ug/l

1.81

963

366

Implicit Sepsis

3966

7497

4.12

307.65

2.5

1.7

3.14

1.23

ug/l

5.05

3533

6539

ILD differential diagnosis

2454

3663

3.47

307.65

2.1

1.7

1.99

2.61

ug/l

1.13

2202

3204

Type 2 diabetes, wide definition

3058

7933

2.57

307.65

2.1

1.9

2.27

2.26

ug/l

0.01

2744

6919

Non-rheumatic valve diseases

1848

4572

3.07

307.65

2.2

1.9

1.84

2.36

ug/l

1.23

1614

4036

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1194

2003

3.89

307.65

2.4

1.8

1.76

1.90

ug/l

0.17

1090

1781

Complications of medical and surgical care

2934

10835

2.60

307.65

2.3

1.9

2.36

2.23

ug/l

0.19

2581

9523

COPD differential diagnosis

2458

3664

3.47

307.65

2.1

1.7

1.99

2.61

ug/l

1.12

2206

3205

Implicit viral Sepsis

1603

3537

4.97

307.65

2.6

1.6

3.25

1.32

ug/l

1.33

1421

3051

5126

5503

6.10

307.65

2.3

1.7

2.19

2.49

ug/l

0.39

4625

4801

Certain infectious and parasitic diseases

2343

3407

3.56

307.65

2.0

1.7

2.60

1.45

ug/l

2.77

2115

2845

Diseases of arteries, arterioles and capillaries (FINNGEN)

1055

1287

6.09

307.65

2.2

1.8

2.21

2.09

ug/l

0.10

964

1153

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1175

2537

5.25

307.65

2.0

1.8

2.12

1.71

ug/l

0.57

1091

2206

Hypertension, essential

2371

5371

2.58

307.65

2.2

1.9

2.49

2.14

ug/l

0.36

2127

4741

Any death

3631

6735

4.24

307.65

2.4

1.8

3.20

1.84

ug/l

2.29

3302

5916

Heart failure, strict

3097

7059

3.34

307.65

2.2

1.9

2.75

2.22

ug/l

0.50

2766

6153

Acute tubulo-interstitial nephritis

3065

7252

3.89

307.65

2.2

1.8

3.14

1.57

ug/l

7.13

2692

6287

Fever of other and unknown origin

4139

5539

7.44

307.65

2.3

1.8

1.81

2.27

ug/l

1.31

3764

4847

Viral pneumonia

943

1186

9.25

307.65

2.6

1.7

1.22

2.81

ug/l

1.83

851

1015

COPD/asthma related infections

3830

5503

3.63

307.65

2.2

1.7

1.96

2.49

ug/l

1.39

3420

4801

Asthma-related infections

2207

8995

2.50

307.65

2.2

2.0

2.01

2.24

ug/l

0.40

1966

7851

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2750

10050

2.57

307.65

2.2

1.9

1.73

2.26

ug/l

1.55

2442

8810

Streptococcal septicaemia

588

810

8.41

307.65

2.4

1.6

4.25

1.95

ug/l

2.03

536

673

Abnormal findings on diagnostic imaging of lung

2132

8237

2.62

307.65

2.2

1.9

1.74

2.31

ug/l

1.31

1908

7228

Chronic kidney disease

1872

5173

3.92

307.65

2.5

1.8

3.70

1.83

ug/l

4.30

1706

4428

Liquid cancers, helper endpoint

2114

4718

4.27

307.65

2.3

1.9

2.36

2.12

ug/l

0.27

1916

4101

Complications of surgical and medical care, not elsewhere classified

3958

10626

2.66

307.65

2.3

1.9

2.24

2.29

ug/l

0.07

3489

9333

Any gastric operation

2447

3278

3.86

307.65

2.1

1.6

2.39

2.16

ug/l

0.27

2172

2855

Bacterial Sepsis

3607

5395

6.51

307.65

2.6

1.7

3.70

1.27

ug/l

6.30

3249

4667

All kidney diseases

4632

8693

3.86

307.65

2.3

1.8

3.29

1.61

ug/l

4.92

4165

7578

Erysipelas

3267

5813

4.56

307.65

2.1

1.7

2.34

1.39

ug/l

4.00

2919

4933

Other septicaemia

3296

3997

9.32

307.65

2.6

1.7

4.86

1.39

ug/l

19.15

3006

3351

Heart failure and bmi 25plus

1785

3952

3.30

307.65

2.2

1.8

2.36

2.16

ug/l

0.23

1571

3394

Asthma, unspecified (mode)

1842

3474

4.17

307.65

2.1

1.7

1.90

2.55

ug/l

1.34

1628

3042

Heart failure,strict

2872

5370

4.10

307.65

2.2

1.9

2.88

2.22

ug/l

0.61

2569

4737

Implicit bacterial Sepsis

3221

4968

6.59

307.65

2.6

1.7

3.70

1.27

ug/l

5.28

2899

4298

First line medication for Crohn's disease

4452

7487

3.35

307.65

2.2

1.9

1.98

2.29

ug/l

0.79

4011

6476

Pneumonia, organism unspecified

5243

6842

5.82

307.65

2.3

1.8

2.33

2.34

ug/l

0.01

4736

5966

Asthma, excluding more controls

2159

3061

3.80

307.65

2.1

1.7

2.13

2.68

ug/l

0.78

1942

2676

Bacterial pneumonia (organism specified)

2262

6544

3.35

307.65

2.7

1.8

2.06

2.32

ug/l

0.42

2032

5645

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

670

655

8.08

307.65

2.5

1.8

2.23

2.49

ug/l

0.10

610

585

Nephropathy related operations

871

1789

5.67

307.65

3.1

1.9

3.54

2.64

ug/l

0.68

826

1586

Other bacterial diseases

6675

6506

7.67

307.65

2.3

1.7

3.01

1.35

ug/l

8.15

6093

5536

Non-ischemic cardiomyopathy

1445

3656

3.42

307.65

2.2

1.8

3.38

2.38

ug/l

0.46

1261

3152

Oral corticosteroids

4489

9042

3.08

307.65

2.2

1.9

1.91

2.31

ug/l

1.21

4021

7891

Any event in cancer register

2899

7453

2.36

307.65

2.2

2.0

2.58

1.96

ug/l

1.19

2610

6537

All pneumoniae

5732

7284

5.68

307.65

2.3

1.8

2.26

2.32

ug/l

0.06

5171

6339

Asthma, hospital admissions 3, pneumonia

1793

6024

3.17

307.65

2.3

1.9

2.20

2.37

ug/l

0.20

1615

5209

Asthma (mode)

2116

3663

3.18

307.65

2.1

1.7

2.10

2.61

ug/l

0.80

1899

3204

Renal tubulo-interstitial diseases

4716

8618

4.38

307.65

2.3

1.8

3.44

1.57

ug/l

6.10

4240

7521

Malignant neoplasm, wide definition for exclusion

2892

6970

2.51

307.65

2.2

2.0

2.54

2.11

ug/l

0.67

2627

6087

Abnormalities of breathing

3070

6964

2.64

307.65

2.1

1.9

2.03

2.40

ug/l

0.82

2740

6125

Heart failure and antihypertensive medication

1373

1664

5.91

307.65

2.4

1.8

2.39

2.60

ug/l

0.09

1262

1478

Other bacterial diseases

6316

6264

6.99

307.65

2.3

1.7

2.94

1.40

ug/l

6.56

5774

5310

Asthma, hospital admission 2, infections

2207

8995

2.50

307.65

2.2

2.0

2.01

2.24

ug/l

0.40

1966

7851

Condition for Implicit Sepsis (Organ dysfunction codes)

3750

7466

3.64

307.65

2.4

1.7

3.16

1.24

ug/l

4.73

3355

6505

Explicit Sepsis

3648

5291

7.43

307.65

2.6

1.7

4.70

1.24

ug/l

23.99

3327

4575

Polyarthropathies

2735

6648

2.80

307.65

2.1

1.9

1.93

2.36

ug/l

0.75

2461

5878

Implicit bacterial Sepsis

3327

5280

6.17

307.65

2.6

1.7

3.63

1.28

ug/l

5.23

2990

4574

Oedema, not elsewhere classified

1320

3605

3.83

307.65

2.2

1.8

1.90

2.38

ug/l

0.73

1136

3151

Bacterial infection, other or unspecified

5224

5200

9.97

307.65

2.3

1.7

2.33

1.42

ug/l

2.24

4763

4388

Renal failure

3006

7059

4.17

307.65

2.6

1.8

4.20

1.81

ug/l

4.51

2738

6079

Provisional assignment of new diseases of uncertain etiology

3151

7382

4.66

307.65

2.2

1.9

1.50

2.33

ug/l

4.26

2774

6476

Acute renal failure

1621

3473

5.38

307.65

2.8

1.8

5.16

1.96

ug/l

2.87

1480

2993

3691

9169

2.13

307.65

2.1

1.9

2.21

2.33

ug/l

0.11

3251

8011

ILD, hospital admission 2, with pulmonary infections

683

994

8.00

307.65

2.5

1.7

2.13

3.07

ug/l

0.48

621

844

Heart failure, not strict

3921

6903

4.16

307.65

2.3

1.9

2.84

2.10

ug/l

1.04

3531

6117

Oxycodone

2735

4980

5.58

307.65

2.3

1.9

2.51

2.27

ug/l

0.17

2428

4407

Codes for special purposes

3154

7395

4.65

307.65

2.2

1.9

1.50

2.33

ug/l

4.27

2777

6488

Cardiovascular diseases

1381

2100

3.62

307.65

2.2

1.8

1.95

1.98

ug/l

0.03

1248

1862

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5126

5503

6.10

307.65

2.3

1.7

2.19

2.49

ug/l

0.39

4625

4801

General symptoms and signs

4025

6208

3.38

307.65

2.2

1.8

2.00

2.45

ug/l

0.74

3592

5442

Condition for Implicit Sepsis (Organ dysfunction codes)

3839

7534

3.80

307.65

2.5

1.7

3.20

1.23

ug/l

5.06

3422

6576

GASTRO-related operations

2447

3278

3.86

307.65

2.1

1.6

2.39

2.16

ug/l

0.27

2172

2855

Tramadol

2579

6305

2.59

307.65

2.2

1.9

2.55

2.19

ug/l

0.55

2299

5557

Other disorders of fluid, electrolyte and acid-base balance

1743

4609

3.93

307.65

2.4

1.9

2.55

2.34

ug/l

0.23

1534

4019

Atrial fibrillation and flutter with reimbursement

957

1296

4.97

307.65

2.3

1.8

2.29

2.10

ug/l

0.17

862

1163

All influenza

1117

2527

4.74

307.65

2.3

1.7

1.91

2.51

ug/l

0.85

974

2189

Care involving dialysis

574

898

7.54

307.65

2.7

1.7

3.44

2.93

ug/l

0.19

545

791

ILD, hospital admissions 3, with pneumonia sepsis

644

923

8.30

307.65

2.6

1.6

2.07

2.95

ug/l

0.46

588

781

Atrial fibrillation and flutter

1129

1553

4.96

307.65

2.4

1.8

2.21

2.20

ug/l

0.00

1028

1386

Bacterial pneumoniae

2032

4105

4.70

307.65

2.7

1.7

2.22

2.43

ug/l

0.26

1818

3546

Asthma-related pneumonia

1791

6016

3.18

307.65

2.3

1.9

2.17

2.36

ug/l

0.23

1613

5203

Other heart diseases, wide

2902

6770

2.71

307.65

2.3

1.9

2.15

2.21

ug/l

0.08

2608

5989

Dyspnoea

3612

10442

2.67

307.65

2.2

1.9

2.54

2.15

ug/l

0.40

3220

9151

Parasetamol

2204

4010

2.86

307.65

2.0

1.9

2.41

2.01

ug/l

0.55

1958

3567

Valvular heart disease excluding rheumatic fever

1858

4585

3.08

307.65

2.2

1.9

1.85

2.36

ug/l

1.20

1623

4048

Persons encountering health services for specific procedures and health care

4380

8587

3.19

307.65

2.3

1.8

2.31

2.09

ug/l

0.47

3903

7513

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1461

3429

4.71

307.65

2.0

1.9

3.00

1.89

ug/l

0.57

1363

2998

Other anaemias

2259

7168

3.22

307.65

2.3

1.9

3.24

2.17

ug/l

0.87

2019

6197

Pneumonias (Asthma/COPD co-morbidities)

5707

7280

5.69

307.65

2.3

1.7

2.26

2.33

ug/l

0.07

5151

6331

Asthma, unspecified (mode), excluding more controls

1766

2925

4.72

307.65

2.1

1.7

1.89

2.63

ug/l

1.40

1569

2561

Cardiac arrhythmias

1605

3452

3.11

307.65

2.3

1.8

2.00

2.21

ug/l

0.28

1444

3044

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

857

1990

4.80

307.65

2.2

1.8

2.25

1.69

ug/l

0.54

789

1726

Other pulmonary diagnosis

2523

3665

3.57

307.65

2.1

1.7

2.01

2.60

ug/l

1.06

2266

3208

Opioids

3014

6550

2.45

307.65

2.1

1.9

1.92

2.20

ug/l

0.50

2652

5766

Other and unspecified anaemias

2242

7120

3.23

307.65

2.3

1.9

3.25

2.17

ug/l

0.86

2003

6155

Bleeding

3139

10036

2.31

307.65

2.2

1.9

2.39

2.20

ug/l

0.25

2754

8863

Other diseases of pleura

2441

7160

3.23

307.65

2.4

1.9

2.32

2.31

ug/l

0.00

2184

6248

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3404

9243

2.48

307.65

2.3

1.9

2.35

2.30

ug/l

0.07

3031

8165

Hypertensive diseases (excluding secondary)

1447

2136

4.07

307.65

2.3

1.8

2.14

1.90

ug/l

0.31

1318

1899

Malignant neoplasm

2878

6859

2.57

307.65

2.2

2.0

2.53

2.11

ug/l

0.65

2623

5983

All chronic kidney diseases

2959

6221

4.21

307.65

2.4

1.8

3.16

1.62

ug/l

5.95

2684

5395

Cerebrovascular diseases (FINNGEN)

1077

1623

4.93

307.65

2.3

1.7

2.26

2.17

ug/l

0.07

931

1450

Implicit viral Sepsis

1315

2384

6.22

307.65

2.8

1.6

3.41

1.31

ug/l

1.13

1163

2049

Viral pneumonia (unknown virus, not influenza)

537

798

8.02

307.65

2.6

2.0

1.17

1.96

ug/l

0.73

502

703

Implicit Sepsis

4030

7221

4.53

307.65

2.5

1.7

3.10

1.25

ug/l

4.87

3585

6290

Transplanted organ and tissue status

637

1095

6.70

307.65

2.7

1.9

2.55

2.81

ug/l

0.13

611

988

Intestinal infectious diseases

3214

11398

2.20

307.65

2.3

1.9

2.68

2.13

ug/l

0.57

2867

9980

Other medical care

2871

6014

4.73

307.65

2.2

1.8

2.60

2.21

ug/l

0.31

2583

5223

Certain infectious and parasitic diseases

3686

4426

4.35

307.65

2.2

1.7

2.26

1.44

ug/l

2.82

3350

3715

Asthma-related pneumonia or sepsis

1793

6024

3.17

307.65

2.3

1.9

2.20

2.37

ug/l

0.20

1615

5209

Excluding asthma or asthma-COPD overlap

2469

3665

3.49

307.65

2.1

1.7

1.88

2.60

ug/l

1.50

2215

3208

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5511

7575

5.35

307.65

2.3

1.8

2.34

2.24

ug/l

0.12

4973

6598

Bronchitis

3512

10953

2.07

307.04

2.1

1.9

2.16

2.31

ug/l

0.14

3096

9605

Nutritional anaemias

2026

8047

2.54

307.00

2.2

1.9

3.43

2.09

ug/l

1.06

1789

6988

Codeine

2723

6496

2.34

306.84

2.1

1.9

1.94

2.19

ug/l

0.52

2399

5721

Autoimmune diseases excluding thyroid diseases

3408

8993

2.12

305.57

2.1

2.0

2.24

ug/l

0.00

3053

7877

Primary_lymphoid and hematopoietic malignant neoplasms

1242

4029

3.35

304.52

2.5

1.9

2.29

2.08

ug/l

0.17

1142

3513

Nausea and vomiting

1166

3529

3.43

304.36

2.2

1.8

2.51

2.52

ug/l

0.01

1031

3029

Autoimmune diseases excluding thyroid diseases, strict definition

3316

8775

2.12

298.19

2.1

2.0

2.20

2.27

ug/l

0.11

2969

7685

Other bacterial intestinal infections

951

2648

3.91

296.50

2.6

1.8

2.22

2.37

ug/l

0.12

863

2277

L04AA Selective immunosuppressants

986

2812

3.77

294.89

2.4

2.0

2.16

2.22

ug/l

0.05

906

2518

Hernia of abdominal wall, postoperative

673

1444

4.94

293.69

2.4

1.6

2.19

2.02

ug/l

0.13

609

1271

Gout

1393

4253

3.09

293.42

2.2

1.9

2.13

2.18

ug/l

0.05

1259

3746

Diseases of arteries, arterioles and capillaries

2646

8997

2.26

293.36

2.1

1.9

2.29

2.15

ug/l

0.22

2369

7861

Diarrhoea and gastroenteritis of presumed infectious origin

2370

9550

2.31

290.58

2.3

1.9

2.83

2.15

ug/l

0.53

2117

8363

Hypertensive diseases

2291

5424

2.45

289.11

2.2

1.9

2.56

2.14

ug/l

0.46

2060

4787

Hypertension

2290

5424

2.45

288.59

2.2

1.9

2.56

2.14

ug/l

0.46

2059

4787

Hard cardiovascular diseases

2697

7334

2.26

287.53

2.3

1.9

2.06

2.38

ug/l

0.45

2391

6461

Enterocolitis due to Clostridium difficile

701

1614

4.92

286.87

2.8

1.9

2.40

2.21

ug/l

0.11

640

1380

Caries of dentine

1045

3085

3.52

281.38

2.4

2.0

2.03

2.32

ug/l

0.38

937

2737

Implicit fungal Sepsis

440

677

7.54

280.58

3.1

1.6

2.05

1.32

ug/l

0.69

396

579

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2998

8716

2.13

277.76

2.1

1.9

2.41

2.22

ug/l

0.29

2716

7590

L04AD Calcineurin inhibitors

598

1242

5.39

276.00

2.6

2.0

2.74

2.21

ug/l

0.39

567

1121

Diabetes mellitus

3111

8937

2.09

272.16

2.2

1.9

2.30

2.22

ug/l

0.11

2821

7780

Diabetes, varying definitions

3098

8940

2.08

270.15

2.2

1.9

2.30

2.22

ug/l

0.11

2809

7782

Other diseases of blood and blood-forming organs, wide

1034

3226

3.46

269.53

2.5

1.9

1.78

2.26

ug/l

0.71

959

2839

Other acute lower respiratory infections

1964

8040

2.42

269.15

2.2

1.9

2.45

2.28

ug/l

0.08

1738

7012

Ischemic heart diseases

2709

7648

2.19

269.00

2.2

1.9

1.89

2.52

ug/l

1.43

2443

6699

Type 2 diabetes

3057

8763

2.09

268.86

2.2

1.9

2.23

2.22

ug/l

0.01

2767

7632

Malignant neoplasm of digestive organs

1558

4673

2.77

267.59

2.0

1.9

2.17

2.19

ug/l

0.02

1411

4047

Autoimmune diseases related-to ILD

2722

11323

2.11

267.28

2.1

1.9

2.53

2.21

ug/l

0.24

2431

9927

Dental caries

1108

3447

3.28

267.06

2.3

2.0

1.97

2.45

ug/l

0.75

993

3063

Percutaneous Coronary Intervention

2612

7506

2.20

262.75

2.2

1.9

1.72

2.54

ug/l

2.18

2362

6574

Pulmonary heart disease, diseases of pulmonary circulation

1441

5473

2.80

262.53

2.3

1.9

2.78

2.29

ug/l

0.20

1279

4772

Fentanyl

616

1365

5.00

261.90

2.4

1.8

2.55

2.71

ug/l

0.07

541

1184

Fungal Sepsis

336

418

9.93

261.18

3.3

1.6

2.03

1.66

ug/l

0.19

311

363

Bacterial intestinal infections, IBD co-morbidities

936

2803

3.63

261.16

2.7

1.8

2.24

2.29

ug/l

0.04

851

2432

Hypo-osmolality and hyponatraemia

897

2606

3.72

259.85

2.2

1.8

2.04

2.61

ug/l

0.67

791

2242

Other CVD (FINNGEN)

524

721

6.12

258.68

2.2

1.8

1.89

2.11

ug/l

0.15

460

635

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2180

7880

2.32

258.49

2.1

2.0

2.33

2.25

ug/l

0.11

1942

6899

STROKE

1745

4748

2.59

257.00

2.2

1.9

2.11

2.57

ug/l

0.44

1516

4204

Enlarged lymph nodes

644

1489

4.62

256.88

2.3

1.8

1.56

2.32

ug/l

0.88

575

1311

Diabetes, insulin treatment (Kela reimbursement)

3200

9844

2.01

256.73

2.1

2.0

2.41

2.17

ug/l

0.42

2895

8573

Secondary uncertain malignant neoplasm

707

1777

4.39

255.92

2.2

1.8

2.26

1.87

ug/l

0.31

649

1529

Drug-induced neutropenia

491

928

6.21

255.34

2.6

2.0

1.72

1.92

ug/l

0.15

471

830

Second line medication for Crohn's disease

1924

8410

2.37

255.16

2.1

2.0

2.35

2.20

ug/l

0.07

1721

7459

Later onset COPD, excluding more controls

850

1773

3.96

255.05

2.0

1.7

1.85

2.85

ug/l

1.27

734

1520

Coronary revascularization (ANGIO or CABG)

2593

7509

2.18

255.00

2.2

1.9

1.72

2.54

ug/l

2.16

2347

6577

Venous thromboembolism

2107

9255

2.29

254.23

2.3

1.9

2.63

2.22

ug/l

0.25

1864

8072

L04AX Other immunosuppressants

1886

8194

2.39

253.80

2.1

2.0

2.36

2.20

ug/l

0.07

1689

7269

Insulin, fast-acting

1413

5396

2.75

252.60

2.3

1.9

2.50

2.15

ug/l

0.59

1304

4712

Presence of cardiac and vascular implants and grafts

1880

5942

2.47

252.14

2.1

1.9

1.81

2.28

ug/l

1.29

1619

5207

Gout, FINNGEN

1393

5304

2.80

252.12

2.2

1.9

2.13

2.16

ug/l

0.02

1259

4616

Other respiratory disorders and diseases

1076

3589

3.25

251.72

2.7

1.9

1.97

2.39

ug/l

0.42

940

3108

Other diseases of the respiratory system

1076

3589

3.25

251.72

2.7

1.9

1.97

2.39

ug/l

0.42

940

3108

Respiratory insufficiency

437

736

6.57

251.53

2.5

1.7

1.72

3.31

ug/l

1.26

382

628

DVT of lower extremities and pulmonary embolism

1734

7302

2.49

250.59

2.3

1.9

2.79

2.25

ug/l

0.27

1534

6382

Extracorporeal dialysis

468

869

6.48

249.70

2.8

1.9

3.53

2.22

ug/l

0.68

444

775

Major coronary heart disease event

2776

8195

2.11

249.48

2.2

1.9

1.83

2.45

ug/l

1.53

2506

7143

Medical observation and evaluation for suspected diseases and conditions

2147

4726

2.39

248.97

2.0

1.8

1.61

2.54

ug/l

3.13

1864

4212

Other bacterial intestinal infections

1021

3308

3.29

248.78

2.6

1.8

2.59

2.32

ug/l

0.21

927

2864

Care involving use of rehabilitation procedures

1950

7908

2.34

248.26

2.5

1.8

1.93

2.11

ug/l

0.36

1742

6925

Infections of the skin and subcutaneous tissue

1951

8591

2.33

247.97

2.4

2.0

2.37

2.05

ug/l

0.44

1771

7585

Pulmonary embolism

1318

4955

2.83

245.12

2.4

1.9

2.76

2.32

ug/l

0.16

1164

4323

Secondary hypertension

369

526

7.59

245.09

2.4

1.7

2.93

2.33

ug/l

0.21

338

460

Pneumonia due to other infectious organisms, not elsewhere classified

274

287

11.79

242.84

3.0

1.7

0.71

2.42

ug/l

0.95

254

244

Pulmonary heart disease

1318

4984

2.81

242.33

2.4

1.9

2.76

2.37

ug/l

0.14

1164

4351

Systemic connective tissue disorders

1378

5322

2.73

241.57

2.1

1.9

1.29

2.39

ug/l

4.85

1205

4649

Osteopathies and chondropathies

1969

8258

2.31

240.82

2.2

1.9

2.07

2.27

ug/l

0.30

1720

7256

Emergency coronary revascularization (for ACS)

2861

8730

2.05

240.38

2.2

1.9

1.78

2.50

ug/l

2.02

2581

7592

Syncope and collapse

1431

4739

2.68

239.06

2.0

1.8

1.76

2.32

ug/l

1.35

1229

4128

Glomerular diseases

891

2750

3.52

237.12

2.6

1.9

3.59

2.15

ug/l

1.34

819

2409

Implicit fungal Sepsis

308

388

9.80

237.04

3.4

1.6

2.07

1.72

ug/l

0.17

286

336

Other respiratory diseases principally affecting the interstitium

966

3144

3.36

236.57

2.6

1.9

2.10

2.41

ug/l

0.24

885

2727

Other and unspecified iron deficiency

1360

5275

2.71

236.10

2.2

1.9

3.68

2.19

ug/l

0.73

1204

4579

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2056

9551

2.23

235.25

2.3

1.9

2.34

2.18

ug/l

0.21

1810

8388

Hypertensive heart and/or renal disease

1120

2842

3.12

232.74

2.1

1.9

2.01

2.03

ug/l

0.01

995

2481

Diabetes medication

3095

9577

1.96

230.05

2.1

1.9

2.10

2.29

ug/l

0.34

2789

8346

Pleural effusion

842

2573

3.59

228.88

2.3

1.8

3.43

2.71

ug/l

0.17

783

2238

General examination and investigation of persons without complaint and reported diagnosis

2052

4716

2.33

227.62

2.3

1.8

1.90

2.54

ug/l

1.63

1836

4204

Pain in throat and chest

2395

6886

2.14

225.51

2.0

1.9

1.53

2.40

ug/l

4.21

2114

6059

Pain, not elsewhere classified

848

2611

3.38

222.00

2.1

1.8

1.68

2.21

ug/l

0.81

758

2286

Headache

1609

5388

2.44

221.72

2.0

1.8

2.16

2.52

ug/l

0.39

1406

4739

Insulin, fast-acting or short human

1416

5788

2.56

219.75

2.3

1.9

2.52

2.16

ug/l

0.62

1307

5053

Other disorders of urethra and urinary system

2255

7843

2.14

219.42

2.2

1.9

2.98

2.06

ug/l

0.74

1981

6898

Disorders of gallbladder, biliary tract and pancreas

3139

10635

1.91

217.59

2.2

1.9

2.34

2.17

ug/l

0.25

2822

9315

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

845

1130

3.83

215.41

2.1

1.8

1.68

2.61

ug/l

0.89

761

985

Hypothyroidism (congenital or acquired)

478

445

6.21

214.39

2.3

1.6

1.83

1.65

ug/l

0.14

428

381

Other disorders of skin and subcutaneous tissue

2361

10564

2.05

213.42

2.2

1.9

2.26

2.27

ug/l

0.01

2099

9250

Glomerular disorders in diseases classified elsewhere

645

1736

4.12

213.08

2.5

1.9

3.11

2.35

ug/l

0.47

593

1520

Depression medications

531

466

5.85

213.01

2.1

1.5

1.57

1.58

ug/l

0.01

480

400

Intracranial trauma

1664

5016

2.39

212.35

2.1

1.9

1.64

2.51

ug/l

1.51

1434

4508

Other diseases of intestines

3018

9101

1.93

211.46

2.1

1.9

2.10

2.27

ug/l

0.26

2674

7991

Symptoms and signs involving the urinary system

2558

10078

1.99

207.78

2.0

2.65

2.05

ug/l

1.15

2184

8929

Myocardial infarction

1814

5771

2.30

207.63

2.1

1.9

1.87

2.43

ug/l

1.13

1620

5023

Autoimmune diseases

3264

9013

1.88

206.97

2.1

2.0

2.12

2.24

ug/l

0.22

2907

7893

Intestinal infectious diseases

3469

11080

1.83

206.53

2.2

1.9

2.64

2.11

ug/l

0.61

3100

9694

Diseases of oesophagus, stomach and duodenum

3204

10503

1.86

205.68

2.1

2.0

2.42

2.20

ug/l

0.31

2841

9231

Hypothyroidism and >3 levothyroxin purchases

464

444

6.04

203.40

2.3

1.6

1.83

1.66

ug/l

0.13

415

380

Hypothyroidism, levothyroxine purchases

464

444

6.04

203.40

2.3

1.6

1.83

1.66

ug/l

0.13

415

380

Volume depletion

542

1329

4.52

203.20

2.3

1.8

2.63

2.47

ug/l

0.09

497

1127

Neoplasms

1920

4579

2.27

202.55

2.2

2.0

2.48

2.02

ug/l

0.57

1728

4014

Symptoms and signs involving the circulatory and respiratory systems

2712

6971

1.99

201.85

2.1

1.9

1.83

2.40

ug/l

1.60

2397

6130

Type 2 diabetes, definitions combined

2783

8605

1.94

201.05

2.1

1.9

2.26

2.22

ug/l

0.05

2496

7491

Hydronephrosis

561

1423

4.31

199.95

2.1

1.7

2.77

2.08

ug/l

0.49

511

1240

Peripheral artery disease

1806

6707

2.24

198.15

2.2

1.9

2.25

2.24

ug/l

0.01

1621

5806

Endocrine, nutritional and metabolic diseases

2038

4784

2.20

197.82

2.1

1.9

2.02

2.20

ug/l

0.24

1837

4145

Other functional intestinal disorders

1564

6453

2.33

196.70

2.1

1.9

2.07

2.15

ug/l

0.09

1365

5613

Coronary atherosclerosis

2162

6700

2.11

196.61

2.1

1.9

1.91

2.40

ug/l

1.24

1950

5866

Disorders of lipoprotein metabolism and other lipidaemias

2542

8156

1.98

195.74

2.0

1.9

1.92

2.38

ug/l

1.02

2246

7174

Type 2 diabetes, strict (exclude DM1)

2789

8723

1.92

194.78

2.1

1.9

2.27

2.20

ug/l

0.08

2502

7597

Major coronary heart disease event excluding revascularizations

2109

6885

2.11

194.39

2.1

1.9

1.98

2.34

ug/l

0.70

1895

5984

Other nutritional deficiencies

1931

8829

2.12

193.98

2.3

2.0

2.08

2.11

ug/l

0.04

1722

7819

Paralytic ileus and intestinal obstruction

1072

4089

2.76

192.83

2.3

1.9

2.74

2.26

ug/l

0.59

957

3578

1407

6014

2.40

192.57

2.3

2.0

1.78

2.26

ug/l

0.94

1239

5267

Obesity due to excess calories

1424

6193

2.38

191.14

2.2

2.0

1.92

2.16

ug/l

0.42

1267

5515

COPD

1760

6754

2.22

190.77

2.1

1.9

1.74

2.25

ug/l

1.53

1559

5913

Non-Hodgkin lymphoma, all, including Hilmo

629

1787

3.83

190.64

2.6

1.8

2.22

1.83

ug/l

0.31

583

1541

Finngen Rheumatological endpoints

2681

8050

1.93

190.37

2.1

2.0

2.03

2.39

ug/l

0.55

2343

7119

COPD, hospital admissions 3, with asthma pneumonia sepsis

1281

4528

2.57

190.04

2.2

1.9

1.67

2.31

ug/l

1.55

1134

3925

Hypertensive Heart Disease

972

2700

2.98

189.91

2.1

1.9

1.86

2.02

ug/l

0.14

856

2351

Other systemic involvement of connective tissue (FG)

943

3344

2.92

189.37

2.1

1.9

1.23

2.25

ug/l

3.12

813

2924

Acute bronchitis

1455

6301

2.35

188.31

2.2

1.9

2.89

2.23

ug/l

0.28

1271

5455

ILD medications: azathioprine

541

1388

4.13

187.71

2.3

1.9

4.33

2.63

ug/l

0.29

497

1230

Ischaemic heart disease, wide definition

2473

7992

1.97

187.39

2.1

2.0

1.96

2.43

ug/l

0.91

2236

7022

Gout, idiopatic and unspecified

1150

4644

2.65

186.18

2.2

1.9

2.13

2.18

ug/l

0.05

1030

4058

Symptoms and signs involving the digestive system and abdomen

2930

7972

1.88

185.02

2.1

1.9

1.88

2.38

ug/l

1.06

2616

6950

Other interstitial pulmonary diseases

792

2654

3.26

184.72

2.5

1.9

2.15

2.56

ug/l

0.26

720

2298

COPD, hospital admission 2, with asthma infections

1405

5255

2.42

184.67

2.2

1.9

1.68

2.22

ug/l

1.41

1246

4569

Other chronic obstructive pulmonary disease

1697

6565

2.22

184.32

2.1

1.9

1.78

2.24

ug/l

1.23

1498

5744

Interstitial lung disease endpoints

792

2665

3.24

183.40

2.5

1.9

2.15

2.54

ug/l

0.25

720

2309

Interstitial lung disease

792

2665

3.24

183.40

2.5

1.9

2.15

2.54

ug/l

0.25

720

2309

Type 2 diabetes, definitions combined, including avohilmo

2733

8586

1.89

183.21

2.1

1.9

2.24

2.19

ug/l

0.06

2454

7481

ILD, hospital admissions

780

2605

3.27

183.05

2.4

1.9

2.13

2.57

ug/l

0.28

709

2260

Chronic lower respiratory diseases

3444

10555

1.77

182.79

2.1

2.0

2.10

2.33

ug/l

0.43

3079

9270

Pain in limb

2432

8547

1.95

182.61

2.0

2.00

2.50

ug/l

0.93

2106

7524

Codeine or tramadol medication

3325

10398

1.78

182.12

2.1

2.0

1.98

2.24

ug/l

0.64

2910

9164

Diseases of the digestive system

1693

8041

2.18

181.66

2.3

1.9

2.39

2.21

ug/l

0.22

1496

7024

Haemorrhage from respiratory passages

1271

4818

2.48

181.49

2.3

1.9

2.31

2.46

ug/l

0.13

1108

4210

Kidney transplant status

333

602

6.41

181.15

2.6

2.1

3.39

1.88

ug/l

1.09

322

553

Other soft tissue disorders, not elsewhere classified

2736

8696

1.88

180.77

2.1

2.0

2.10

2.50

ug/l

0.71

2392

7656

Obesity and other hyperalimentation

1817

8569

2.10

179.45

2.2

2.0

1.90

2.10

ug/l

0.40

1612

7592

Obesity

1807

8523

2.10

179.13

2.2

2.0

1.90

2.09

ug/l

0.37

1605

7554

Diagnoses used for exclusion with ILD

1065

4223

2.66

177.69

2.3

1.9

2.34

2.17

ug/l

0.14

943

3691

Conduction disorders

1047

3268

2.71

175.64

2.1

1.8

1.76

2.32

ug/l

1.05

900

2854

Pure hypercholesterolaemia

2301

7843

1.97

175.56

2.0

1.9

1.94

2.39

ug/l

0.96

2016

6907

Gout, unspecified

970

3720

2.80

175.08

2.2

1.9

2.33

2.20

ug/l

0.11

872

3247

Other or unspecified ileus, impaction or obstruction

824

2891

3.03

174.76

2.3

1.9

2.78

2.36

ug/l

0.37

742

2520

Azathioprine

541

1469

3.90

173.24

2.3

1.9

4.33

2.67

ug/l

0.28

497

1303

Used for control exclusion in common control thyroid runs

2994

8455

1.82

172.84

2.1

1.9

2.18

2.28

ug/l

0.16

2664

7396

Other (not insulin) diabetes medications

2826

9335

1.83

172.35

2.1

1.9

2.06

2.28

ug/l

0.39

2535

8141

Sequelae of external causes of morbidity and mortality

1022

4044

2.67

171.21

2.5

1.9

2.29

2.24

ug/l

0.05

938

3549

Osteoporosis

1036

3834

2.67

170.97

2.2

1.9

1.81

2.35

ug/l

0.70

881

3317

Pneumocystosis

212

261

11.52

170.31

3.2

2.1

0.92

2.59

ug/l

0.82

201

234

Intestinal stricture

1236

5348

2.43

170.18

2.3

1.9

2.79

2.21

ug/l

0.86

1106

4672

Abdominal and pelvic pain

2863

7972

1.84

169.56

2.1

1.9

1.88

2.38

ug/l

1.08

2559

6950

Substance abuse, excluding more controls

1740

7248

2.10

169.05

2.2

2.0

2.31

2.10

ug/l

0.37

1545

6491

Mycoses

994

3900

2.68

168.96

2.6

1.9

2.09

2.20

ug/l

0.12

897

3426

Rheumatoid arthritis

1141

4236

2.52

168.39

2.1

1.9

1.58

2.42

ug/l

1.08

1017

3733

Paroxysmal tachycardia

573

1329

3.74

167.71

2.1

1.7

2.80

2.05

ug/l

0.43

506

1180

Other infectious diseases

503

1347

4.14

167.42

2.5

1.9

2.11

2.31

ug/l

0.09

462

1169

Antihypertensive medication - note that there are other indications

1257

2692

2.52

167.26

2.2

1.8

2.14

2.22

ug/l

0.04

1130

2374

Atherosclerosis, excluding cerebral and coronary sclerosis

1660

6339

2.17

167.15

2.1

1.9

2.37

2.24

ug/l

0.16

1482

5464

Constipation

2737

10674

1.82

166.43

2.1

2.0

2.59

2.17

ug/l

0.33

2391

9425

Reimbursement for rheumatic diseases

1765

8779

2.06

166.40

2.1

1.9

1.80

2.21

ug/l

0.68

1575

7710

Hypokalaemia

550

1563

3.81

166.25

2.4

1.8

2.19

2.42

ug/l

0.15

489

1360

Low back pain

2220

8442

1.93

165.13

2.1

1.9

1.71

2.26

ug/l

2.15

1950

7455

Dialysis

275

454

7.16

164.86

2.9

1.8

3.73

1.91

ug/l

0.66

264

407

Other disorders of skin and subcutaneous tissue, not elsewhere classified

656

2109

3.35

163.03

2.3

1.9

2.56

2.51

ug/l

0.03

559

1846

Other diseases of urinary system

2901

9320

1.78

160.00

2.1

2.0

2.23

2.07

ug/l

0.28

2534

8246

Ulcer of lower limb, not elsewhere classified

709

2421

3.18

159.61

2.2

1.9

2.11

2.49

ug/l

0.36

641

2110

Gout, strict definition

875

3344

2.82

159.46

2.2

1.9

2.20

2.27

ug/l

0.05

784

2917

Asthma (diagnoses ohter than nonallergic)

2545

11904

1.81

159.33

2.1

2.0

1.96

2.31

ug/l

0.81

2254

10443

Other special examinations and investigations of persons without complaint or reported diagnosis

1898

4729

2.08

159.13

2.1

1.8

2.08

2.54

ug/l

0.74

1645

4213

GI-bleeding

1287

5853

2.30

157.16

2.2

1.9

2.48

2.13

ug/l

0.35

1134

5083

Other diseases of pericardium

286

512

6.44

157.07

2.7

1.9

0.76

2.52

ug/l

1.63

261

459

Other arthritis (FG)

995

4031

2.56

157.00

2.0

1.9

1.48

2.20

ug/l

1.67

889

3575

Other diseases of the digestive system

1281

5819

2.30

156.93

2.2

1.9

2.49

2.16

ug/l

0.32

1126

5055

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

451

1180

4.27

155.66

2.4

1.9

1.25

2.09

ug/l

1.12

385

1007

Hyperkalaemia

360

795

5.15

155.65

2.6

1.9

2.22

2.90

ug/l

0.39

322

679

Acute upper respiratory infections of multiple and unspecified sites

2111

8329

1.92

155.48

2.1

2.0

1.65

2.33

ug/l

2.75

1866

7345

Convulsions, not elsewhere classified

660

2138

3.16

154.84

2.2

1.8

2.55

2.26

ug/l

0.25

572

1873

Examination and observation for other reasons

1673

4653

2.13

154.79

2.1

1.8

2.58

2.50

ug/l

0.07

1508

4155

Other pleural conditions

548

1641

3.67

154.22

2.2

1.8

4.34

2.74

ug/l

0.26

500

1415

Unspecified kidney failure

537

1588

3.71

153.93

2.6

1.7

3.83

2.01

ug/l

1.06

491

1348

Myocardial infarction, without ST-elevation

1607

7271

2.10

153.83

2.0

1.9

2.23

2.24

ug/l

0.01

1414

6308

Chronic ulcer of skin, not elsewhere classified

412

1029

4.52

151.93

2.5

1.9

2.89

2.29

ug/l

0.29

359

896

ILD, hospital admissions 1, main diag only

680

2340

3.17

151.49

2.4

1.9

1.88

2.59

ug/l

0.51

622

2027

Lung diseases due to external agents

692

2401

3.11

151.10

2.3

1.9

2.41

2.50

ug/l

0.06

607

2062

Presence of other functional implants

1933

7009

1.97

149.72

2.0

1.9

2.24

2.25

ug/l

0.01

1683

6162

Fall on same level

3114

10084

1.71

149.38

2.1

2.0

2.22

2.31

ug/l

0.12

2729

8988

Factors influencing health status and contact with health services

862

1509

2.94

148.54

2.0

1.7

1.74

2.95

ug/l

1.34

760

1361

Cellulitis

815

3090

2.77

148.50

2.5

1.9

2.22

2.14

ug/l

0.07

737

2721

Gastrointestinal diseases

1377

3064

2.29

147.24

2.0

1.8

2.00

2.18

ug/l

0.20

1221

2644

Concussion

1322

4983

2.21

146.54

2.0

1.9

1.65

2.46

ug/l

1.21

1148

4479

COPD, early/later onset

1711

7406

2.02

146.42

2.1

1.9

1.77

2.20

ug/l

1.18

1511

6488

Unspecified acute lower respiratory infection

616

2032

3.22

145.77

2.6

1.9

1.41

2.41

ug/l

1.49

570

1799

Secondary and unspecified malignant neoplasm of lymph nodes

400

1002

4.39

145.55

2.4

1.7

1.73

1.61

ug/l

0.07

367

867

Injuries to the head

3112

11515

1.69

145.33

2.0

2.19

2.30

ug/l

0.16

2682

10206

AV-block

725

2259

2.97

145.22

2.1

1.8

1.52

2.51

ug/l

1.95

613

1950

Angina pectoris

1824

6287

1.99

144.66

2.1

1.9

1.95

2.41

ug/l

0.83

1633

5498

Retention of urine

1359

5285

2.20

144.21

2.0

1.9

2.64

1.99

ug/l

0.86

1165

4666

COPD, hospital admissions

1695

7379

2.02

144.04

2.1

1.9

1.75

2.20

ug/l

1.30

1497

6460

Myocardial infarction, strict

1576

5555

2.09

143.78

2.1

1.9

1.92

2.41

ug/l

0.73

1406

4832

Other chronic obstructive pulmonary disease, including avohilmo

1905

8426

1.93

143.12

2.1

2.0

1.76

2.29

ug/l

1.77

1681

7408

Diabetic nephropathy, excluding more controls

660

1844

3.18

142.88

2.4

2.0

3.40

2.14

ug/l

1.10

610

1606

Anaemia in chronic diseases classified elsewhere

208

303

8.66

142.21

2.8

1.8

2.38

1.46

ug/l

0.69

198

264

Purpura and other haemorrhagic conditions

584

1909

3.28

141.07

2.5

1.9

2.27

2.33

ug/l

0.04

534

1678

Biguanides

2718

9693

1.74

140.95

2.0

1.93

2.33

ug/l

0.99

2434

8483

Valvular operations

580

1889

3.27

140.36

2.2

1.8

1.61

2.31

ug/l

1.08

492

1658

Seropositive rheumatoid arthritis

857

3405

2.62

140.20

2.0

1.9

1.67

2.25

ug/l

0.73

767

3002

Other arrhythmias

1579

5952

2.04

140.19

2.0

1.9

1.52

2.24

ug/l

2.68

1392

5259

Benzodiazepine use

2869

11826

1.70

140.05

2.1

2.0

2.01

2.31

ug/l

0.68

2483

10459

Disorders of lens

2084

7076

1.89

139.49

2.1

2.0

3.16

2.06

ug/l

0.81

1865

6368

Endocarditis

238

402

6.90

139.08

2.7

1.7

1.84

3.18

ug/l

0.67

215

357

Amputation

534

1684

3.47

138.20

2.3

1.9

2.11

2.42

ug/l

0.25

484

1436

COPD related to multimorbidity

1532

6543

2.06

137.48

2.1

1.9

1.82

2.20

ug/l

0.91

1351

5709

Diarrhoea and gastroenteritis of presumed infectious origin

2805

11033

1.71

137.36

2.2

1.9

2.65

2.15

ug/l

0.44

2500

9652

Diseases of the skin and subcutaneous tissue

2774

8138

1.74

137.16

2.1

1.9

2.21

2.28

ug/l

0.09

2457

7099

Symptoms and signs involving cognition, perception, emotional state and behaviour

2747

11144

1.71

136.99

2.1

2.0

2.02

2.33

ug/l

0.58

2366

9898

All influenza (not pneumonia)

457

1297

3.69

136.60

2.3

1.7

1.67

2.67

ug/l

0.98

408

1126

Dermatitis

1831

9880

1.89

135.59

2.2

1.9

1.76

2.35

ug/l

1.59

1649

8669

Neurological diseases, wide definition

668

1056

3.24

135.30

2.2

1.8

1.69

2.24

ug/l

0.38

596

942

Other systemic involvement of connective tissue

954

4069

2.45

135.24

2.1

1.9

1.23

2.45

ug/l

4.15

823

3551

Sequelae with surgical and medical care as external cause

813

3246

2.65

134.20

2.6

1.9

1.91

2.29

ug/l

0.48

745

2847

Hypothyroidism, drug reimbursement

260

294

6.41

133.76

2.7

1.5

2.19

1.51

ug/l

0.46

238

255

Iron deficiency anaemia secondary to blood loss (chronic)

682

2504

2.90

133.27

2.2

1.9

2.80

2.16

ug/l

0.55

600

2156

Obesity related asthma

1086

4917

2.29

133.20

2.3

2.0

1.98

2.22

ug/l

0.24

971

4361

Coagulation defects, purpura and other haemorrhagic conditions

727

2757

2.78

132.73

2.6

1.9

2.33

2.44

ug/l

0.08

654

2420

Misadventures to patients during surgical and medical care

571

1913

3.18

131.77

2.6

1.9

1.72

2.44

ug/l

0.86

503

1696

Pacemaker

1328

6274

2.12

131.31

2.1

1.9

2.00

2.22

ug/l

0.35

1124

5431

Abnormal findings on examination of blood, without diagnosis

1645

7982

1.96

130.90

2.2

2.0

2.32

2.07

ug/l

0.30

1478

7035

Peripheral artery operations in Hilmo

609

2132

3.07

130.59

2.2

1.9

2.16

2.64

ug/l

0.43

554

1817

Genitourinary diseases

1548

3808

2.08

130.43

2.2

1.9

2.55

1.61

ug/l

1.41

1389

3389

Peripheral arterial reconstruction

793

3184

2.67

130.38

2.2

1.9

2.26

2.47

ug/l

0.21

704

2758

Cutaneous abscess, furuncle and carbuncle

835

3406

2.55

130.18

2.4

2.0

3.02

2.17

ug/l

0.59

773

3005

Cerebrovascular diseases

2371

9712

1.76

129.43

2.1

2.0

2.07

2.18

ug/l

0.14

2015

8629

Mental and behavioural disorders due to psychoactive substance use

1793

9054

1.88

128.61

2.2

2.0

2.38

2.12

ug/l

0.49

1592

8052

Undetermined asthma, excluding more controls

349

854

4.26

128.42

2.2

1.7

1.52

3.10

ug/l

1.15

315

736

Vocal cord dysfunction

369

825

4.17

128.21

2.4

1.8

1.40

1.96

ug/l

0.57

323

750

Protozoal diseases

225

397

6.88

127.17

3.1

2.0

0.92

2.03

ug/l

0.78

210

357

Diseases of liver

1149

5428

2.20

127.01

2.4

2.0

2.36

2.18

ug/l

0.24

1045

4815

Nerve, nerve root and plexus disorders

3010

11408

1.64

126.43

2.1

2.0

2.34

2.23

ug/l

0.15

2654

10023

Other specified/unspecified arthritis

864

3630

2.47

126.13

2.0

1.9

1.37

2.14

ug/l

1.86

767

3221

Disorders of mineral metabolism

375

1002

4.06

124.38

2.7

1.9

2.45

2.56

ug/l

0.04

342

891

Candidiasis

513

1674

3.26

123.70

2.8

1.9

1.78

2.10

ug/l

0.34

460

1482

Hyperlipidaemia, other/unspecified

1319

6067

2.07

123.56

1.9

2.13

2.32

ug/l

0.23

1177

5321

Substance abuse

1740

8950

1.87

123.39

2.2

2.0

2.31

2.12

ug/l

0.34

1545

7972

Diverticular disease of intestine

2149

7831

1.79

123.34

2.0

1.9

1.72

2.31

ug/l

1.49

1895

6876

Other infectious diseases

400

1129

3.90

123.30

2.6

1.9

2.30

2.39

ug/l

0.03

366

982

Spondylopathies

2332

8108

1.75

123.04

2.0

1.9

2.04

2.28

ug/l

0.35

2035

7145

Lower back pain or/and sciatica

2912

11802

1.64

122.37

2.1

2.0

1.77

2.36

ug/l

2.15

2562

10386

Any mental disorder

3000

9277

1.65

121.12

2.1

2.0

2.13

2.30

ug/l

0.25

2610

8254

Noninfective enteritis and colitis

1348

6845

2.02

120.94

2.2

2.0

3.55

2.11

ug/l

0.69

1209

6037

Cardiac arrest

272

473

5.28

120.72

2.5

1.7

3.99

2.33

ug/l

0.53

239

411

Acute peritonitis

356

944

4.21

120.71

2.7

1.9

3.40

1.74

ug/l

1.59

340

819

Asthma/COPD (KELA code 203)

2546

10538

1.68

120.24

2.0

2.22

2.34

ug/l

0.16

2263

9257

Non-allergic asthma (mode), excluding more controls

444

1330

3.41

119.20

2.2

1.7

2.43

2.62

ug/l

0.07

397

1155

Other necrotizing vasculopathies (FG)

312

760

4.56

118.41

2.2

1.9

1.36

2.11

ug/l

0.64

272

672

Fitting and adjustment of other devices

1159

5064

2.14

117.70

2.0

1.8

1.65

2.31

ug/l

1.49

952

4363

Dorsalgia

2651

8600

1.68

117.29

2.1

1.9

1.75

2.27

ug/l

1.72

2326

7580

Other necrotizing vasculopathies

367

1013

4.01

117.18

2.1

1.9

1.41

2.11

ug/l

0.65

321

884

Rheumatoid arthritis, including avohilmo

1200

5950

2.09

116.35

2.1

1.9

1.53

2.30

ug/l

1.69

1069

5211

Cough

1125

5125

2.13

116.01

2.2

1.9

2.11

2.39

ug/l

0.26

990

4515

Colorectal cancer

822

3434

2.45

115.93

2.0

1.8

1.83

2.07

ug/l

0.33

738

2969

Pneumonitis due to solids and liquids

438

1365

3.51

115.72

2.5

1.9

2.42

2.53

ug/l

0.06

376

1173

Suppurative and necrotic conditions of lower respiratory tract

331

862

4.34

115.67

2.8

1.9

2.01

2.24

ug/l

0.11

303

757

Cytomegalovirus infection, IBD co-morbidity

174

260

8.19

115.64

3.6

2.0

1.92

2.52

ug/l

0.19

163

238

Other CVD

839

3641

2.44

115.60

2.1

1.9

1.87

2.51

ug/l

0.93

709

3135

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

369

1027

3.86

115.00

2.4

1.9

2.70

2.08

ug/l

0.33

328

911

Type 1 diabetes, wide definition, subgroup 1

611

2279

2.78

113.92

2.4

1.9

3.03

2.12

ug/l

1.03

567

1992

Undetermined asthma

349

933

3.90

113.64

2.2

1.7

1.52

3.12

ug/l

1.31

315

807

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2727

10860

1.64

113.46

2.2

1.9

2.43

2.22

ug/l

0.30

2412

9566

Cytomegaloviral disease

174

265

7.95

113.38

3.6

2.0

1.92

2.48

ug/l

0.18

163

241

Ascites

356

981

3.97

113.36

2.4

1.9

1.58

2.33

ug/l

0.62

338

849

Disorders of calcium metabolism

300

732

4.50

113.15

2.8

2.0

2.59

2.32

ug/l

0.09

271

651

Acute upper respiratory infections

2846

11004

1.62

112.84

2.1

1.9

1.76

2.43

ug/l

2.26

2495

9664

Other and unspecified dermatitis

1489

8028

1.90

112.08

2.2

1.9

1.74

2.15

ug/l

1.06

1340

7040

Cholelithiasis, broad definition with cholecystitis

2446

10033

1.67

111.44

2.1

1.9

2.35

2.17

ug/l

0.25

2176

8766

Gastroduodenal ulcer

997

4688

2.21

111.26

2.3

1.9

2.60

2.12

ug/l

0.52

896

4083

Non-follicular lymphoma

466

1544

3.30

111.20

2.7

1.9

2.60

2.62

ug/l

0.01

433

1358

Viral infections characterized by skin and mucous membrane lesions

1229

6243

2.02

110.59

2.2

2.0

3.66

2.22

ug/l

0.61

1109

5505

Non-Hodgkin lymphoma, all

258

577

5.09

110.02

3.0

1.7

2.82

1.65

ug/l

0.49

243

498

Other complications of surgical and medical care, not elsewhere classified

383

1124

3.64

109.98

2.6

1.9

3.27

2.14

ug/l

0.47

348

1003

Other antidepressants

2881

9259

1.62

109.97

2.1

2.0

1.97

2.38

ug/l

0.88

2486

8219

Sulfasalazine

789

3381

2.41

109.79

2.1

1.9

1.66

2.24

ug/l

0.62

688

2988

Calcific aortic valvular stenosis, operated

1183

5802

2.07

109.21

2.1

1.9

2.12

2.25

ug/l

0.16

1025

4990

Calcific aortic valvular stenosis

1183

5802

2.07

109.21

2.1

1.9

2.12

2.25

ug/l

0.16

1025

4990

Operations 2 for CAVS

1180

5798

2.06

108.35

2.1

1.9

2.12

2.25

ug/l

0.17

1022

4987

Calcific aortic valvular stenosis, diagnosis (helper)

1180

5798

2.06

108.35

2.1

1.9

2.12

2.25

ug/l

0.17

1022

4987

Unspecified haematuria

1437

6375

1.93

108.08

2.1

2.0

2.66

2.05

ug/l

0.91

1228

5655

Persons encountering health services for examination and investigation

1730

4729

1.87

108.06

2.0

1.8

1.90

2.54

ug/l

1.17

1513

4213

Disorders of other endocrine glands

1241

6271

2.00

107.88

2.3

1.9

2.37

2.20

ug/l

0.15

1102

5468

Malignant neoplasm of bronchus and lung, including Hilmo

797

2868

2.44

107.58

2.0

1.9

1.81

1.80

ug/l

0.01

721

2475

Calcific aortic valvular stenosis, including rheumatic fever

1180

5809

2.06

107.45

2.1

1.9

2.12

2.25

ug/l

0.16

1022

4997

Other/unspecified cytomegaloviral diseases

154

219

8.73

107.30

3.5

2.1

2.10

2.81

ug/l

0.20

146

201

Supplementary factors related to causes of morbidity and mortality classified elsewhere

961

4518

2.20

107.29

2.3

2.0

2.62

2.20

ug/l

0.35

828

3984

Type 1 diabetes

720

2996

2.48

106.76

2.3

1.9

2.74

2.04

ug/l

0.92

671

2611

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

659

2631

2.56

105.63

2.2

2.0

2.25

2.07

ug/l

0.15

573

2350

1784

9047

1.78

105.59

2.2

2.0

2.45

2.07

ug/l

0.81

1587

8038

Senile cataract

1880

6614

1.78

105.18

2.2

2.0

3.17

2.06

ug/l

0.71

1669

5942

Covid-19 suspected case

575

2174

2.74

104.47

2.1

1.9

1.36

2.17

ug/l

1.56

523

1936

Stroke, including SAH

2030

8750

1.73

104.34

2.1

1.9

2.25

2.17

ug/l

0.08

1731

7720

Substance use, excluding alcohol

594

2301

2.68

103.20

2.2

2.0

1.88

2.21

ug/l

0.35

531

2056

Malignant neoplasm of respiratory system and intrathoracic organs

774

2784

2.42

103.11

2.0

1.9

1.77

1.79

ug/l

0.01

699

2404

Diseases of peritoneum

444

1489

3.21

103.01

2.6

1.9

3.16

2.35

ug/l

0.60

414

1304

Cholangitis (primary sclerosing, PSC)

305

810

4.13

102.63

2.2

1.9

2.90

2.36

ug/l

0.28

280

694

Disorders resulting from impaired renal tubular function

227

486

5.41

102.61

2.8

2.0

2.73

1.92

ug/l

0.44

216

435

1714

8905

1.78

102.52

2.2

2.0

2.46

2.09

ug/l

0.75

1522

7916

Other reaction to severe stress, and adjustment disorders

861

3932

2.24

102.51

2.2

2.0

1.76

1.97

ug/l

0.27

784

3495

Neurological diseases

2097

6187

1.73

102.19

2.1

1.9

2.30

2.35

ug/l

0.05

1853

5514

Alcohol use disorder, Swedish definition

1642

8601

1.79

100.73

2.2

2.0

2.32

2.14

ug/l

0.31

1460

7649

Certain disorders involving the immune mechanism

645

2639

2.56

100.63

2.6

1.9

1.98

2.24

ug/l

0.20

591

2343

External causes of morbidity and mortality

1621

4444

1.86

99.99

2.0

1.9

2.42

2.40

ug/l

0.02

1441

3953

Diffuse large B-cell lymphoma

244

563

4.88

99.86

2.6

1.7

3.45

1.82

ug/l

0.64

223

492

Diffuse large B-cell lymphoma, including Hilmo

244

563

4.88

99.86

2.6

1.7

3.45

1.82

ug/l

0.64

223

492

Diffuse large B-cell lymphoma, helper endpoint

244

563

4.88

99.86

2.6

1.7

3.45

1.82

ug/l

0.64

223

492

Thrombocytopenia, unspecified

348

1031

3.70

99.69

2.5

1.9

2.33

2.15

ug/l

0.08

320

908

Symptoms and signs concerning food and fluid intake

346

1010

3.61

99.31

2.2

1.7

2.90

2.36

ug/l

0.27

299

880

Falls/tendency to fall

2727

8665

1.60

98.50

2.1

2.0

2.36

2.34

ug/l

0.03

2389

7732

Pyothorax

265

663

4.57

98.21

2.8

1.9

1.92

2.46

ug/l

0.24

245

579

Acute sinusitis

1250

6122

1.93

97.96

2.2

2.0

1.94

2.33

ug/l

0.60

1106

5443

Other and unspecified drugs and medicaments

354

1068

3.57

97.82

2.4

2.0

2.68

2.07

ug/l

0.30

315

946

Other dialysis

195

382

5.97

97.80

2.5

2.0

1.95

1.38

ug/l

0.44

187

345

Hypotension

722

3160

2.42

97.76

2.0

1.8

1.94

2.58

ug/l

0.81

614

2712

Type 1 diabetes, wide definition

623

2534

2.54

97.24

2.4

1.9

2.98

2.15

ug/l

0.96

579

2208

Extreme obesity with alveolar hypoventilation

228

510

5.06

97.13

2.5

2.0

1.88

1.60

ug/l

0.14

203

454

Non-allergic asthma (mode)

444

1503

3.01

97.06

2.2

1.7

2.43

2.72

ug/l

0.11

397

1316

COPD-related respiratory insufficiency

532

2034

2.81

96.94

2.4

1.8

1.79

2.44

ug/l

0.66

458

1757

Osteomyelitis

323

934

3.80

96.19

2.4

1.9

2.21

2.43

ug/l

0.11

287

826

Candidiasis

821

3787

2.24

96.19

2.5

1.9

1.64

2.24

ug/l

1.13

716

3339

Non-small cell lung cancer, including Hilmo

584

2189

2.65

95.84

1.9

1.8

1.77

1.90

ug/l

0.09

530

1880

Stroke, excluding SAH

1934

8480

1.71

95.72

2.1

2.0

2.28

2.20

ug/l

0.08

1651

7467

Multiple myeloma, including Hilmo

244

583

4.71

95.52

2.4

1.8

2.15

1.71

ug/l

0.27

222

503

Other noninfective gastroenteritis and colitis

765

3446

2.30

95.03

2.2

1.9

2.44

2.21

ug/l

0.16

686

3012

Use of hypnotics and sedatives

2851

10677

1.56

94.48

2.2

2.0

2.26

2.13

ug/l

0.20

2527

9426

Decubitus ulcer and pressure area

326

962

3.74

94.33

2.7

1.8

2.23

2.48

ug/l

0.12

289

833

Other viral diseases

749

3340

2.30

94.15

2.5

2.0

1.60

2.19

ug/l

1.04

679

2959

Persons encountering health services in other circumstances, wide

3117

10645

1.53

93.27

2.1

2.0

1.67

2.46

ug/l

3.33

2781

9324

Acute pancreatitis

685

2980

2.40

93.20

2.3

1.9

2.67

2.24

ug/l

0.43

615

2610

Amputation of toe

372

1204

3.40

92.85

2.3

1.9

2.24

2.57

ug/l

0.20

338

1047

Intracranial injury

1656

9187

1.74

92.74

2.1

2.0

1.78

2.21

ug/l

0.90

1401

8115

Type of accident

874

4199

2.15

92.32

2.2

1.9

2.49

2.23

ug/l

0.20

747

3709

Early onset COPD

766

3511

2.28

92.07

2.3

2.0

1.90

2.23

ug/l

0.41

702

3124

Cholelithiasis

2281

9897

1.62

91.77

2.0

1.9

2.35

2.17

ug/l

0.24

2017

8640

Adrenocortical insufficiency

196

405

5.46

91.67

2.9

2.0

1.74

1.96

ug/l

0.10

177

361

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

837

3988

2.18

90.85

2.1

1.9

1.69

2.30

ug/l

0.76

749

3509

Poisoning by drugs, medicaments and biological substances

620

2604

2.46

90.38

2.2

2.0

2.80

2.15

ug/l

0.41

544

2321

Pneumonia due to Streptococcus pneumoniae

185

365

5.54

90.34

2.3

1.7

3.89

2.39

ug/l

0.69

168

311

Mental and behavioural disorders due to alcohol

1478

8148

1.78

90.15

2.2

2.0

2.51

2.12

ug/l

0.71

1311

7262

Seropositive rheumatoid arthritis, wide

856

4125

2.15

90.15

2.0

1.9

1.67

2.28

ug/l

0.79

766

3628

Other/unspecified seropositive rheumatoid arthritis

848

4075

2.16

89.98

2.0

1.9

1.68

2.28

ug/l

0.77

760

3585

Cardiomyopathy

551

2211

2.60

89.35

2.2

1.8

4.49

2.25

ug/l

0.42

498

1959

Episodal and paroxysmal disorders

2786

9259

1.55

89.24

2.1

1.9

1.80

2.40

ug/l

1.50

2448

8153

Osteoporosis with pathological fracture (FG)

292

834

3.78

87.94

2.2

1.8

1.52

1.76

ug/l

0.26

257

710

Viral pneumonia (known virus, not influenza)

171

328

6.09

87.80

2.7

1.8

2.44

2.31

ug/l

0.03

150

289

Other diseases of biliary tract

368

1216

3.25

87.63

2.2

1.9

2.09

2.47

ug/l

0.26

342

1045

Pain (limb, back, neck, head abdominally)

1890

5652

1.70

86.98

2.0

1.9

1.94

2.37

ug/l

0.71

1659

4939

Asthma, hospital admissions , main diagnosis only

2125

11864

1.61

86.90

2.1

2.0

2.02

2.28

ug/l

0.39

1877

10409

Mood disorders, excluding more controls

2347

8926

1.59

86.88

2.1

2.0

2.03

2.31

ug/l

0.49

2076

7954

ILD-related respiratory insufficiency

223

542

4.82

86.68

3.1

1.8

2.36

2.77

ug/l

0.11

199

474

Other neurological diseases

2125

10556

1.61

86.41

2.1

2.0

2.08

2.20

ug/l

0.18

1857

9251

Continuous positive airway pressure

438

1308

2.90

86.33

2.0

1.7

1.10

2.31

ug/l

1.52

370

1160

Other retinal disorders

1948

9406

1.65

86.03

2.1

2.0

2.90

2.06

ug/l

1.39

1688

8274

Other dorsopathies, not elsewhere classified

2542

8605

1.57

85.56

2.1

1.9

1.70

2.27

ug/l

1.79

2209

7585

Malignant neoplasm of bronchus and lung

665

2424

2.38

85.48

2.0

1.8

1.91

1.87

ug/l

0.03

600

2083

Injuries to the abdomen, lower back, lumbar spine and pelvis

1183

6401

1.88

85.31

2.3

1.9

2.31

2.29

ug/l

0.02

1012

5585

Dizziness and giddiness

2051

10215

1.62

85.30

2.0

1.72

2.36

ug/l

1.64

1787

9058

Other viral diseases

873

4271

2.07

85.14

2.3

2.0

1.60

2.17

ug/l

1.19

794

3780

Status post-ami

938

3589

2.07

84.32

2.0

1.9

2.05

2.45

ug/l

0.41

828

3061

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1309

7374

1.81

84.27

2.2

2.0

2.35

2.14

ug/l

0.30

1158

6582

Other disorders of adrenal gland

210

493

4.69

83.52

2.8

2.0

1.68

1.81

ug/l

0.07

191

441

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

397

1414

3.00

82.65

2.6

2.0

2.60

2.16

ug/l

0.25

352

1254

Gastric ulcer

667

3023

2.31

82.60

2.4

1.9

2.35

2.06

ug/l

0.30

601

2633

Schizophrenia or delusion, excluding more controls

753

3522

2.17

82.41

2.2

2.0

1.99

2.04

ug/l

0.05

674

3144

Diabetic retinopathy, excluding more controls

856

2286

2.19

82.27

2.3

2.0

2.84

2.03

ug/l

0.98

782

2006

Diseases of the myoneural junction and muscle

473

1848

2.71

82.05

2.2

2.0

2.60

2.17

ug/l

0.33

384

1626

Polyneuropathies and other disorders of the peripheral nervous system

767

3691

2.17

81.63

2.5

2.0

2.02

2.30

ug/l

0.34

693

3231

Polymyalgia rheumatica

538

2244

2.55

81.48

2.0

1.9

1.07

2.37

ug/l

2.99

458

1927

Ischaemic Stroke, excluding all haemorrhages

1796

8225

1.67

81.35

2.0

1.9

2.33

2.22

ug/l

0.13

1534

7212

Chronic pancreatitis

466

1817

2.72

81.09

2.4

1.9

2.80

2.44

ug/l

0.21

438

1604

Cystitis

2157

8148

1.60

80.87

2.0

1.9

2.29

2.02

ug/l

0.43

1870

7176

Alcohol use disorder, ICD-based

1215

6815

1.83

80.84

2.2

2.0

2.30

2.17

ug/l

0.17

1076

6076

Secondary thrombocytopenia

109

146

9.52

80.44

3.1

1.9

4.59

3.65

ug/l

0.13

104

133

Disorders of choroid and retina

2307

10692

1.56

80.34

2.1

2.0

2.56

2.17

ug/l

0.55

2004

9442

Epilepsy

899

4573

2.01

80.20

2.6

1.9

2.42

2.34

ug/l

0.07

769

4011

Poisoning by medicine

552

2329

2.44

79.75

2.2

2.0

2.93

2.04

ug/l

0.57

492

2073

Dermatitis and eczema

2842

11941

1.49

79.73

2.2

2.0

1.89

2.34

ug/l

1.27

2541

10471

Soft tissue disorders

2581

8755

1.54

79.71

2.0

1.82

2.49

ug/l

1.51

2276

7696

Colorectal adenocarcinoma

649

2943

2.29

79.53

1.9

1.98

2.02

ug/l

0.03

584

2539

Obesity, other/unspecified

821

4064

2.07

79.52

2.3

2.0

1.83

2.21

ug/l

0.53

735

3603

Sequelae of cerebrovascular disease

1222

5936

1.83

78.94

2.0

1.9

2.43

2.30

ug/l

0.09

968

5193

Psychiatric diseases

2551

8420

1.54

78.26

2.1

2.0

2.18

2.36

ug/l

0.25

2229

7514

Allergic asthma (mode), excluding more controls

380

1309

2.89

78.17

2.1

1.7

2.21

2.72

ug/l

0.26

347

1144

Morphin

138

242

6.68

77.95

1.8

1.00

1.72

ug/l

0.62

119

216

Acute pancreatitis (for exclusion)

685

3222

2.22

77.21

2.3

1.9

2.67

2.32

ug/l

0.34

615

2830

Disorders of thyroid, IBD co-morbidities

371

871

3.06

77.04

2.2

1.8

0.89

2.31

ug/l

1.88

326

785

Sleep apnoea

2463

10598

1.53

76.93

2.1

2.0

1.84

2.29

ug/l

0.99

2151

9422

Other and unspecified polyneuropathies, also in other diseases

689

3260

2.21

76.84

2.5

1.9

2.04

2.39

ug/l

0.38

620

2852

Spinal stenosis

1548

7070

1.70

76.71

2.0

1.9

2.20

2.30

ug/l

0.10

1328

6229

Injuries to the hip and thigh

1452

7839

1.72

76.63

2.2

1.9

2.60

2.19

ug/l

0.49

1229

6863

Abnormalities of heart beat

907

4615

1.97

76.44

1.9

1.86

2.35

ug/l

0.49

786

4034

Gonarthrosis [arthrosis of knee](FG)

1958

7161

1.62

76.38

2.0

2.30

2.40

ug/l

0.10

1702

6339

Idiopathic pulmonary fibrosis

375

1362

3.00

76.16

2.3

1.9

1.23

2.43

ug/l

1.47

341

1173

Malignant neoplasm of pancreas, including Hilmo

332

1120

3.17

76.15

2.3

1.7

1.87

1.77

ug/l

0.06

303

955

Diabetic maculopathy, excluding more controls

387

1416

2.88

76.06

2.1

1.9

1.85

2.41

ug/l

0.50

356

1227

Pericarditis

174

379

5.07

76.06

2.4

1.9

0.65

2.12

ug/l

1.17

158

335

Asthma, including avohilmo

3011

11656

1.47

76.06

2.1

2.0

2.06

2.33

ug/l

0.53

2680

10219

COPD, hospital admissions 1, only main diagnosis

1200

5820

1.82

76.06

2.1

1.9

1.61

2.22

ug/l

1.79

1064

5056

Anxiety disorders, excluding more controls

1929

7912

1.61

75.99

2.2

1.9

2.08

2.39

ug/l

0.49

1703

7058

Injuries to the thorax

1360

8020

1.74

75.78

2.2

2.0

2.05

2.15

ug/l

0.12

1180

7051

Delirium, not induced by alcohol and other psychoactive substances

496

2063

2.54

75.22

2.5

1.9

1.69

2.22

ug/l

0.61

423

1806

Spondyloarthritis

543

2344

2.40

74.84

2.2

1.9

1.71

2.41

ug/l

0.44

485

2054

Accidents

2026

6411

1.60

74.75

2.0

2.20

2.38

ug/l

0.17

1769

5717

Dysphagia

741

3626

2.11

74.71

2.2

1.9

1.56

2.37

ug/l

1.62

642

3157

Other external causes of accidental injury

2025

6411

1.60

74.56

2.0

2.26

2.38

ug/l

0.11

1764

5717

Other (seronegative) rheumatoid arthritis, wide

617

2837

2.27

73.63

2.2

1.9

1.65

2.26

ug/l

0.53

541

2484

Haemorrhage, not elsewhere classified

175

395

4.86

73.09

2.2

1.7

3.43

1.88

ug/l

0.33

159

344

Other/unspecified rheumatoid arthritis

454

1839

2.61

72.98

2.2

1.9

1.91

2.10

ug/l

0.10

402

1599

Pyogenic arthritis

282

887

3.41

72.95

2.4

1.9

2.30

2.38

ug/l

0.03

257

793

Other cataract

1275

5581

1.77

72.87

2.0

3.10

1.98

ug/l

0.47

1130

5003

Immunodeficiency with predominantly antibody defects

139

261

6.02

72.47

3.3

2.1

1.12

2.53

ug/l

0.68

133

243

Personality disorders, excluding more controls

548

2401

2.33

72.22

2.2

2.0

2.71

1.93

ug/l

0.78

500

2156

Familial hypercholesterolemia

550

2436

2.37

72.16

2.1

1.9

2.47

2.60

ug/l

0.09

488

2102

Malignant neoplasm of colon

506

2162

2.45

72.03

2.0

1.8

1.47

1.95

ug/l

1.07

452

1851

Malignant neoplasm of colon, including Hilmo

607

2795

2.26

71.96

2.0

1.8

1.44

2.18

ug/l

1.98

545

2407

Other symptoms and signs involving the digestive system and abdomen

466

1914

2.52

71.72

2.0

1.9

2.04

2.25

ug/l

0.15

404

1668

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

543

2404

2.38

71.59

2.3

2.0

2.75

2.36

ug/l

0.33

492

2138

Discitis, unspecified

122

208

7.06

71.42

2.6

2.0

4.21

2.47

ug/l

0.24

116

187

Other and unspecified myopathies

367

1363

2.88

70.87

2.2

1.9

2.51

2.32

ug/l

0.11

292

1192

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

659

3138

2.15

70.84

2.2

2.0

2.25

2.04

ug/l

0.19

573

2797

Diabetic nephropathy

666

3183

2.19

70.76

2.4

2.1

3.38

2.18

ug/l

1.09

615

2824

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

411

1600

2.65

70.67

2.3

2.0

2.57

1.94

ug/l

0.54

358

1437

Benign neoplasm of colon, rectum, anus and anal canal

1867

10470

1.58

70.61

2.1

2.0

2.04

2.21

ug/l

0.30

1655

9200

Noninfectious colitis NAS

438

1767

2.59

70.50

2.2

2.0

2.75

2.20

ug/l

0.25

388

1552

Viral hepatitis, IBD co-morbidity

145

284

5.33

70.49

2.4

1.9

1.59

3.63

ug/l

0.66

131

258

Disorders of oesophagus in diseases classified elsewhere

140

276

5.96

69.96

2.5

1.9

1.20

2.04

ug/l

0.35

129

241

malignant neoplasm of female genital organs

416

1632

2.64

69.87

2.0

1.8

3.48

2.42

ug/l

0.64

377

1375

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

767

3897

2.03

69.54

2.1

2.0

2.49

2.14

ug/l

0.32

693

3487

Glucagon-like peptide-1 (GLP-1) analogues

767

3897

2.03

69.54

2.1

2.0

2.49

2.14

ug/l

0.32

693

3487

Viral and other specified intestinal infections

474

1942

2.44

68.72

2.5

1.9

2.23

2.22

ug/l

0.01

425

1682

Non-small cell lung cancer

389

1495

2.73

68.50

2.0

1.8

2.28

2.02

ug/l

0.13

349

1274

Secondary malignant neoplasm of other and unspecified sites

120

211

6.79

67.99

2.1

1.8

3.10

2.11

ug/l

0.23

114

185

Hernia

2397

10907

1.49

67.92

2.1

2.0

2.15

2.30

ug/l

0.21

2118

9607

Injury, poisoning and certain other consequences of external causes

1243

3543

1.78

67.90

2.0

1.9

2.39

2.50

ug/l

0.06

1102

3137

Coxarthrosis [arthrosis of hip](FG)

1491

6424

1.66

67.77

2.0

1.9

2.69

2.48

ug/l

0.16

1295

5676

Viral and other specified intestinal infections

598

2685

2.19

67.57

2.4

1.9

2.78

2.13

ug/l

0.49

541

2327

Rare circulating lymphoid malignancy, including Hilmo

149

316

5.27

67.52

2.8

1.7

1.02

1.89

ug/l

0.94

143

275

Multiple myeloma and malignant plasma cell neoplasms

249

770

3.59

67.40

2.5

1.9

2.21

2.42

ug/l

0.09

227

670

Unstable angina pectoris

1142

5183

1.79

67.35

2.2

1.9

2.25

2.30

ug/l

0.04

1022

4438

Methotrexate

396

1554

2.65

67.25

2.1

1.9

1.72

2.38

ug/l

0.39

351

1369

Allergic asthma (mode)

380

1422

2.66

66.79

2.1

1.7

2.21

2.69

ug/l

0.25

347

1250

Tubulo-interstitial nephritis, not specified as acute or chronic

246

749

3.48

66.74

2.1

1.7

2.11

1.84

ug/l

0.13

220

635

Immunodeficiencies

201

539

4.06

66.70

3.3

2.0

1.44

1.84

ug/l

0.26

189

476

Persons encountering health services in other circumstances

1022

5729

1.81

66.64

1.9

2.0

1.47

2.28

ug/l

2.47

901

5051

Gastro-oesophageal reflux disease

1745

9690

1.58

66.47

2.1

2.0

1.96

2.18

ug/l

0.34

1511

8537

Cardiomyopathies, Primary/intrinsic

391

1538

2.66

66.46

2.3

1.8

5.65

2.34

ug/l

0.45

356

1363

Explicit fungal Sepsis

15.42

66.40

3.8

1.7

1.77

0.77

ug/l

0.93

Acute myeloid leukaemia and myelodysplastic syndromes

126

236

6.17

66.29

2.5

1.7

4.52

2.20

ug/l

0.46

113

198

Cardiomyopathy (excluding other)

402

1605

2.62

66.23

2.3

1.8

5.73

2.30

ug/l

0.48

366

1426

Diseases of the musculoskeletal system and connective tissue

1198

3411

1.78

65.73

2.0

2.06

2.40

ug/l

0.31

1063

3017

Open wound of head

1493

9005

1.63

65.43

1.9

2.0

2.37

2.19

ug/l

0.20

1268

7989

Phlebitis and thrombophlebitis (not including DVT)

672

3350

2.07

64.60

2.3

1.9

1.75

2.25

ug/l

0.64

596

2938

Other embolism and thrombosis

443

1874

2.48

64.60

2.3

1.9

1.65

2.30

ug/l

0.69

401

1641

Unspecified mental disorder

968

5423

1.82

64.35

2.1

2.0

2.29

2.10

ug/l

0.24

863

4811

Suicide or other Intentional self-harm

598

2852

2.15

64.30

2.3

2.0

2.40

2.14

ug/l

0.22

524

2547

Sensorineural hearing loss

2124

9691

1.51

63.84

1.9

2.0

2.32

2.29

ug/l

0.03

1816

8599

Complications of internal orthopaedic prosthetic devices, implants and grafts

703

3585

2.03

63.58

2.1

1.8

2.06

2.44

ug/l

0.26

595

3126

Glomerulonephritis

356

1372

2.74

63.52

2.8

2.0

5.09

2.08

ug/l

1.29

325

1218

Conductive and sensorineural hearing loss

2178

9941

1.50

63.28

1.9

2.0

2.23

2.28

ug/l

0.06

1864

8822

L01XE Protein kinase inhibitors

249

798

3.42

63.26

2.2

1.9

7.02

2.29

ug/l

0.42

235

716

Other disorders of kidney and ureter

465

2034

2.41

63.11

2.5

2.0

2.05

2.68

ug/l

0.58

430

1792

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2766

10557

1.44

62.97

2.1

2.0

1.67

2.44

ug/l

2.92

2462

9265

Cholecystitis

495

2221

2.33

62.93

2.3

1.8

2.16

2.45

ug/l

0.23

437

1913

Idiopathic gout

398

1634

2.61

62.91

2.3

1.9

1.30

2.66

ug/l

1.74

354

1424

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

215

631

3.72

62.65

2.2

1.7

2.74

1.46

ug/l

0.86

188

547

Arthropathies

2086

7003

1.53

62.57

2.0

2.29

2.36

ug/l

0.06

1823

6191

Unspecified fall

1362

8337

1.64

61.82

2.1

1.9

2.25

ug/l

0.00

1156

7330

Abnormal findings on diagnostic imaging of other body structures

424

1795

2.47

61.60

2.0

1.9

1.82

2.19

ug/l

0.29

371

1590

Benign neoplasms

2416

9160

1.47

61.57

2.0

2.04

2.15

ug/l

0.18

2116

8107

Drug-induced adrenocortical insufficiency

110

196

6.53

61.12

3.0

1.9

1.07

3.30

ug/l

0.85

102

178

Other diseases of anus and rectum

850

4651

1.87

61.10

2.1

1.9

2.44

2.20

ug/l

0.18

729

4063

Problems related to lifestyle

310

1130

2.86

61.09

2.2

2.0

2.89

2.61

ug/l

0.13

283

1009

Zoster [herpes zoster]

594

2903

2.13

60.66

2.3

1.9

5.31

2.22

ug/l

0.64

522

2520

Biological medication for rheuma

417

1758

2.45

60.58

2.0

2.1

1.44

2.08

ug/l

0.74

367

1595

Preparatory care for dialysis

212

634

3.70

60.39

2.1

2.0

3.03

2.55

ug/l

0.13

200

569

Drug-induced osteoporosis with pathological fracture

110

200

6.56

60.25

2.7

1.7

1.86

3.36

ug/l

0.46

174

Artificial opening status

222

681

3.52

60.11

3.3

1.8

2.94

2.78

ug/l

0.05

203

596

Shock, not elsewhere classified

10.03

59.98

4.8

1.6

13.88

2.61

ug/l

1.79

Unknown and unspecified causes of morbidity

210

618

3.56

59.81

2.1

1.7

2.75

2.79

ug/l

0.01

196

543

Other postsurgical states

234

741

3.36

59.77

2.2

1.8

3.21

2.23

ug/l

0.46

215

658

Coronary artery bypass grafting

868

3552

1.88

59.54

2.1

1.9

1.92

2.34

ug/l

0.50

763

3030

Sleep apnoea, including avohilmo

2479

10734

1.45

59.51

2.1

2.0

1.90

2.28

ug/l

0.79

2165

9543

Nonhereditary hypogammaglobulinemia

10.01

58.99

3.3

2.1

1.24

1.60

ug/l

0.18

Malignant neoplasm of pancreas

265

913

3.10

58.77

2.3

1.7

1.89

1.75

ug/l

0.08

241

778

Sub-endpoint used in defining T1D endpoints

800

4282

1.88

58.71

2.3

1.9

2.84

2.31

ug/l

0.67

744

3709

Other/unspecified dorsalgia

962

5483

1.77

58.61

2.1

1.9

2.24

2.34

ug/l

0.06

835

4817

Vascular disorders of the intestines

288

1041

2.96

58.57

2.3

1.8

2.80

2.62

ug/l

0.08

263

894

Kela-code for severe mental illness

883

4956

1.82

58.53

2.1

2.0

2.34

2.12

ug/l

0.26

788

4387

Secondary malignant neoplasm of respiratory and digestive organs

107

195

6.45

58.25

1.7

2.93

1.98

ug/l

0.22

171

Unspecified misadventure during surgical and medical care

235

763

3.34

58.13

2.7

2.0

1.92

2.20

ug/l

0.13

202

679

Multiple myeloma

142

329

4.87

58.08

2.4

1.7

3.41

1.92

ug/l

0.66

128

282

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

142

329

4.87

58.08

2.4

1.7

3.41

1.92

ug/l

0.66

128

282

Other intervertebral disc disorders

2044

8321

1.50

57.98

2.1

1.9

2.00

2.26

ug/l

0.43

1768

7344

Fracture of lumbar spine and pelvis

707

3726

1.96

57.79

2.3

1.9

1.83

2.42

ug/l

0.85

586

3211

Ventral hernia

724

3849

1.94

57.78

2.3

1.9

2.14

2.09

ug/l

0.04

649

3390

Dorsopathies

2438

8618

1.45

57.62

2.1

2.0

1.86

2.27

ug/l

0.80

2126

7597

Schizophrenia or delusion

753

4047

1.90

57.50

2.2

2.0

1.99

ug/l

0.00

674

3589

Myelodysplastic syndrome, including Hilmo

155

388

4.47

57.21

2.4

1.7

6.08

1.91

ug/l

0.63

132

333

Other viral diseases, not elsewhere classified

469

2125

2.27

57.20

2.2

2.0

1.35

2.61

ug/l

2.25

421

1882

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

253

863

3.13

57.15

2.2

1.7

2.61

1.62

ug/l

0.67

237

732

Chronic apical periodontitis

2756

11231

1.41

57.08

2.1

2.0

1.84

2.23

ug/l

1.35

2440

9875

Fracture of rib(s), sternum and thoracic spine

915

5248

1.79

56.92

2.2

2.0

2.02

2.22

ug/l

0.21

781

4610

Mental and behavioural disorders due to opioids

129

277

4.98

56.87

2.9

2.1

2.23

2.53

ug/l

0.09

117

251

Other specific joint derangements/joint disorders

1605

6706

1.57

56.78

2.1

2.0

2.02

2.32

ug/l

0.37

1398

5943

Neurotic, stress-related and somatoform disorders

1995

9481

1.49

56.74

2.2

2.0

2.08

2.27

ug/l

0.31

1766

8392

Other disorders of ear

2334

10690

1.45

56.52

1.9

2.0

2.39

2.22

ug/l

0.21

2011

9490

Schizophrenia, schizotypal and delusional disorders

756

4096

1.89

56.29

2.2

2.0

1.99

2.01

ug/l

0.02

673

3631

Gonarthrosis

1672

6207

1.56

56.00

2.0

1.9

2.34

2.37

ug/l

0.02

1454

5501

Missing teeth due to accident, extraction or parodontitis

1626

10140

1.54

55.68

2.1

2.0

2.20

2.32

ug/l

0.15

1381

9011

Mood disorders

2440

11160

1.43

55.46

2.2

2.0

2.07

2.31

ug/l

0.47

2158

9840

Anxiety disorders

2016

9606

1.48

55.43

2.2

2.0

2.06

2.29

ug/l

0.40

1781

8506

Depression

2215

10444

1.45

55.34

2.2

2.0

2.12

2.32

ug/l

0.32

1956

9219

Hernia of abdominal wall

1263

7929

1.63

55.32

2.2

2.0

2.12

2.16

ug/l

0.05

1137

7005

Exclusions for E4_PCOS_BROAD

456

2080

2.26

55.17

2.6

2.0

1.83

2.20

ug/l

0.43

412

1847

Crohn disease

357

1469

2.52

55.00

2.0

6.81

1.92

ug/l

0.66

330

1319

Pain in joint

1322

5247

1.63

54.91

2.1

2.0

1.92

2.40

ug/l

0.70

1158

4613

Fibrosis and cirrhosis of liver

292

1100

2.83

54.88

2.3

1.9

2.45

2.41

ug/l

0.02

263

975

Symptoms and signs involving the skin and subcutaneous tissue

1737

11444

1.51

54.67

2.1

2.0

1.94

2.27

ug/l

0.56

1524

10069

Exposure to unspecified factor

2422

12379

1.42

54.62

2.0

2.43

2.22

ug/l

0.31

2097

10940

Non-selective monoamine reuptake inhibitors

1001

5726

1.72

54.28

2.1

1.9

2.41

2.52

ug/l

0.08

865

5076

Shoulder lesions

1959

8078

1.49

54.03

2.0

1.86

2.52

ug/l

1.23

1744

7130

Mood [affective] disorders

2425

11150

1.42

54.03

2.2

2.0

2.08

2.30

ug/l

0.43

2148

9829

Familial hypercholesterolemia, with ischemic heart disease

363

1530

2.52

53.98

2.1

1.8

2.35

2.88

ug/l

0.33

322

1302

Alcohol abuse, main dg, excluding more controls

411

1817

2.34

53.76

2.1

2.0

3.14

2.39

ug/l

0.53

368

1638

Other obstructive and reflux uropathy

155

402

4.11

53.59

2.4

1.7

5.10

1.81

ug/l

0.93

143

347

Acidosis

122

270

5.17

53.06

2.3

2.0

2.59

2.49

ug/l

0.03

102

241

Hypercalcemia

197

610

3.54

53.01

3.2

1.9

2.35

1.86

ug/l

0.16

179

534

Other gastritis (incl. Duodenitis)

669

3568

1.93

52.89

2.2

1.9

2.67

2.10

ug/l

0.40

607

3138

Other and unspecified local infections of skin and subcutaneous tissue

315

1255

2.63

52.41

2.2

1.9

1.81

2.28

ug/l

0.38

284

1107

Traumatic subdural haemorrhage

442

1952

2.26

52.38

2.2

1.8

1.92

2.37

ug/l

0.42

368

1722

Speech therapy

758

4220

1.85

52.24

2.1

1.9

1.70

2.30

ug/l

1.09

710

3695

Status epilepticus

159

431

4.01

52.06

4.1

1.8

2.42

2.43

ug/l

0.00

133

373

Inflammatory bowel disease

769

4313

1.82

51.26

2.0

4.04

2.05

ug/l

0.53

691

3822

Other viral diseases, not elsewhere classified

582

2968

1.99

51.17

2.1

2.0

1.33

2.28

ug/l

2.15

526

2620

Coxarthrosis

1361

5751

1.59

51.15

2.0

1.9

2.84

2.43

ug/l

0.31

1181

5094

Polyarthrosis

581

2763

2.01

51.15

2.0

1.9

1.42

2.32

ug/l

2.05

483

2427

Other local infections of skin and subcutaneous tissue

327

1342

2.55

51.06

2.2

1.9

1.77

2.37

ug/l

0.55

293

1184

Viral infections characterized by skin and mucous membrane lesions

2051

12306

1.44

50.86

2.1

2.0

2.92

2.14

ug/l

0.52

1839

10819

Giant cell arteritis

191

596

3.51

50.81

1.7

1.9

1.48

1.90

ug/l

0.26

163

513

Cirrhosis of liver, NAS

232

810

3.11

50.77

2.3

2.0

2.87

1.93

ug/l

0.60

210

722

Disorders of parathyroid gland

624

3259

1.95

50.70

2.2

1.9

3.13

2.49

ug/l

0.37

548

2808

Dental operations

1715

5878

1.52

50.46

1.9

2.34

2.45

ug/l

0.11

1483

5133

Charcot foot

176

6.12

50.39

2.6

1.9

3.96

2.87

ug/l

0.21

158

Malignant neoplasm of breast, HER2-negative, including Hilmo

796

2861

1.83

50.37

1.9

1.83

2.13

ug/l

0.37

702

2434

Malignant neoplasm of breast, including Hilmo

796

2861

1.83

50.35

1.9

1.83

2.13

ug/l

0.37

702

2434

Malignant neoplasm of breast, HER2-negative

780

2819

1.84

50.29

1.9

1.80

2.15

ug/l

0.44

696

2397

Disorders of adult personality and behaviour

585

3023

1.97

50.27

2.2

2.0

2.57

1.96

ug/l

0.62

527

2698

Sciatica+with lumbago

1216

7090

1.60

50.18

2.2

1.9

1.89

2.29

ug/l

0.83

1086

6290

Malignant neoplasm of breast

785

2837

1.83

50.08

1.9

1.79

2.15

ug/l

0.46

699

2414

Alcohol dependence

764

4317

1.82

50.01

2.1

2.0

2.30

2.34

ug/l

0.04

688

3846

Adult respiratory distress syndrome

184

6.26

49.86

3.9

2.0

1.10

3.39

ug/l

0.81

163

Other condition

404

1833

2.28

49.84

2.3

2.0

3.48

2.37

ug/l

0.54

368

1635

Myocarditis

127

298

4.46

49.82

2.8

1.7

1.30

2.95

ug/l

0.90

120

270

Respiratory conditions due to other external agents

119

274

4.97

49.34

2.2

1.9

3.37

2.54

ug/l

0.16

111

241

Infection of intervertebral disc (pyogenic)

164

6.52

49.19

2.2

2.1

1.42

2.99

ug/l

0.41

145

Budesonide

338

1428

2.44

49.01

2.0

1.9

6.37

2.62

ug/l

0.42

303

1259

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

199

648

3.30

48.92

2.1

1.7

2.63

1.80

ug/l

0.41

187

555

Benign neoplasm: Colon

1544

9933

1.51

48.82

2.1

2.0

1.90

2.23

ug/l

0.85

1361

8736

Hepatic failure, not elsewhere classified

170

506

3.68

48.67

3.2

1.9

3.71

2.01

ug/l

0.84

154

449

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

267

1021

2.76

48.55

2.5

1.9

1.45

2.02

ug/l

0.49

237

895

Symptoms and signs involving the nervous and musculoskeletal systems

1463

9782

1.52

47.94

2.1

2.0

2.60

2.09

ug/l

0.61

1274

8611

Fracture of femur

859

4604

1.74

47.40

2.2

1.8

3.40

2.41

ug/l

0.87

723

3952

DVT of lower extremities

576

3038

1.96

47.31

2.3

1.9

2.46

2.28

ug/l

0.11

511

2649

Other ill-defined and unspecified causes of mortality

318

1343

2.52

47.28

2.0

1.9

1.93

2.59

ug/l

0.49

290

1155

Elevated blood glucose level

280

1110

2.65

47.25

2.2

2.0

1.73

1.77

ug/l

0.03

250

975

Other abnormalities of plasma proteins

100

208

5.61

47.12

2.4

1.9

0.79

2.97

ug/l

0.88

182

Congenital malformations, deformations and chromosomal abnormalities

1211

7419

1.57

46.87

2.3

2.0

2.18

2.14

ug/l

0.04

1079

6603

Intestinal adhesions without obstruction

294

1198

2.58

46.84

2.3

1.9

2.08

2.04

ug/l

0.03

263

1037

Dermatitis due to substances taken internally

187

600

3.30

46.79

2.6

1.9

1.16

1.74

ug/l

0.47

166

520

Seropositive rheumatoid arthritis, strict definition

428

2043

2.17

46.58

2.0

1.23

2.01

ug/l

1.30

380

1809

Tumor necrosis factor alpha inhibitors

354

1560

2.33

46.58

2.0

2.1

1.42

2.11

ug/l

0.69

314

1415

Malignant neoplasm of rectum, including Hilmo

375

1702

2.29

46.47

2.0

1.8

2.31

1.76

ug/l

0.49

336

1465

Depression or dysthymia

1669

6241

1.49

46.25

2.1

2.0

2.10

2.44

ug/l

0.46

1454

5614

Arthrosis

1729

6474

1.48

46.18

1.9

2.55

2.38

ug/l

0.14

1485

5729

Other diseases of intestine

432

2077

2.16

46.16

2.6

1.9

3.13

2.28

ug/l

0.47

386

1824

Nonischemic cardiomyopathy

316

1338

2.47

46.07

2.1

1.9

6.53

2.81

ug/l

0.38

281

1157

Chronic lymphocytic leukaemia

139

377

4.10

45.96

2.3

1.7

0.98

1.80

ug/l

0.87

122

320

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

139

377

4.10

45.96

2.3

1.7

0.98

1.80

ug/l

0.87

122

320

Chronic lymphocytic leukaemia, helper endpoint

139

377

4.10

45.96

2.3

1.7

0.98

1.80

ug/l

0.87

122

320

Herpesviral [herpes simplex] infections

326

1403

2.41

45.66

2.2

2.0

1.28

2.03

ug/l

0.82

300

1246

Mycoses

1997

12392

1.42

45.31

2.2

2.0

2.29

2.25

ug/l

0.04

1752

10947

Personality disorders

548

2871

1.95

45.28

2.2

2.0

2.71

1.95

ug/l

0.79

500

2576

Combinations of oral blood glucose lowering drugs

796

4698

1.74

44.84

2.0

2.17

2.31

ug/l

0.16

743

4165

Other skin changes

559

2975

1.94

44.79

2.2

1.9

2.41

2.32

ug/l

0.05

496

2619

Organic, including symptomatic, mental disorders

1518

7329

1.50

44.58

2.0

1.9

2.51

2.16

ug/l

0.42

1236

6484

5-aminosalicylic acid

450

2216

2.07

44.48

2.0

1.9

5.24

2.44

ug/l

0.41

405

1950

Aortic aneurysm

734

4170

1.78

44.29

2.1

1.9

1.68

2.23

ug/l

1.03

636

3630

Lymphoid leukaemia

229

855

2.88

44.13

2.3

1.9

1.80

2.19

ug/l

0.22

206

755

Malignant neoplasm of breast, ER-positive, including Hilmo

623

2607

1.88

44.12

1.8

1.99

2.21

ug/l

0.21

535

2221

Other symptoms and signs involving the circulatory and respiratory systems

212

754

2.95

44.11

2.2

1.9

1.22

2.07

ug/l

0.63

180

661

Invasive ventilation

261

1038

2.66

43.98

3.0

2.0

2.06

2.01

ug/l

0.03

246

915

Left ventricular outflow tract obstruction (LVOTO), broad definition

298

1256

2.48

43.94

2.5

2.1

1.93

2.15

ug/l

0.14

275

1149

Colectomy operation

537

2842

1.96

43.92

2.3

1.9

5.20

2.28

ug/l

0.57

489

2478

Other joint disorders

1895

6998

1.44

43.66

2.0

1.60

2.36

ug/l

1.77

1657

6187

Malignant neoplasm of breast, HER-positive

612

2585

1.88

43.65

1.8

1.98

2.23

ug/l

0.22

527

2201

Spondylosis

1370

7489

1.51

43.13

2.0

1.9

2.22

2.26

ug/l

0.03

1211

6620

Injuries to the knee and lower leg

2815

11734

1.34

42.96

2.1

2.0

2.06

2.30

ug/l

0.50

2443

10369

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

312

1357

2.41

42.95

2.0

1.8

2.43

1.69

ug/l

0.60

282

1169

Malignant neoplasm of rectum

304

1308

2.43

42.90

1.9

1.8

2.55

1.72

ug/l

0.67

275

1124

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

400

1858

2.15

42.55

2.6

2.0

2.54

2.22

ug/l

0.23

365

1666

Ill-defined and unknown causes of mortality

332

1496

2.34

42.42

2.0

1.9

2.04

2.52

ug/l

0.33

303

1288

Focal epilepsy

575

3136

1.88

42.35

2.5

1.9

2.70

2.27

ug/l

0.29

484

2758

Later onset COPD

958

4765

1.65

42.22

2.0

1.9

1.76

2.28

ug/l

1.02

821

4091

Polycystic ovarian syndrome, consortium definition

1301

5065

1.54

42.20

2.0

1.9

3.25

2.10

ug/l

0.48

1107

4434

Generalized skin eruption due to drugs and medicaments

151

456

3.56

42.03

2.6

1.9

1.24

1.94

ug/l

0.45

137

402

Aortic valve malfunction, age under 60 years

281

1178

2.49

42.01

2.6

2.1

2.00

1.81

ug/l

0.13

259

1081

Amputation of foot

138

398

3.89

41.99

2.3

1.9

1.42

2.43

ug/l

0.56

125

351

Schizophrenia

400

1933

2.13

41.93

2.2

2.0

2.24

2.02

ug/l

0.17

363

1746

Specific personality disorders

474

2429

1.99

41.89

2.3

2.0

2.53

1.87

ug/l

0.65

427

2179

Other symptoms and signs involving cognitive functions and awareness

1259

7637

1.53

41.80

2.1

2.0

2.49

2.24

ug/l

0.29

1035

6743

Colon adenocarcinoma

363

1699

2.22

41.77

1.9

1.8

1.53

1.83

ug/l

0.51

328

1458

Myeloid leukaemia

134

379

3.93

41.76

3.1

2.0

6.18

2.20

ug/l

0.65

128

333

Other diseases of liver

473

2440

2.00

41.44

2.2

1.9

1.90

2.50

ug/l

0.70

435

2176

Leisure time condition

489

2559

1.97

41.06

2.2

1.9

1.47

2.59

ug/l

2.02

397

2263

Hypertensive Renal Disease

153

473

3.48

41.05

2.2

1.7

5.36

2.95

ug/l

0.47

144

409

Cholecystectomy

1761

10802

1.42

40.95

2.0

2.31

2.26

ug/l

0.06

1563

9464

Anxiety (asthma-related co-morbidities)

1130

5679

1.56

40.55

2.3

2.0

2.52

2.08

ug/l

0.64

999

5072

Diseases of the eye and adnexa

1711

5959

1.45

40.52

2.1

2.0

2.27

2.11

ug/l

0.15

1517

5354

Mental and behavioural disorders due to tobacco

266

1108

2.51

40.37

2.0

2.1

1.71

2.02

ug/l

0.22

241

1001

Smoking dependency

266

1108

2.51

40.37

2.0

2.1

1.71

2.10

ug/l

0.29

241

1000

SLE (Finngen)

116

301

4.11

40.22

2.1

1.8

1.45

1.62

ug/l

0.09

109

266

Malignant neoplasm of ovary, including Hilmo

172

574

3.14

40.13

1.9

1.8

2.01

1.18

ug/l

0.61

165

484

Adenocarcinoma and papilloma adenocarcinoma of rectum

295

1293

2.38

39.92

2.0

1.8

2.52

1.69

ug/l

0.64

265

1110

Open wound of lower leg

419

2105

2.05

39.68

2.3

1.9

2.55

2.38

ug/l

0.11

369

1857

Sequelae of other external causes

193

694

2.94

39.63

2.3

2.0

4.13

1.63

ug/l

1.41

178

605

Pneumonia derived septicemia

141

424

3.59

39.61

2.3

1.9

3.30

2.09

ug/l

0.65

128

378

Myelodysplastic syndrome

127

6.57

39.50

2.1

1.6

4.65

2.43

ug/l

0.22

105

Collagenous colitis

270

1144

2.46

39.44

2.2

2.0

1.67

2.11

ug/l

0.30

250

1010

Arthropathies in other diseases classified elsewhere

139

415

3.60

39.39

2.3

2.1

3.04

1.40

ug/l

0.84

125

375

Other or ill-defined heart diseases

168

560

3.15

39.28

2.1

1.9

1.86

2.48

ug/l

0.31

159

498

Complications of cardiac and vascular prosthetic devices, implants and grafts

109

279

4.38

39.25

2.3

1.9

1.64

2.02

ug/l

0.13

243

Acute posthaemorrhagic anaemia

146

452

3.49

39.17

2.3

1.8

2.14

1.32

ug/l

0.43

129

384

Other diseases of pancreas

268

1139

2.47

39.07

2.7

1.9

3.53

2.20

ug/l

0.74

243

999

Emphysema

268

1143

2.47

38.88

2.1

1.9

1.07

2.96

ug/l

2.42

241

998

Amputation of ankle bones

118

323

4.09

38.72

2.6

2.0

2.55

2.53

ug/l

0.00

111

281

Adjustment and management of implanted device

516

2804

1.89

38.68

1.9

1.8

2.31

2.43

ug/l

0.09

458

2397

Emotionally unstable personality disorder

238

955

2.55

38.58

2.3

2.0

2.61

1.78

ug/l

0.47

212

864

Non-small cell lung cancer, adenocarcinoma

211

807

2.77

38.55

1.8

1.7

3.00

1.70

ug/l

0.49

190

692

Osteonecrosis

210

802

2.77

38.48

2.2

2.0

2.89

1.70

ug/l

0.75

190

720

Malignant neoplasm of urinary organs

295

1314

2.34

38.44

2.0

1.8

1.70

1.75

ug/l

0.04

264

1132

Secondary right heart disease

172

596

3.11

38.19

2.5

1.8

1.64

2.44

ug/l

0.38

155

515

Malignant neoplasm of bladder, including Hilmo

387

1908

2.09

38.17

1.9

1.8

2.12

1.98

ug/l

0.10

334

1653

Acute generalized exanthematous pustulosis

158

521

3.23

37.99

2.5

1.9

1.26

1.82

ug/l

0.39

143

461

Sulfonylureas

1036

5364

1.57

37.99

2.0

1.9

2.23

2.34

ug/l

0.10

910

4607

Arterial embolism and thrombosis

221

873

2.68

37.82

2.4

1.8

1.37

2.58

ug/l

0.96

195

737

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

411

2018

2.03

37.78

2.6

2.0

2.53

2.25

ug/l

0.20

374

1806

Crohn's disease NAS

188

687

2.86

37.24

2.0

3.21

1.65

ug/l

0.45

174

612

Superficial injury of head

596

3420

1.78

36.99

1.9

1.97

2.42

ug/l

0.46

499

2977

Other and unspecified types of non-Hodgkin lymphoma, hilmo

177

636

3.01

36.89

2.9

1.8

1.59

1.89

ug/l

0.16

159

559

Deforming dorsopathies

640

3754

1.74

36.64

2.2

1.9

2.63

2.28

ug/l

0.27

567

3353

Duodenal ulcer

366

1811

2.10

36.50

2.2

1.9

3.01

2.37

ug/l

0.26

332

1566

Rotator cuff syndrome

1520

7678

1.44

36.46

2.0

1.67

2.52

ug/l

2.05

1362

6785

Other degenerative diseases of the nervous system

698

3097

1.72

36.36

1.9

1.8

2.78

2.24

ug/l

0.32

551

2754

Other symptoms and signs involving the nervous and musculoskeletal systems

973

6341

1.56

36.21

2.1

2.0

2.17

2.02

ug/l

0.16

847

5592

Dermatophytosis

384

1938

2.05

36.16

2.3

1.9

2.61

2.70

ug/l

0.04

347

1722

Alcohol abuse, main dg

411

2119

2.00

36.15

2.1

2.0

3.14

2.11

ug/l

0.88

368

1901

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1128

5086

1.53

36.06

2.0

1.9

2.50

2.16

ug/l

0.35

970

4422

Carpal tunnel syndrome

1414

8730

1.45

35.98

2.0

2.54

2.25

ug/l

0.29

1255

7691

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

239

4.44

35.74

2.4

1.7

3.63

1.44

ug/l

0.60

204

Congenital malformations, deformations and chromosomal abnormalities

1286

8173

1.47

35.56

2.3

2.0

2.15

2.16

ug/l

0.01

1142

7273

Temporal arteritis

155

530

3.17

35.41

1.7

1.9

1.45

1.89

ug/l

0.24

130

455

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

169

598

2.93

35.37

2.3

2.1

1.93

2.03

ug/l

0.05

152

541

Diseases of spleen

203

4.78

35.31

2.5

1.8

3.55

2.83

ug/l

0.15

180

Seronegative rheumatoid arthritis

308

1442

2.21

35.30

2.1

1.9

1.72

2.00

ug/l

0.11

271

1280

Injuries to the shoulder and upper arm

2027

12157

1.36

35.21

2.0

2.12

2.27

ug/l

0.19

1759

10744

Urticaria and erythema

761

4715

1.64

35.17

2.1

2.0

1.64

2.12

ug/l

0.62

665

4167

Hyperparathyroidism

518

2870

1.84

35.13

2.2

1.9

2.77

2.36

ug/l

0.21

461

2456

Acute alcohol intoxication, ICD10

519

2908

1.83

35.13

2.0

2.96

2.34

ug/l

0.49

463

2610

Other disorders involving the immune mechanism, not elsewhere classified

121

357

3.66

35.06

2.7

2.1

1.85

2.37

ug/l

0.16

112

321

Focal epilepsy, strict definition

523

2940

1.82

35.03

2.5

1.9

2.87

2.33

ug/l

0.34

436

2585

Other specified/unspecified systemic involvement of connective tissue

172

621

2.91

34.98

2.5

1.9

1.88

2.07

ug/l

0.09

149

539

Diabetic retinopathy, strict definition

570

2902

1.80

34.94

2.4

2.1

2.74

2.20

ug/l

0.57

512

2594

Other blood glucose lowering drugs, excl. Insulins

473

2587

1.89

34.92

2.0

1.9

1.74

2.30

ug/l

0.66

419

2224

Hypothyroidism, strict autoimmune

1593

7469

1.42

34.90

2.0

1.9

1.77

2.33

ug/l

1.63

1398

6522

Other pulmonary heart/vessel disease

180

671

2.87

34.85

2.5

1.8

3.13

2.38

ug/l

0.17

163

582

Pneumococcal septicemia

137

440

3.36

34.70

2.3

2.0

3.38

1.97

ug/l

0.81

124

390

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

114

326

3.78

34.66

2.7

2.0

1.96

2.55

ug/l

0.17

105

292

Amputation of thigh

142

468

3.31

34.64

2.4

1.8

1.86

3.92

ug/l

0.85

125

389

Selective serotonin reuptake inhibitors

2354

9273

1.34

34.54

2.0

2.08

2.38

ug/l

0.44

2057

8230

Other disorders of lacrimal gland

833

5305

1.60

34.53

2.1

1.9

2.00

2.21

ug/l

0.17

732

4673

Kela reimbursement Agammaglobulinemia (D80-84)

8.75

34.53

3.9

1.9

1.33

1.02

ug/l

0.21

Hodgkin lymphoma, hilmo

114

327

3.77

34.51

2.5

1.9

0.71

2.25

ug/l

1.01

108

291

Acute alcohol intoxication

672

4065

1.69

34.48

2.1

2.0

2.88

2.32

ug/l

0.55

599

3608

Ulcerative colitis, NAS

342

1680

2.09

34.44

2.1

2.0

5.92

2.27

ug/l

0.43

311

1497

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

299

1402

2.22

34.36

2.0

1.8

1.88

1.75

ug/l

0.10

272

1207

Other and unspecified disorders of skin and subcutaneous tissue

204

812

2.64

34.31

1.9

2.26

2.12

ug/l

0.05

159

720

Spondylopathies (FG)

309

1462

2.17

34.27

2.1

1.9

0.95

2.29

ug/l

2.75

275

1326

Zoster [herpes zoster]

1232

8396

1.47

34.10

2.1

1.9

3.42

2.21

ug/l

0.48

1083

7338

Mixed connective tissue disease

187

715

2.74

34.06

2.3

2.0

1.93

2.05

ug/l

0.06

159

631

Other inflammatory liver diseases

206

827

2.61

34.00

2.3

1.9

2.62

1.64

ug/l

0.62

188

738

Inflammatory diseases of the central nervous system

241

1038

2.42

33.96

2.5

2.0

3.50

2.16

ug/l

0.34

219

917

Attention to artificial openings

146

494

3.15

33.66

2.8

1.7

2.13

2.71

ug/l

0.21

128

434

Other anxiety disorders

820

4504

1.60

33.56

2.3

2.0

2.28

2.10

ug/l

0.19

721

3998

Malignant neoplasm, without specification of site, including Hilmo

168

615

2.89

33.41

2.1

1.7

1.57

1.71

ug/l

0.11

151

515

Other headache syndromes

851

5472

1.57

33.40

2.1

1.9

2.28

2.30

ug/l

0.01

758

4830

681

3922

1.68

33.34

1.9

1.8

3.46

2.42

ug/l

0.52

559

3347

Visual disturbances and blindness

1229

8538

1.46

33.34

2.1

2.0

2.29

2.13

ug/l

0.13

1038

7520

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

488

2686

1.82

33.24

2.2

2.0

1.81

2.00

ug/l

0.18

433

2375

Lumbar disc prolapse

1423

7738

1.43

33.12

2.2

2.0

1.77

2.26

ug/l

1.11

1242

6874

Disorders of eyelid, lacrimal system and orbit

2041

11645

1.34

33.07

2.1

2.0

2.38

2.22

ug/l

0.16

1784

10243

Giant cell arteritis with polymyalgia rheumatica

155

551

3.05

33.06

1.7

1.9

1.45

1.97

ug/l

0.30

130

478

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

180

684

2.74

33.03

2.5

2.0

5.34

1.78

ug/l

0.96

162

611

Other diseases of arteries and capillaries

271

1242

2.27

33.02

2.2

1.9

3.20

2.38

ug/l

0.24

241

1065

Crohn's disease of small intestine

183

704

2.70

32.78

2.0

10.25

1.72

ug/l

0.58

168

631

Superficial injury of hip and thigh

420

2256

1.92

32.73

2.1

1.9

2.50

2.36

ug/l

0.05

364

1949

Cerebral palsy and other paralytic syndromes

312

1514

2.13

32.68

2.5

2.0

2.62

2.16

ug/l

0.19

265

1339

Post-traumatic stress disorder

150

518

2.97

32.65

2.4

2.0

1.57

2.13

ug/l

0.28

136

460

Insulin, fast-acting (human)

323

1584

2.09

32.60

2.4

1.9

3.00

2.37

ug/l

0.41

308

1385

All anxiety disorders

1140

6150

1.48

32.51

2.3

2.0

2.57

2.15

ug/l

0.61

1008

5471

Adalimumab

220

925

2.45

32.51

2.0

2.1

1.17

1.84

ug/l

0.59

195

845

Malignant neoplasm of kidney, except renal pelvis

261

1186

2.29

32.50

2.0

1.8

1.45

1.80

ug/l

0.42

237

1022

Hypocalcemia

100

275

4.00

32.44

2.4

1.9

3.13

2.39

ug/l

0.14

250

Neuromuscular dysfunction of bladder

268

1232

2.26

32.39

2.3

2.0

2.01

2.19

ug/l

0.09

221

1092

Sarcoidosis

354

1805

2.02

32.33

2.3

1.9

2.30

2.32

ug/l

0.01

318

1619

Diabetic retinopathy

1084

4571

1.52

32.16

2.2

2.1

2.70

2.23

ug/l

0.61

972

4085

Malnutrition

249

4.15

32.14

2.2

2.1

2.76

3.01

ug/l

0.05

211

Drug-induced cataract

102

286

3.91

32.14

2.7

1.9

2.96

2.37

ug/l

0.15

262

Abnormal results of function studies

235

1025

2.38

32.13

2.5

2.0

1.61

2.25

ug/l

0.52

206

915

Sleep disorders (combined)

2637

10720

1.30

32.09

2.0

1.94

2.35

ug/l

0.90

2309

9460

Malignant neoplasm of oesophagus, including Hilmo

138

466

3.18

32.06

2.1

1.7

1.14

1.98

ug/l

1.16

129

408

Unspecified jaundice

175

669

2.76

32.04

2.1

1.9

2.40

3.08

ug/l

0.25

151

567

Abscess of lung

194

4.69

31.92

2.6

1.9

1.47

1.51

ug/l

0.02

173

Focal epilepsy, mode (most common among epilepsy diagnosis)

486

2750

1.81

31.88

2.5

1.9

2.99

2.36

ug/l

0.38

407

2417

Malignant neoplasm of skin

1121

5236

1.49

31.82

1.9

2.46

2.16

ug/l

0.30

955

4552

Adenocarcinoma and ductal carcinoma of pancreas

129

422

3.29

31.68

2.2

1.7

2.78

1.93

ug/l

0.32

122

365

Systemic lupus erythematosus

116

355

3.47

31.58

2.1

2.0

1.45

1.82

ug/l

0.15

109

311

Crystal arthropathies, rheuma endpoint

258

4.10

31.54

2.2

1.9

0.53

1.40

ug/l

1.53

229

Diseases of the ear and mastoid process

2590

10061

1.30

31.45

2.0

2.36

2.20

ug/l

0.19

2253

8954

Other disorders of glucose regulation and pancreatic internal secretion

247

1112

2.31

31.41

2.0

3.59

2.09

ug/l

0.99

217

964

Sicca syndrome [Sjögren]

227

986

2.39

31.39

2.4

2.0

1.30

2.06

ug/l

0.69

204

870

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1047

4841

1.50

31.39

1.9

2.49

2.08

ug/l

0.43

892

4197

Diseases of pulp and periapical tissues, including avohilmo

2464

9824

1.31

31.37

2.0

1.83

2.31

ug/l

1.50

2185

8593

Malignant neoplasm of other and unspecified parts of biliary tract

159

5.07

31.36

2.1

1.7

4.57

1.74

ug/l

0.57

137

Soft tissue disorders related to use, overuse and pressure

655

4034

1.66

31.30

2.2

2.0

1.47

2.38

ug/l

1.13

574

3565

Ulcerative colitis

554

3267

1.73

31.23

2.1

2.0

4.74

2.22

ug/l

0.47

495

2889

Transient ischemic attack

1400

8124

1.42

31.18

2.0

1.9

2.05

2.19

ug/l

0.21

1228

7118

Psoriatic and enteropathic arthropathies

279

1321

2.17

31.05

2.2

1.9

1.84

2.19

ug/l

0.26

252

1204

Acquired absence of limb

115

6.05

31.00

2.6

1.8

3.81

4.57

ug/l

0.10

102

Other and unspecified effects of external causes

561

3326

1.72

30.92

2.2

1.9

1.73

2.27

ug/l

0.72

494

2933

Bipolar affective disorders

366

1910

1.95

30.85

2.0

2.09

1.88

ug/l

0.15

330

1704

Malignant neoplasm of bladder

234

1042

2.35

30.66

1.8

1.7

2.83

1.89

ug/l

0.61

203

892

Follow-up examination after treatment for conditions other than malignant neoplasms

874

3766

1.55

30.47

2.0

1.8

3.78

2.66

ug/l

0.79

762

3357

IBD patients in KELA-register

486

2790

1.77

30.16

2.0

5.05

2.22

ug/l

0.46

437

2495

Other and unspecified nonorganic psychotic disorders

374

1982

1.92

30.11

2.3

2.0

1.78

1.86

ug/l

0.06

327

1780

Psoriasis

669

4185

1.63

30.03

2.1

2.0

2.29

2.03

ug/l

0.25

600

3728

Total colectomy operation

140

494

3.00

29.94

2.5

2.0

13.08

1.76

ug/l

0.61

131

447

Total colectomy

140

494

3.00

29.94

2.4

2.0

13.08

1.76

ug/l

0.61

131

447

Other crystal arthropathies

268

3.94

29.87

2.2

1.9

0.53

1.68

ug/l

1.88

238

Disorders of lacrimal system

987

6709

1.49

29.79

2.1

1.9

1.91

2.12

ug/l

0.19

866

5877

Somatoform disorder

358

1880

1.95

29.77

2.2

2.0

1.65

1.97

ug/l

0.28

298

1668

Vascular diseases of the intestine

151

559

2.88

29.66

2.5

1.8

3.64

2.00

ug/l

0.87

137

470

901

5250

1.53

29.63

1.9

3.22

2.23

ug/l

0.68

739

4525

Mental and behavioural disorders due to sedatives or hypnotics

179

717

2.59

29.57

2.0

2.1

2.27

1.92

ug/l

0.18

157

646

Other arthrosis

1219

5935

1.44

29.45

2.1

2.0

2.60

2.43

ug/l

0.12

1052

5271

290

1420

2.09

29.44

2.4

2.0

2.50

2.32

ug/l

0.10

265

1269

Pneumothorax

225

1004

2.34

29.42

2.6

1.9

2.01

2.76

ug/l

0.34

192

879

Thoracic aortic aneurysm

418

2330

1.85

29.23

2.2

1.9

1.35

2.38

ug/l

1.72

356

2056

Paracetamol or NSAID medication

372

952

2.00

29.09

1.9

2.21

2.27

ug/l

0.03

320

845

Malignant neoplasm of oesophagus

105

320

3.55

29.07

2.1

1.8

1.03

1.85

ug/l

0.87

281

Malignant neoplasm of stomach, including Hilmo

191

798

2.51

29.00

1.9

1.7

2.71

1.80

ug/l

0.47

173

679

Osteonecrosis due to drugs

201

4.49

28.99

2.1

1.9

1.78

3.05

ug/l

0.38

176

severe traumatic brain injury, does not include concussion

643

4029

1.63

28.93

2.4

1.9

2.16

2.30

ug/l

0.12

527

3501

Transport accidents

931

5399

1.50

28.82

2.1

2.0

2.21

2.15

ug/l

0.05

829

4833

Chronic nephritic syndrome

142

517

2.93

28.79

2.5

1.9

5.12

2.07

ug/l

0.62

132

467

Microscopic polyangiitis

7.58

28.43

2.5

1.8

0.96

5.07

ug/l

0.55

Diseases of oral cavity, salivary glands and jaws

1572

5918

1.38

28.36

1.9

2.47

2.44

ug/l

0.02

1356

5176

Superficial injury of lower leg

544

3279

1.69

28.28

2.1

1.9

2.01

2.25

ug/l

0.23

465

2894

Convalescence

137

491

2.91

28.22

3.9

1.8

2.52

2.04

ug/l

0.23

106

437

Postprocedural disorders of digestive system, not elsewhere classified

122

414

3.15

28.13

2.8

2.0

3.39

2.13

ug/l

0.46

113

366

Cardiomyopathy, other and unspecified

209

920

2.36

28.06

2.2

1.9

1.34

2.51

ug/l

1.01

190

813

Postmenopausal osteoporosis with pathological fracture

197

851

2.43

27.90

2.0

1.8

1.41

2.15

ug/l

0.72

172

723

Bronchiectasis

248

1177

2.20

27.89

2.4

1.9

1.26

2.99

ug/l

2.17

214

1016

Myalgia

489

2875

1.73

27.88

2.0

1.9

1.33

2.43

ug/l

2.09

421

2541

Papulosquamous disorders

904

6145

1.49

27.73

2.0

2.25

2.17

ug/l

0.09

798

5466

Malignant neoplasm of corpus uteri

205

900

2.37

27.72

2.1

1.7

4.65

2.21

ug/l

0.87

176

754

Arterial embolism and thrombosis of lower extremity artery

139

511

2.90

27.70

2.2

1.8

1.78

2.77

ug/l

0.44

117

436

Non-small cell lung cancer, squamous

162

642

2.65

27.63

2.1

1.7

1.25

1.96

ug/l

0.64

145

551

Other and unspecified tonsillitis

539

2716

1.69

27.60

2.1

1.70

2.35

ug/l

0.97

497

2465

Cystic kidney disease

116

388

3.20

27.44

2.6

1.9

3.81

2.09

ug/l

0.60

110

345

Viral warts

233

1081

2.22

27.42

2.2

2.0

2.99

2.05

ug/l

0.55

216

969

Gonarthrosis,primary

2228

10675

1.30

27.35

1.9

2.0

2.54

2.21

ug/l

0.43

1931

9436

Cardiodefibrillation

1014

7078

1.46

27.04

2.0

2.18

2.13

ug/l

0.05

898

6205

Disorder of lipoprotein metabolism, unspecified

372

2048

1.87

27.02

1.9

2.30

2.54

ug/l

0.13

320

1785

Other Crohn's disease

168

682

2.55

26.97

2.0

2.1

1.76

1.89

ug/l

0.06

156

609

Sequelae of injuries, of poisoning and of other consequences of external causes

535

3254

1.68

26.97

2.4

2.0

2.21

2.24

ug/l

0.02

474

2914

Malignant neoplasm of corpus uteri, including Hilmo

225

1038

2.24

26.95

2.1

1.7

4.28

2.07

ug/l

0.87

194

873

Fracture of shoulder and upper arm

855

5775

1.50

26.93

1.9

2.0

2.74

2.35

ug/l

0.31

741

5073

Paralytic ileus

141

530

2.83

26.89

2.9

1.9

4.46

2.09

ug/l

0.53

126

451

Other abnormal uterine and vaginal bleeding

499

2103

1.73

26.89

1.9

2.16

2.02

ug/l

0.11

404

1849

Inflammatory bowel disease, strict (require KELA)

486

2883

1.72

26.87

2.0

5.05

2.24

ug/l

0.46

437

2577

Chronic tubulo-interstitial nephritis

112

370

3.18

26.81

2.4

1.8

6.54

1.70

ug/l

0.80

106

317

Visual disturbances

1096

7772

1.43

26.75

2.1

2.0

2.28

2.14

ug/l

0.10

942

6862

Diabetic neuropathy

395

2222

1.85

26.71

2.2

2.1

2.13

2.34

ug/l

0.18

361

1988

malignant neoplasm of male genital organs

774

3080

1.56

26.69

2.0

3.80

2.12

ug/l

1.28

668

2730

Hypoglycaemia, other or unspecified

198

872

2.36

26.65

1.9

2.0

3.41

1.71

ug/l

1.22

171

761

Unspecified urinary incontinence

238

1130

2.18

26.57

1.9

2.40

1.85

ug/l

0.34

179

988

Other specified/unspecified necrotizing vasculopathies

169

4.57

26.46

3.1

1.9

1.09

3.31

ug/l

0.68

147

SLE, strict definition

108

353

3.24

26.46

2.1

1.9

1.49

1.79

ug/l

0.11

101

312

SLE, ICD10

108

353

3.24

26.46

2.1

1.9

1.49

1.79

ug/l

0.11

101

312

Cystic kidney disease

119

413

3.07

26.35

2.6

1.9

3.75

2.05

ug/l

0.62

113

369

Folate deficiency anaemia

125

5.37

26.32

2.8

2.1

2.42

1.14

ug/l

0.80

106

Statin medication

1385

5665

1.39

26.30

2.0

2.40

2.27

ug/l

0.10

1229

5025

Diseases of pulp and periapical tissues and dental caries

1704

6547

1.35

26.26

1.9

2.0

2.30

2.39

ug/l

0.09

1485

5715

Other ulcerative colitis

157

628

2.60

26.12

2.3

2.1

9.79

1.70

ug/l

0.44

143

563

Diaphragmatic hernia

902

6215

1.48

25.95

2.1

1.9

2.16

2.07

ug/l

0.09

790

5461

Infective dermatitis

299

1556

1.98

25.85

2.0

1.9

1.48

2.85

ug/l

1.46

271

1378

Fracture of lower leg, including ankle

1224

8802

1.39

25.78

2.2

2.0

2.05

2.33

ug/l

0.40

1071

7779

Alcoholic liver disease

303

1592

1.97

25.66

2.3

1.9

2.63

2.53

ug/l

0.05

276

1417

Open wound of ankle and foot

269

1354

2.05

25.59

2.1

2.0

2.74

2.17

ug/l

0.33

239

1200

Injuries to the ankle and foot

1381

9072

1.36

25.59

2.0

1.99

2.14

ug/l

0.25

1232

8066

Benign neoplasm of other and ill-defined parts of digestive system

474

2843

1.71

25.50

2.2

1.9

2.92

2.33

ug/l

0.45

412

2503

Cervical disc disorders

836

5692

1.49

25.47

2.1

2.0

2.28

2.13

ug/l

0.10

734

5082

Rheumatism, unspecified

304

1598

1.95

25.36

2.2

1.9

2.45

1.91

ug/l

0.38

270

1416

Hypoparathyroidism

121

433

2.97

25.35

2.4

2.0

2.66

1.87

ug/l

0.33

103

378

Pleural plaque

327

1779

1.91

25.04

1.7

1.8

1.27

2.72

ug/l

2.50

286

1532

Polyarteritis nodosa and related conditions

150

4.63

24.94

2.4

1.9

0.62

3.57

ug/l

0.91

133

Nontraumatic intracranial haemmorrhage

554

3473

1.63

24.92

2.4

1.9

2.60

2.42

ug/l

0.08

462

3022

Other and unspecified vasculitis limited to skin

295

3.44

24.88

2.7

1.8

2.39

2.80

ug/l

0.11

259

Exposure to other specified factors

1588

11056

1.33

24.85

2.1

2.0

2.14

2.17

ug/l

0.03

1389

9817

Vasculitis limited to skin, not elsewhere classified

100

326

3.30

24.82

2.6

1.9

3.33

2.64

ug/l

0.20

288

Other disorders of nervous system

205

946

2.26

24.81

1.9

2.0

3.87

1.85

ug/l

0.51

181

844

Caries of dentine, including avohilmo

1955

7708

1.31

24.61

1.9

2.0

1.84

2.39

ug/l

1.39

1695

6766

Congenital malformations of the urinary system

154

631

2.54

24.40

2.6

2.0

3.59

2.07

ug/l

0.69

144

560

Basal cell carcinoma

975

4720

1.45

24.38

1.9

2.62

2.09

ug/l

0.55

817

4092

Degeneration of macula and posterior pole

1304

7664

1.37

24.37

1.9

3.28

2.05

ug/l

1.39

1096

6698

Clear cell adenocarcinoma of kidney

140

551

2.68

24.34

1.9

1.8

0.92

1.69

ug/l

1.30

127

487

Periodontitis

2219

11735

1.27

24.14

2.0

3.05

2.09

ug/l

0.72

1933

10391

Disorders of sclera, cornea, iris and ciliary body

1199

8782

1.38

24.12

2.1

2.0

2.20

2.14

ug/l

0.07

1083

7733

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

350

1957

1.84

24.03

1.9

1.8

1.38

2.23

ug/l

1.55

299

1658

Complications following infusion, transfusion and therapeutic injection

168

4.31

23.93

3.3

1.9

1.84

1.86

ug/l

0.01

150

Chronic periodontitis, including avohilmo

2212

11734

1.27

23.90

2.0

3.01

2.10

ug/l

0.67

1927

10391

Pulmonary oedema

248

3.65

23.85

3.3

1.9

6.88

2.89

ug/l

0.44

205

Fracture of skull and facial bones

480

2933

1.67

23.81

2.5

2.0

2.41

2.34

ug/l

0.04

406

2612

Fibromyalgia

175

765

2.34

23.74

2.3

1.9

3.52

2.10

ug/l

0.58

143

680

Vitreous haemorrhage

287

1520

1.95

23.71

2.3

2.0

3.14

2.54

ug/l

0.24

262

1334

Abscess of anal and rectal regions

208

979

2.19

23.69

2.1

2.0

1.58

2.93

ug/l

0.99

187

878

Varicose veins

1463

8317

1.34

23.67

2.1

1.9

2.25

2.29

ug/l

0.04

1285

7279

Injury of other and unspecified intrathoracic organs

199

925

2.24

23.67

2.2

2.0

1.33

2.15

ug/l

0.52

167

823

Portal vein thrombosis

197

4.02

23.66

2.6

2.0

4.28

2.69

ug/l

0.30

180

Functional dyspepsia

573

3665

1.59

23.48

2.0

1.9

1.53

2.07

ug/l

0.84

507

3240

Alcohol-induced chronic pancreatitis

199

929

2.24

23.46

2.5

2.1

2.66

1.79

ug/l

0.43

187

852

Hyperosmolality and hypernatraemia

181

4.16

23.30

2.5

1.9

9.69

3.31

ug/l

0.54

154

Seborrhoeic dermatitis

259

1333

2.01

23.25

2.3

1.9

1.14

2.80

ug/l

2.14

220

1185

Acute gastritis

213

1022

2.16

23.24

2.3

1.9

2.23

2.56

ug/l

0.15

194

897

Internal derangement of knee

785

5347

1.48

23.21

2.0

1.56

2.05

ug/l

0.88

674

4755

Systemic lupus erythematosus, unspecified

302

3.26

23.10

2.2

1.9

1.72

2.00

ug/l

0.09

271

Psychotic depression

150

622

2.49

23.06

2.1

2.42

2.08

ug/l

0.15

135

570

Other specified/unspecified inflammatory spondylopathies

115

419

2.85

23.02

2.2

0.99

2.08

ug/l

0.76

106

379

Dissection of aorta

123

469

2.80

22.97

2.4

1.8

1.08

2.73

ug/l

0.95

108

403

Other viral hepatitis

147

606

2.51

22.91

2.4

2.2

1.55

1.74

ug/l

0.13

135

551

Nonorganic sleeping disorders, excluding more controls

346

1953

1.80

22.85

2.1

1.9

2.10

1.88

ug/l

0.13

310

1739

Lichen simplex chronicus and prurigo

177

795

2.32

22.85

1.9

2.0

2.22

2.32

ug/l

0.05

159

705

Other and unspecified nerve root and plexus disorders, also in other diseases

441

2673

1.68

22.66

2.1

2.0

1.73

2.03

ug/l

0.19

374

2392

Diseases of male genital organs

1288

4783

1.37

22.57

2.0

2.1

2.19

2.21

ug/l

0.02

1155

4303

Unspecified nephritic syndrome

283

3.36

22.43

3.0

1.9

4.08

2.43

ug/l

0.49

252

L02BX Other hormone antagonists and related agents

217

1074

2.15

22.40

1.9

2.60

2.33

ug/l

0.07

195

938

Diseases of external ear

777

5356

1.47

22.34

1.9

2.0

3.09

2.00

ug/l

0.75

611

4763

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

158

681

2.40

22.31

2.0

1.96

1.71

ug/l

0.13

146

611

Psoriasis vulgaris

441

2687

1.68

22.28

2.0

2.40

2.34

ug/l

0.03

394

2398

Asthma and allergy, excluding more controls

141

566

2.49

22.21

2.0

1.7

2.67

2.07

ug/l

0.15

134

495

Caries of enamel

1081

10625

0.73

22.20

2.0

1.77

2.29

ug/l

1.05

952

9462

Congenital malformations of the urinary system

158

684

2.40

22.18

2.6

2.0

3.55

1.96

ug/l

0.77

147

604

Other general symptoms and signs

335

3.01

22.15

1.9

1.8

1.36

2.13

ug/l

0.54

293

Disorders of synovium and tendon

1099

7028

1.38

22.14

2.1

2.0

1.90

2.56

ug/l

0.70

993

6221

Polyarthritis, unspecified

114

425

2.82

22.07

2.0

1.76

1.43

ug/l

0.21

103

380

Recurrent or chronic depression

728

3449

1.50

22.03

2.2

2.0

2.26

2.50

ug/l

0.17

647

3128

Listeriosis

9.60

22.02

2.4

1.5

2.85

0.27

ug/l

1.82

Malignant neoplasm of prostate

746

3015

1.51

22.01

2.0

3.77

2.11

ug/l

1.20

641

2672

Basal cell carcinoma, including avohilmo

989

4869

1.42

21.99

1.9

2.56

2.08

ug/l

0.49

831

4227

Ulcer of oesophagus

216

1067

2.11

21.97

2.4

1.9

4.63

2.64

ug/l

0.45

199

933

Speech and linguistic disorders, excluding more controls

129

475

2.61

21.94

2.3

2.1

3.17

2.16

ug/l

0.37

105

414

Other noninfective disorders of lymphatic vessels and lymph nodes

111

410

2.85

21.88

2.2

2.1

1.68

1.82

ug/l

0.06

358

Malignant neoplasm of liver and intrahepatic bile ducts

103

367

2.99

21.86

2.1

1.7

1.27

2.11

ug/l

1.02

317

Abdominal aortic aneurysm (AAA)

329

1850

1.82

21.85

1.9

1.8

2.18

2.54

ug/l

0.26

287

1571

Non-small cell lung cancer, adenocarcinoma, helper endpoint

211

1041

2.12

21.67

1.8

1.9

3.00

2.71

ug/l

0.08

190

904

Phobic anxiety disorders

206

995

2.10

21.63

2.7

2.0

3.05

1.78

ug/l

0.68

177

891

Poisoning by narcotics and psychodysleptics [hallucinogens]

106

4.92

21.60

1.7

1.8

2.57

3.81

ug/l

0.18

Other other unspecified disorders of the circulatory system

126

501

2.66

21.58

2.4

2.0

1.36

1.83

ug/l

0.24

104

444

Somnolence, stupor and coma

140

584

2.51

21.53

2.4

1.9

1.62

1.52

ug/l

0.07

127

510

Tobacco use

147

626

2.45

21.51

2.1

2.0

2.23

1.78

ug/l

0.24

134

572

Dental caries, including avohilmo

1847

7371

1.29

21.50

1.9

2.0

2.09

2.32

ug/l

0.29

1604

6452

Other diseases of stomach and duodenum

185

868

2.22

21.48

2.0

1.9

1.52

2.40

ug/l

0.68

160

773

Herpesviral [herpes simplex] infections

461

2862

1.63

21.43

2.2

1.9

1.67

1.82

ug/l

0.13

416

2523

Corns and callosities

183

856

2.22

21.39

2.2

1.9

2.53

1.75

ug/l

0.41

163

764

Other disorders of bladder

334

1914

1.80

21.38

2.0

1.9

1.60

2.44

ug/l

0.88

284

1684

Use of disulfiram, acamprosate or naltrexone

211

1041

2.09

21.32

1.9

2.1

1.85

1.99

ug/l

0.07

197

955

Traumatic subarachnoid haemorrhage

114

434

2.76

21.18

2.7

1.9

3.37

2.01

ug/l

0.50

380

Artificial joint operation, meniscal resection

2186

11381

1.26

21.14

1.9

2.0

2.31

2.27

ug/l

0.05

1910

10050

Malignant neoplasm of prostate, including Hilmo

757

3073

1.49

21.13

2.0

3.69

2.10

ug/l

1.16

656

2724

Crohn disease (strict definition, require KELA)

148

636

2.40

21.08

2.0

2.10

1.58

ug/l

0.27

136

573

Disorders of skin appendages

918

6574

1.41

21.06

2.1

2.0

2.70

1.97

ug/l

0.61

819

5828

Crohn disease (strict definition, require KELA, min 2 HDR)

146

625

2.41

20.98

2.0

2.11

1.60

ug/l

0.26

134

563

Schizoaffective disorder

170

776

2.26

20.97

2.4

2.1

2.37

1.93

ug/l

0.23

157

705

Injury of intra-abdominal organs

257

3.34

20.95

2.9

1.9

3.08

2.23

ug/l

0.23

229

Follicular lymphoma, hilmo

143

615

2.46

20.72

2.3

1.9

0.56

2.36

ug/l

1.63

130

547

Other sleep disorders

266

1435

1.90

20.65

2.1

1.9

1.32

2.92

ug/l

2.06

236

1267

Meniscus derangement

1217

6117

1.35

20.58

1.9

2.0

1.83

2.35

ug/l

0.83

1051

5437

Psoriatic arthropathies

234

1214

1.98

20.46

2.2

1.9

1.78

2.00

ug/l

0.16

208

1106

Hyperplasia of prostate

1009

4141

1.40

20.46

1.9

2.1

1.92

2.26

ug/l

0.43

889

3732

Other problems related to primary support group, including family circumstances

186

861

2.14

20.38

2.5

2.0

2.00

2.08

ug/l

0.04

171

772

Haemorrhoids and perianal venous thrombosis

731

5062

1.46

20.28

2.0

1.9

1.62

2.25

ug/l

0.87

632

4433

Viral haemorrhagic fevers, not elsewhere classified/unspecified

211

1063

2.05

20.26

2.4

2.1

2.09

2.13

ug/l

0.02

197

956

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

184

3.82

20.24

1.6

1.28

1.93

ug/l

0.37

160

Implicit parasitic Sepsis

7.57

20.18

1.5

1.03

7.43

ug/l

0.49

Early complications of trauma

130

541

2.52

20.11

2.6

2.0

1.93

1.98

ug/l

0.02

117

481

!Aliquae complicationes praecoces traumatis

130

541

2.52

20.11

2.6

2.0

1.93

1.98

ug/l

0.02

117

481

Disorders of muscles

246

1306

1.93

20.10

2.3

2.0

1.59

2.87

ug/l

1.18

214

1151

L04AC Interleukin inhibitors

138

588

2.43

20.09

2.3

2.1

1.59

1.69

ug/l

0.04

122

537

Asthma and allergy

141

594

2.37

20.02

2.0

1.7

2.67

2.11

ug/l

0.14

134

521

Stomatitis and related lesions

415

2558

1.65

20.01

2.2

2.0

2.15

1.97

ug/l

0.14

360

2267

Alzheimer disease, excluding more controls

463

1902

1.64

19.99

1.8

2.80

2.55

ug/l

0.09

360

1682

Acquired haemolytic anaemia

309

3.08

19.89

3.1

1.9

5.33

2.52

ug/l

0.41

268

Other bursopathies

329

1915

1.76

19.86

2.0

1.71

2.59

ug/l

0.84

286

1684

Diabetic maculopathy

380

2170

1.70

19.83

2.1

1.86

2.27

ug/l

0.48

349

1934

Chronic viral hepatitis

118

471

2.59

19.77

2.5

2.3

1.81

1.95

ug/l

0.07

106

434

Implicit parasitic Sepsis

8.07

19.74

1.4

1.5

1.09

7.82

ug/l

0.47

Late syphilis

160

4.06

19.70

2.4

2.2

4.77

3.70

ug/l

0.15

146

Nonalcoholic fatty liver disease

224

1162

1.98

19.66

1.9

2.1

2.05

1.90

ug/l

0.11

206

1054

Paraplegia, diplegia of upper limbs

279

3.19

19.65

2.9

2.1

4.95

2.49

ug/l

0.35

250

Lesion of ulnar nerve

327

1906

1.75

19.61

2.1

1.9

1.55

2.22

ug/l

0.71

278

1716

Persons with potential health hazards related to communicable diseases

600

3990

1.50

19.61

2.2

2.0

1.65

2.11

ug/l

0.71

547

3544

Intestinal malabsorption

129

541

2.49

19.59

3.0

1.9

1.62

1.88

ug/l

0.14

116

479

Chronic gastritis

671

4622

1.48

19.51

1.9

2.06

2.23

ug/l

0.17

570

4035

Superficial injury of thorax

357

2134

1.71

19.51

2.3

2.0

1.73

2.42

ug/l

0.55

315

1883

Dilated cardiomyopathy

349

2083

1.73

19.44

2.3

1.9

6.00

2.52

ug/l

0.41

316

1833

Injuries to the elbow and forearm

1460

9956

1.30

19.41

1.9

2.0

1.98

2.27

ug/l

0.46

1275

8749

Excessive, frequent and irregular menstruation

667

2461

1.50

19.40

2.1

1.9

2.04

2.01

ug/l

0.02

559

2165

Small fibre neuropathy

106

410

2.76

19.36

2.5

1.9

0.85

2.07

ug/l

0.89

371

Alzheimer’s disease (Atypical or mixed), excluding more controls

258

1110

1.91

19.33

1.6

1.8

2.12

2.39

ug/l

0.12

202

964

Postprocedural musculoskeletal disorders, not elsewhere classified

206

1049

2.04

19.31

2.4

2.0

2.80

1.80

ug/l

0.40

182

922

Thiazolidinediones

310

1793

1.78

19.29

1.8

1.9

3.08

2.62

ug/l

0.16

274

1558

Inflammatory diseases of female pelvic organs

989

5316

1.38

19.26

2.0

1.9

2.83

2.15

ug/l

0.68

838

4669

Arthropod-borne viral fevers and viral haemorrhagic fevers

249

1351

1.90

19.17

2.3

2.0

1.98

2.12

ug/l

0.08

229

1214

Malignant neoplasm of stomach

150

679

2.30

19.10

2.0

1.7

3.03

1.93

ug/l

0.44

135

578

Complications of genitourinary prosthetic devices, implants and grafts

256

3.22

19.10

2.1

2.0

8.71

1.94

ug/l

0.66

226

Childhood asthma (age<16), excluding more controls

111

334

2.64

18.96

2.3

1.6

3.95

2.03

ug/l

0.67

100

290

Reactive arthropathies

202

1024

2.02

18.94

2.2

1.9

2.93

2.14

ug/l

0.18

188

927

Fall involving bed

120

498

2.56

18.93

2.1

1.8

1.82

2.13

ug/l

0.14

423

Malignant neoplasm, without specification of site

106

413

2.70

18.92

2.0

1.6

2.01

1.83

ug/l

0.11

347

Viral hepatitis

162

757

2.20

18.91

2.5

2.1

1.52

1.76

ug/l

0.19

146

689

Assault

240

1287

1.90

18.89

2.4

2.1

3.73

1.77

ug/l

0.98

211

1173

Irregular menses

666

3607

1.47

18.84

2.1

1.9

4.18

1.95

ug/l

0.51

587

3205

Crohn's disease of large intestine

123

514

2.48

18.74

2.1

2.0

5.09

1.65

ug/l

0.74

114

461

Oesophageal varices

133

579

2.42

18.73

2.6

2.0

2.81

2.01

ug/l

0.34

122

514

Other chondrocalcinosis

191

3.75

18.73

2.4

1.8

0.60

3.07

ug/l

0.95

167

Exclusions for E4_PCOS_CONSORTIUM

1283

6112

1.32

18.72

2.2

1.9

2.04

2.18

ug/l

0.19

1121

5355

Congenital malformations of the circulatory system

293

1624

1.79

18.71

2.6

2.0

2.25

2.32

ug/l

0.04

260

1462

Left ventricular outflow tract obstruction, narrow definition

132

571

2.41

18.70

3.2

2.1

2.34

2.02

ug/l

0.13

121

519

Urticaria

545

3627

1.52

18.68

2.1

2.0

1.70

2.14

ug/l

0.37

474

3210

Nephrotic syndrome

376

2.78

18.62

3.0

1.8

5.87

2.12

ug/l

0.49

338

Vitamin deficiency, wide

133

579

2.39

18.58

2.5

2.0

2.43

1.53

ug/l

0.45

120

503

Vitamin deficiency

133

579

2.39

18.58

2.5

2.0

2.43

1.53

ug/l

0.45

120

503

Aneurysms, operations, SAH

401

2502

1.64

18.57

2.3

1.9

2.33

2.50

ug/l

0.10

337

2220

Protein-energy malnutrition of moderate and mild degree

5.09

18.56

2.4

1.8

3.57

5.56

ug/l

0.20

Benign neoplasm: Colon, unspecified

655

4542

1.47

18.54

2.3

1.9

1.87

2.22

ug/l

0.49

566

4000

Other disorders of bone

384

2366

1.65

18.54

1.9

2.46

ug/l

0.00

340

2129

Recurrent aphthous stomatitis , including avohilmo

312

1828

1.74

18.37

2.1

2.0

2.36

2.15

ug/l

0.12

272

1613

Neuralgia and neuritis, unspecified

133

582

2.37

18.32

2.3

2.1

2.17

1.67

ug/l

0.23

109

516

Other disorders of white blood cells

152

705

2.24

18.28

2.8

1.8

1.86

1.89

ug/l

0.01

138

624

Reactive arthropathies, FINNGEN

160

755

2.18

18.24

2.2

2.0

0.93

1.71

ug/l

1.04

149

680

Malignant neoplasm of mesothelium and soft tissue

115

474

2.54

18.23

2.1

1.8

0.82

1.51

ug/l

0.96

104

408

Etanercept

138

614

2.31

18.18

1.9

2.1

1.72

1.84

ug/l

0.04

122

556

Disorders of the thyroid gland

2088

11032

1.24

18.17

2.0

1.65

2.24

ug/l

2.22

1835

9699

Umbilical hernia

630

4350

1.47

18.13

2.0

2.22

2.09

ug/l

0.13

577

3876

Right hemicolectomy

185

930

2.08

18.09

2.3

1.9

1.72

2.11

ug/l

0.24

168

805

Acute bronchiolitis

306

2.80

18.04

2.5

1.9

2.20

3.15

ug/l

0.34

261

Childhood asthma (age<16)

111

343

2.57

18.03

2.3

1.7

3.95

1.99

ug/l

0.69

100

300

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

115

4.45

17.98

2.5

1.7

9.89

3.64

ug/l

0.32

104

Focal brain injury

162

773

2.16

17.96

2.5

1.9

1.52

2.49

ug/l

0.73

131

682

Congenital malformations of heart and great arteries

260

1410

1.82

17.86

2.7

2.0

1.94

2.21

ug/l

0.19

234

1261

Fracture of foot, except ankle

463

3007

1.56

17.85

2.1

2.0

2.49

2.06

ug/l

0.35

418

2672

Myocardial infarction, with ST-elevation

503

3340

1.54

17.80

2.1

1.9

1.84

2.40

ug/l

0.68

460

2886

Other metabolic disorders

242

1327

1.86

17.80

2.4

1.9

2.18

1.93

ug/l

0.13

220

1182

IgA nephropathy (IgA glomerulonephritis)

284

3.04

17.78

2.4

2.0

2.20

2.51

ug/l

0.06

255

Late syphilis

207

3.46

17.66

2.4

2.0

4.38

2.99

ug/l

0.25

187

Haemolytic anaemias

106

428

2.60

17.60

3.2

2.0

4.62

2.02

ug/l

0.48

375

Weight loss

258

1456

1.82

17.51

1.9

3.05

2.40

ug/l

0.26

215

1267

Acute and transient psychotic disorders

238

1307

1.86

17.50

2.2

2.1

2.02

1.85

ug/l

0.09

207

1172

Other misadventures during surgical and medical care

298

2.97

17.49

2.9

1.9

2.24

2.41

ug/l

0.05

265

Spondylolisthesis/Spondylolysis

396

2497

1.61

17.49

2.2

1.9

2.49

2.22

ug/l

0.19

361

2243

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1108

8185

1.33

17.44

2.1

2.0

1.47

2.24

ug/l

2.51

958

7276

Any dementia, excluding more controls

971

4962

1.37

17.38

1.8

1.9

2.92

2.25

ug/l

0.58

756

4364

Congenital malformations of aortic and mitral valves

117

497

2.46

17.36

3.2

2.0

2.51

2.18

ug/l

0.11

107

448

Disorders of continuity of bone

205

1078

1.95

17.30

2.5

2.0

2.20

2.03

ug/l

0.12

185

973

Amiodarone users

298

1764

1.75

17.24

2.0

1.9

1.71

2.46

ug/l

0.67

264

1545

Juvenile arthritis (FINNGEN)

303

2.85

17.17

2.3

2.0

1.13

1.72

ug/l

0.48

272

Personal history of risk-factors, not elsewhere classified

4.61

17.16

2.2

1.8

2.46

1.32

ug/l

0.28

Other juvenile arthritis

260

3.01

17.12

2.4

2.0

1.22

2.15

ug/l

0.67

233

Migraine

769

4473

1.40

17.11

2.0

1.9

2.03

2.20

ug/l

0.17

679

3952

Wegener granulomatosis

191

3.52

17.08

2.6

1.9

2.49

2.94

ug/l

0.09

171

Other epidermal thickening

123

538

2.38

17.07

2.3

1.9

2.30

1.96

ug/l

0.12

117

479

Secondary parkinsonism, excluding more controls

290

2.95

17.05

2.1

1.9

1.03

1.72

ug/l

0.66

263

Acute lymphadenitis

128

568

2.32

17.01

2.3

2.0

1.83

1.95

ug/l

0.05

117

502

Acute laryngitis and tracheitis

173

845

2.04

16.99

1.8

2.0

1.51

2.14

ug/l

0.41

151

751

Pruritus

238

1321

1.84

16.95

2.4

1.9

2.59

2.42

ug/l

0.08

217

1158

Orchitis and epididymitis

258

1471

1.80

16.92

2.1

2.0

1.96

2.65

ug/l

0.48

232

1301

Other diseases of oesophagus

250

1413

1.82

16.87

2.0

1.9

2.99

2.45

ug/l

0.19

219

1229

Parkinson's disease, excluding more controls

327

1869

1.68

16.81

1.8

2.41

2.63

ug/l

0.12

273

1662

Other symptoms and signs involving general sensations and perceptions

116

499

2.42

16.74

1.8

1.43

1.55

ug/l

0.05

432

Localized swelling, mass and lump of skin and subcutaneous tissue

678

4817

1.43

16.67

2.2

2.0

1.76

2.14

ug/l

0.53

603

4273

Myeloproliferative diseases

230

1277

1.86

16.59

2.1

1.9

1.42

2.44

ug/l

0.99

206

1116

Previous suicide attempt

5.36

16.50

2.1

1.7

2.90

1.07

ug/l

0.40

Other fall from one level to another

466

3092

1.53

16.35

2.2

2.0

1.70

2.32

ug/l

0.82

410

2736

Other meningitis

156

3.70

16.29

2.2

1.8

1.16

3.14

ug/l

0.54

139

Other hearing loss

712

5015

1.41

16.27

2.0

1.9

2.66

2.34

ug/l

0.19

604

4397

Other specified/unspecified bacterial intestinal infections

168

847

2.05

16.20

2.0

1.9

2.14

2.17

ug/l

0.01

149

739

Coxarthrosis, primary

1494

10078

1.27

16.18

1.9

2.0

2.70

2.17

ug/l

0.53

1285

8862

Hypopituitarism

158

778

2.09

16.16

2.6

2.0

2.58

2.28

ug/l

0.13

144

707

Primary gonarthrosis, bilateral

1245

8315

1.30

16.13

1.9

2.0

2.40

2.33

ug/l

0.06

1068

7325

Other aneurysm

166

837

2.06

16.11

2.3

1.9

1.68

2.67

ug/l

0.54

141

724

Personal history of certain other diseases

106

4.23

16.07

1.8

1.5

1.87

4.78

ug/l

0.47

Mixed and other personality disorders

154

752

2.10

16.05

2.2

2.1

2.83

1.75

ug/l

0.50

140

686

Primary adrenocortical insufficiency

103

4.43

16.03

2.8

1.7

3.42

3.71

ug/l

0.04

Olecranon bursitis

182

949

1.99

16.00

2.5

2.0

1.02

2.79

ug/l

1.86

164

839

366

2.69

15.98

2.5

1.8

1.10

2.62

ug/l

0.85

318

Hypothyroidism, other/unspecified

1913

10260

1.23

15.98

2.0

1.71

2.28

ug/l

2.14

1680

9015

Chronic sinusitis

854

6336

1.36

15.94

2.2

2.0

2.13

2.25

ug/l

0.10

757

5598

Cholangitis (primary sclerosing, PSC), with reimbursement 202

168

3.54

15.94

1.9

1.8

1.94

1.53

ug/l

0.21

154

Hepatocellular carcinoma, including Hilmo

366

2.65

15.84

2.0

1.7

1.88

1.98

ug/l

0.06

317

Malignant neoplasm of head and neck

199

1070

1.91

15.82

2.0

1.7

1.54

1.71

ug/l

0.12

175

925

Subarachnoid haemorrhage

267

1569

1.75

15.76

2.6

1.9

1.95

2.24

ug/l

0.18

219

1376

Viral infections of the central nervous system

161

806

2.05

15.76

2.0

2.1

1.16

1.67

ug/l

0.40

137

711

Hepatocellular carcinoma

271

2.95

15.65

2.0

1.7

1.39

2.16

ug/l

0.63

233

Other endocrine disorders

106

429

2.44

15.65

2.1

2.0

1.92

2.28

ug/l

0.15

377

Other specified and unspecified personality disorders

175

904

1.98

15.59

2.1

2.11

1.67

ug/l

0.24

162

821

Panic disorder

222

1235

1.82

15.57

2.6

1.9

2.11

1.83

ug/l

0.14

202

1094

Rheumatoid lung disease

5.87

15.55

2.5

1.9

2.37

5.74

ug/l

0.35

Hypothyreosis and Thyroxine purchase for inclusion criteria

1970

10607

1.23

15.47

2.1

2.0

1.73

2.25

ug/l

1.95

1728

9323

Injuries to the neck

444

2952

1.52

15.47

2.1

2.0

2.76

2.28

ug/l

0.21

402

2602

Polycythaemia vera

406

2.53

15.45

2.3

1.7

1.16

1.60

ug/l

0.36

354

Adverse effects, not elsewhere classified

359

2278

1.60

15.44

2.2

2.0

1.49

2.21

ug/l

1.00

310

2021

Squamous cell neoplasms and carcinomas of the skin

222

1246

1.83

15.39

1.7

1.12

1.92

ug/l

1.75

190

1051

Cerebral cysts

137

653

2.16

15.35

3.0

2.0

2.67

1.88

ug/l

0.30

123

579

Presbycusis

395

2549

1.57

15.33

1.9

1.8

3.53

2.61

ug/l

0.36

332

2172

Car occupant injured in other and unspecified transport accidents

355

2252

1.60

15.30

2.2

2.0

1.91

2.55

ug/l

0.60

320

1995

Lesion of lateral popliteal nerve

136

649

2.18

15.29

2.6

2.0

3.91

2.50

ug/l

0.44

124

579

Use of biperiden

137

656

2.16

15.24

2.1

2.0

2.01

1.74

ug/l

0.12

122

589

Follow-up care involving plastic surgery

324

2.68

15.22

2.2

1.7

0.86

2.13

ug/l

1.26

287

Presence of other devices

572

3999

1.45

15.17

2.1

1.9

2.16

2.33

ug/l

0.08

495

3488

Erythema intertrigo

310

2.78

15.16

2.1

1.9

2.81

2.46

ug/l

0.09

271

Dissociative [conversion] disorders

296

2.75

15.12

2.2

2.0

1.21

2.37

ug/l

0.52

262

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

231

1160

1.79

15.09

2.0

2.1

2.71

1.85

ug/l

0.50

208

1037

Asthma mixed form (mode), excluding more controls

313

2.67

15.03

1.8

1.7

0.81

4.16

ug/l

1.59

265

Cardiac murmurs and other cardiac sounds

167

849

1.98

15.00

2.1

1.9

2.54

2.26

ug/l

0.11

148

751

Post-traumatic wound infection, not elsewhere classified

305

2.76

14.99

2.3

2.0

1.44

2.32

ug/l

0.39

274

Visual impairment including blindness (binocular or monocular)

182

970

1.93

14.95

2.0

1.8

3.06

2.34

ug/l

0.28

137

835

Non-small cell lung cancer, squamous, helper endpoint

162

833

2.03

14.95

2.1

1.8

1.25

2.87

ug/l

1.19

145

717

Mental retardation, excluding more controls

284

2.76

14.86

2.0

2.1

1.96

2.45

ug/l

0.13

253

Malignant neoplasm of brain, including Hilmo

114

512

2.30

14.83

2.1

1.8

1.00

1.49

ug/l

0.39

447

Bicuspidal aortic valve syndrome

103

445

2.42

14.80

3.2

2.1

1.83

2.30

ug/l

0.22

406

Pleural plaque with presence of asbestos

255

1515

1.75

14.79

1.7

1.9

1.07

2.63

ug/l

2.54

220

1316

Disorders of ocular muscles, binocular movement, accommodation and refraction

852

6340

1.34

14.78

2.3

2.0

3.24

2.01

ug/l

1.35

741

5640

Viral infections of the central nervous system

166

861

1.98

14.70

2.0

2.1

1.13

1.74

ug/l

0.52

141

762

Speech disturbances, not elsewhere classified

237

1376

1.77

14.70

2.1

1.9

2.96

2.49

ug/l

0.20

194

1185

Other disorders of veins

807

5986

1.35

14.69

1.9

2.17

2.07

ug/l

0.06

689

5250

L01XX Other antineoplastic agents

170

894

1.98

14.69

2.5

1.9

1.49

2.40

ug/l

0.61

153

783

Acute pharyngitis

228

1292

1.77

14.62

2.1

2.29

2.35

ug/l

0.03

204

1170

Pain in thoracic spine

298

1834

1.65

14.60

1.9

1.05

2.22

ug/l

2.42

265

1640

Benign neoplasm: Duodenum

364

2.60

14.60

2.5

1.9

3.60

2.14

ug/l

0.49

323

Sequelae of injuries of neck and trunk

363

2.57

14.54

2.8

2.0

1.30

2.42

ug/l

0.65

324

Oesophagitis

147

736

2.07

14.54

2.0

1.9

2.22

2.51

ug/l

0.12

131

645

Keratitis

725

5331

1.37

14.54

2.1

2.0

2.71

2.14

ug/l

0.58

656

4695

Polyuria

534

3735

1.45

14.52

1.9

2.0

1.44

2.03

ug/l

1.08

452

3301

Adenocarcinoma of pancreas

346

2.62

14.51

1.8

1.7

4.05

1.99

ug/l

0.60

302

Intracerebral haemorrhage

344

2202

1.60

14.48

2.3

1.8

3.13

2.60

ug/l

0.17

287

1892

Conjunctivitis (acute, non atopic)

530

3687

1.45

14.39

2.0

1.24

2.22

ug/l

2.42

470

3260

Spondylopathies in diseases classified elsewhere

171

3.46

14.37

1.8

2.0

1.09

2.82

ug/l

0.51

153

Problems related to social environment

317

2.67

14.36

2.4

1.8

2.53

2.49

ug/l

0.01

271

Cervicobrachial syndrome

425

2845

1.51

14.36

2.1

2.0

1.28

2.22

ug/l

1.96

381

2557

Congenital iodine-deficiency syndrome/hypothyroidism

348

2.59

14.29

2.4

2.0

1.19

2.50

ug/l

0.79

299

Gonarthrosis, primary, with knee surgery

1409

9004

1.26

14.28

1.9

2.0

2.68

2.32

ug/l

0.38

1220

7934

Superficial injury of abdomen, lower back and pelvis

309

1931

1.63

14.27

2.1

1.9

2.75

2.34

ug/l

0.22

268

1703

Kyphosis

151

3.57

14.22

2.2

2.0

2.55

3.35

ug/l

0.15

134

Amenorrhoea

418

2.39

14.22

2.1

1.9

1.19

1.98

ug/l

0.76

371

Parkinson's disease, strict definition, excluding more controls

302

1790

1.64

14.15

1.8

2.32

2.64

ug/l

0.18

251

1593

Irritable bowel syndrome

483

3325

1.47

14.13

2.0

1.9

1.85

2.09

ug/l

0.20

425

2912

Acute suppurative otitis media

367

2223

1.55

14.07

2.3

2.0

1.66

1.85

ug/l

0.14

328

1982

Abnormal weight loss

232

1357

1.76

14.03

2.0

3.22

2.45

ug/l

0.28

190

1182

Emotional disorders starting during childhood or adolecense, excluding more controls

141

3.44

13.97

2.0

1.8

3.99

1.31

ug/l

0.61

115

Cervicalgia

423

2851

1.50

13.88

1.9

1.95

2.25

ug/l

0.27

377

2540

Persons encountering health services for specific procedures, not carried out

148

752

2.01

13.86

2.2

1.8

3.42

2.33

ug/l

0.48

136

666

Benign neoplasm: Small intestine

124

596

2.18

13.86

2.5

1.9

3.81

1.90

ug/l

0.76

104

526

Dementia in Alzheimer disease

508

2991

1.46

13.84

1.6

1.8

3.06

2.47

ug/l

0.39

367

2552

Left bundle-branch block

166

880

1.94

13.83

2.0

1.8

2.22

2.16

ug/l

0.02

146

769

Periapical abscess

904

6918

1.32

13.81

2.1

2.05

2.11

ug/l

0.06

820

6150

Infective bursitis

410

2.44

13.80

2.3

2.1

0.83

1.45

ug/l

1.15

369

Other specified/unspecified spondylopathies

325

2.63

13.77

1.8

2.2

1.56

1.92

ug/l

0.13

285

Chronic periodontitis, complicated

1214

9564

1.27

13.74

2.1

2.0

2.58

2.04

ug/l

0.54

1064

8542

Postprocedural endocrine and metabolic disorders, not elsewhere classified

211

1204

1.78

13.72

2.4

1.9

2.30

1.92

ug/l

0.18

191

1072

Other and unspecified disorders of white blood cells

110

505

2.27

13.72

3.0

1.8

2.36

1.88

ug/l

0.22

100

448

Medicines for HER+ breast cancer

672

4666

1.38

13.71

1.9

1.94

2.40

ug/l

0.44

579

4076

Arthropathic psoriasis

245

1461

1.71

13.71

2.1

2.0

1.84

2.41

ug/l

0.51

218

1321

Syphilis

302

2.68

13.69

2.3

2.1

3.87

2.33

ug/l

0.36

270

Syphilis

302

2.68

13.69

2.3

2.1

3.87

2.33

ug/l

0.36

270

Renal tubulo-interstitial disorders in diseases classified elsewhere

107

4.09

13.68

2.8

2.0

5.98

3.77

ug/l

0.16

Behavioural disorders, excluding more controls

4.08

13.67

2.1

1.9

3.76

1.24

ug/l

0.43

Spontaneous rupture of synovium and tendon

203

1151

1.81

13.66

2.1

2.0

1.39

2.80

ug/l

1.36

181

1024

6-mercaptopurine

222

2.92

13.55

1.7

2.1

1.24

1.63

ug/l

0.20

198

Menorrhagia

597

2349

1.42

13.53

2.1

1.9

2.47

2.00

ug/l

0.37

495

2064

Benign neoplasm: Rectum

452

3112

1.48

13.50

1.9

2.0

2.55

2.29

ug/l

0.14

405

2722

Speech and linguistic disorders

131

615

2.08

13.49

2.3

2.0

3.14

2.08

ug/l

0.44

107

539

Open wound of forearm

219

1273

1.76

13.47

2.0

1.9

1.17

2.07

ug/l

0.86

186

1129

Strabismus

497

3465

1.45

13.47

2.5

1.9

2.91

2.22

ug/l

0.47

425

3065

Abnormal findings on examination of urine, without diagnosis

120

575

2.17

13.43

2.0

1.9

1.63

2.07

ug/l

0.26

108

513

Diplopia

303

1917

1.61

13.42

2.1

1.9

1.72

2.51

ug/l

0.47

265

1691

Other/unspecified synovitis and tenosynovitis

242

1446

1.71

13.41

1.9

2.0

0.97

2.71

ug/l

3.07

221

1282

Malignant neoplasm of oral cavity, including Hilmo

112

522

2.22

13.40

2.1

1.8

2.23

1.73

ug/l

0.22

454

Artrosis, including avohilmo

1833

8277

1.22

13.36

2.0

2.37

2.29

ug/l

0.07

1567

7382

Encephalitis

317

2.60

13.35

2.4

2.2

0.68

2.27

ug/l

1.01

280

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

113

3.89

13.35

1.9

1.7

2.19

1.77

ug/l

0.09

100

Moderate visual impairment, binocular

429

2.37

13.31

1.9

1.8

3.95

2.21

ug/l

0.36

355

Malignant neoplasm of small intestine, including Hilmo

348

2.53

13.31

2.0

1.7

3.00

1.75

ug/l

0.41

307

Acute and subacute iridocyclitis

399

2687

1.51

13.21

2.1

1.9

1.63

2.44

ug/l

0.86

358

2367

Extrapyramidal and movement disorders

871

6684

1.32

13.16

2.0

1.9

1.97

2.18

ug/l

0.25

739

5874

Iridocyclitis

472

3287

1.46

13.14

2.1

1.9

1.45

2.30

ug/l

1.20

425

2890

Anterior Iridocyclitis

422

2878

1.49

13.12

2.1

2.0

1.57

2.42

ug/l

1.02

380

2547

Chronic myeloid leukaemia, including Hilmo

4.44

13.10

2.6

1.7

1.81

2.08

ug/l

0.07

Disorders of psychological development

161

792

1.91

13.05

2.2

2.1

3.08

1.86

ug/l

0.61

135

698

Other arterial embolism and thrombosis

389

2.43

13.03

2.7

1.8

0.98

2.09

ug/l

0.70

327

Pain associated with micturition

251

1527

1.68

13.03

2.1

1.9

1.47

1.88

ug/l

0.36

213

1339

Malignant immunoproliferative diseases

151

3.52

13.01

2.7

1.8

3.36

3.76

ug/l

0.06

133

Other renal tubulo-interstitial diseases

201

3.01

12.97

2.3

1.7

2.87

2.47

ug/l

0.06

175

Nummular dermatitis

201

1156

1.79

12.93

2.4

1.9

1.63

2.39

ug/l

0.62

185

1023

Injuries to unspecified part of trunk, limb or body region

233

1395

1.71

12.89

2.3

1.9

2.68

2.03

ug/l

0.33

199

1232

Ovarian cyst

580

2385

1.41

12.85

2.1

1.9

2.10

2.00

ug/l

0.07

491

2103

Artificial joint re-operation

186

1051

1.83

12.81

2.0

1.9

1.78

2.08

ug/l

0.19

159

918

Bronchitis, not specified as acute or chronic

195

1113

1.79

12.81

2.4

2.0

3.73

2.71

ug/l

0.21

164

983

Other diseases of spinal cord

367

2.45

12.78

2.9

2.0

2.09

2.19

ug/l

0.02

331

Meningitis

117

565

2.14

12.77

2.4

2.1

1.02

1.80

ug/l

0.70

105

499

Need for other prophylactic measures

140

723

2.00

12.71

1.8

2.0

2.10

1.72

ug/l

0.20

132

644

Malignant neoplasm of rectosigmoid junction

167

3.25

12.71

2.2

1.8

2.75

2.35

ug/l

0.10

148

Hypothyroidism, strict autoimmune, 3 medication purchases required

1735

9697

1.22

12.70

2.0

1.9

1.75

2.22

ug/l

1.46

1508

8516

Other female pelvic inflammatory diseases

271

1689

1.63

12.69

2.3

1.9

2.30

1.88

ug/l

0.26

221

1502

Female infertility, associated with anovulation

383

2.35

12.67

2.0

1.9

2.94

1.94

ug/l

0.20

337

Migraine with aura

342

2249

1.53

12.55

2.0

1.9

2.08

2.18

ug/l

0.06

293

1999

Haemophagocytic lymphohistiocytosis

17.85

12.55

4.4

1.6

2.03

0.39

ug/l

0.80

Benign neoplasm: Rectum, anus and anal canal

496

3522

1.43

12.53

1.9

2.0

2.37

2.28

ug/l

0.05

444

3082

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

113

3.75

12.53

2.6

2.1

0.64

3.31

ug/l

0.60

106

Hyperkinetic disorders, excluding more controls

106

470

2.18

12.51

1.8

2.0

1.82

1.40

ug/l

0.22

412

Malignant neoplasm of brain

327

2.50

12.47

2.0

1.7

0.66

1.68

ug/l

1.05

287

Other psoriatic arthropathies

221

1319

1.71

12.39

2.2

2.0

1.82

2.00

ug/l

0.14

197

1183

Psoriatic arthropathies, ICD10

226

1357

1.70

12.39

2.2

2.0

1.79

1.96

ug/l

0.13

201

1218

Asthma mixed form (mode)

345

2.42

12.35

1.8

1.7

0.81

3.79

ug/l

1.55

293

Malignant neoplasm of breast, ER-negative, including Hilmo

351

2220

1.52

12.32

1.9

1.8

1.21

2.32

ug/l

2.83

312

1885

Injuries to the wrist and hand

2071

12105

1.19

12.31

2.0

1.86

2.29

ug/l

0.91

1788

10728

Cachexia

6.22

12.25

2.0

1.6

1.78

0.52

ug/l

1.03

Any event in hilmo or specialist outpatient

+∞

12.23

1.9

0.0

16.85

—

ug/l

—

Any dementia

1048

5745

1.28

12.23

1.8

1.9

2.83

2.26

ug/l

0.51

819

5009

Mixed hyperlipidaemia

108

516

2.17

12.21

2.1

2.0

4.07

2.55

ug/l

0.47

457

Open wound of hip and thigh

337

2.46

12.18

2.2

2.0

1.74

2.30

ug/l

0.20

297

Idiopathic thrombocytopenic purpura

363

2.42

12.15

2.1

1.9

0.92

2.02

ug/l

0.67

321

Diseases of salivary glands

631

4676

1.36

12.15

2.1

1.9

1.88

2.14

ug/l

0.32

559

4139

Mental and behavioural disorders due to use of other stimulants, including caffeine

192

2.95

12.09

2.5

2.1

3.31

1.76

ug/l

0.54

177

Systemic sclerosis (FG)

238

2.77

12.07

2.1

1.20

1.27

ug/l

0.06

211

Other follicular disorders

146

781

1.91

11.88

2.3

2.0

0.91

1.84

ug/l

1.32

128

707

Benign neoplasm: Caecum

273

1742

1.61

11.83

2.2

1.9

1.35

2.41

ug/l

1.70

248

1524

Rare circulating lymphoid malignancy

5.04

11.82

3.7

1.8

0.82

2.46

ug/l

0.72

Other encephalitis

306

2.52

11.80

2.4

2.2

0.72

2.31

ug/l

0.96

272

Other enthesopathies

553

4032

1.39

11.79

2.0

1.49

2.41

ug/l

1.79

481

3593

Benign neoplasm: Sigmoid colon

462

3277

1.43

11.79

2.0

1.88

2.28

ug/l

0.44

417

2876

Right bundle-branch block

431

2.26

11.78

2.0

1.7

4.49

2.68

ug/l

0.48

377

Other symptoms and signs involving the urinary system

258

1625

1.62

11.76

1.9

3.69

2.07

ug/l

0.60

239

1439

Other disorders of the musculoskeletal system and connective tissue

329

2188

1.53

11.71

2.3

1.9

2.11

2.23

ug/l

0.06

289

1932

Lichen simplex chronicus

420

2.28

11.70

1.7

1.9

2.07

2.01

ug/l

0.02

371

Malignant neoplasm of eye, brain and central nervous system

438

2.24

11.70

1.9

1.7

0.86

1.81

ug/l

1.00

380

Other mental disorders due to brain damage and dysfunction and to physical disease

296

1930

1.57

11.63

2.0

1.9

1.67

2.06

ug/l

0.44

249

1694

Use of pramipexole

503

3627

1.41

11.63

2.1

1.9

2.44

2.21

ug/l

0.18

438

3185

Other diseases of upper respiratory tract

2464

11006

1.17

11.62

2.0

1.94

2.42

ug/l

1.03

2169

9669

Malignant neoplasm of anus and anal canal

5.73

11.62

1.9

1.4

6.31

3.02

ug/l

0.39

KRA_PSY_EATING, excluding more controls

377

2.30

11.61

2.2

1.8

2.24

2.01

ug/l

0.07

331

Nonorganic sleeping disorders

346

2324

1.51

11.61

2.1

2.0

2.10

2.13

ug/l

0.02

310

2065

Appendectomy

1198

9262

1.24

11.59

2.1

2.0

1.93

2.10

ug/l

0.24

1082

8199

Obsessive-compulsive disorder

425

2.22

11.57

1.7

2.0

1.62

2.51

ug/l

0.40

376

Myeloproliferative diseases (CML excluded)

197

1166

1.74

11.55

2.1

1.9

1.33

2.56

ug/l

1.18

173

1017

Persistent mood disorders

365

2482

1.49

11.55

2.4

1.9

2.26

2.25

ug/l

0.01

322

2179

Thyroiditis, ILD-related definition

197

1161

1.72

11.52

1.9

2.0

9.24

1.94

ug/l

0.49

173

1029

Urolithiasis

761

5854

1.32

11.40

2.0

2.72

2.18

ug/l

0.71

671

5177

Nail disorders

171

974

1.79

11.37

2.4

2.1

2.75

1.92

ug/l

0.41

155

870

Assault by bodily force

137

728

1.92

11.35

2.4

2.1

4.05

1.92

ug/l

0.58

121

664

Other and unspecified psoriasis

162

911

1.83

11.33

2.0

2.35

2.15

ug/l

0.09

142

815

Prurigo nodularis

326

2.45

11.27

2.0

1.9

3.34

2.32

ug/l

0.33

285

Erythema multiforme

253

2.65

11.25

2.6

2.0

1.35

2.67

ug/l

0.47

223

Other/unspecified reactive arthropathies

147

804

1.88

11.24

2.1

0.97

1.81

ug/l

0.98

136

715

Impacted cerumen

246

1553

1.62

11.15

1.8

2.0

4.32

2.29

ug/l

0.36

156

1361

Collapsed vertebra, not elsewhere classified

104

3.81

11.12

1.9

1.8

0.28

4.43

ug/l

0.84

Event of undetermined intent

131

692

1.94

11.12

2.5

2.0

1.71

1.66

ug/l

0.02

114

623

Benign neoplasm: Stomach

229

1423

1.65

11.09

2.0

2.74

2.46

ug/l

0.13

199

1252

D07AA Corticosteroids, weak (group I)

264

1689

1.58

11.05

2.0

2.59

2.20

ug/l

0.15

233

1503

Pre-eclampsia

268

1722

1.57

11.03

1.9

2.0

1.78

1.85

ug/l

0.05

242

1539

Pregnancy hypertension

528

3451

1.38

11.00

1.9

2.0

1.61

2.01

ug/l

0.58

472

3071

Amyloidosis

299

2.50

10.99

2.4

1.9

1.08

2.89

ug/l

1.03

262

Asthma and opportunity respiratory infection

124

649

1.98

10.97

2.6

2.0

1.20

2.44

ug/l

0.89

114

566

Necrosis of pulp, including avohilmo

1044

8353

1.25

10.96

2.2

2.0

3.22

2.12

ug/l

0.36

923

7460

Mental disorders, not otherwise specified

138

744

1.89

10.94

2.2

2.0

1.79

ug/l

0.00

121

668

Benign neoplasm: Transverse colon

274

1783

1.57

10.94

2.2

1.9

1.62

2.39

ug/l

0.83

253

1577

Generalized anxiety disorder

213

1298

1.66

10.92

2.1

2.0

2.96

1.74

ug/l

0.75

191

1149

Allergic urticaria

152

846

1.83

10.91

2.0

1.31

1.74

ug/l

0.27

129

750

Other overlap syndromes

188

2.91

10.91

2.0

1.9

2.64

2.73

ug/l

0.02

169

Alcohol withdrawal state with delirium

182

1072

1.75

10.90

2.3

2.0

3.02

2.48

ug/l

0.20

168

974

Diffuse brain injury

361

2.31

10.84

3.4

1.9

2.85

1.79

ug/l

0.31

322

Follow-up examination after treatment for malignant neoplasms

221

1367

1.65

10.83

2.2

1.8

1.83

2.59

ug/l

0.60

185

1214

Examination and encounter for administrative purposes

111

560

2.04

10.83

2.2

1.9

1.81

3.23

ug/l

0.75

500

Ingrowing nail

114

584

2.00

10.64

2.5

2.1

2.62

1.79

ug/l

0.33

103

519

Benign neoplasm: Skin of other and unspecified parts of face

249

1595

1.59

10.60

1.9

1.23

2.39

ug/l

1.42

208

1379

Unspecified dementia

309

1860

1.52

10.59

1.7

1.8

4.19

2.38

ug/l

0.61

246

1587

Special screening examination for other diseases and disorders

202

1226

1.67

10.58

2.3

1.8

1.88

2.89

ug/l

0.61

184

1101

L02BG Aromatase inhibitors

551

4085

1.36

10.57

1.9

1.98

2.04

ug/l

0.05

479

3585

Malignant neoplasm of breast, HER-negative

313

2062

1.51

10.56

1.9

1.8

1.18

2.32

ug/l

2.79

285

1750

L02BB Anti-androgens

286

1897

1.55

10.55

1.9

3.43

2.44

ug/l

0.31

255

1629

Malignant neoplasm of rectosigmoid junction, including Hilmo

355

2.32

10.50

2.1

1.7

2.71

2.08

ug/l

0.24

310

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

181

2.92

10.49

2.3

1.7

1.75

1.35

ug/l

0.16

158

Tuberculosis, IBD comorbidity

186

1113

1.71

10.48

2.1

1.8

4.02

2.16

ug/l

0.39

158

955

Paralytic strabismus

175

1031

1.74

10.46

1.9

3.78

2.25

ug/l

0.46

147

905

Acquired absence of organs, not elsewhere classified

144

3.19

10.42

2.4

1.8

2.32

4.05

ug/l

0.34

126

Other shoulder lesions

183

1089

1.71

10.41

2.0

2.70

2.40

ug/l

0.10

159

978

Malignant neoplasm of penis, including Hilmo

4.61

10.41

2.2

1.9

2.79

2.12

ug/l

0.11

Myositis

325

2.38

10.39

2.6

2.1

1.13

1.33

ug/l

0.09

285

Left hemicolectomy

346

2.35

10.34

2.3

1.9

2.79

2.09

ug/l

0.22

306

Vitamin B12 deficiency anaemia

253

1636

1.58

10.34

2.0

1.9

3.72

2.22

ug/l

0.82

228

1399

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

598

3908

1.34

10.27

1.9

2.0

1.74

2.36

ug/l

0.67

533

3468

Hypothermia

266

2.55

10.26

1.9

2.0

1.01

2.50

ug/l

0.71

235

Oesophageal obstruction

102

512

2.07

10.23

2.4

1.9

1.04

2.39

ug/l

0.79

447

Sequelae of injuries of head

123

657

1.92

10.19

3.6

2.0

1.98

1.76

ug/l

0.08

100

593

Malignant neoplasm of oral cavity

385

2.24

10.18

1.7

2.49

1.79

ug/l

0.24

335

Malignant neoplasm of small intestine

230

2.64

10.18

2.0

1.8

3.14

2.24

ug/l

0.18

199

Other and unspecified haemorrhagic conditions

173

2.93

10.16

1.8

0.48

2.68

ug/l

0.77

155

Pre-eclampsia or eclampsia

287

1908

1.52

10.15

1.9

2.0

1.67

1.79

ug/l

0.09

261

1705

Wet age-related macular degeneration

468

3314

1.39

10.14

1.8

2.63

2.44

ug/l

0.11

384

2825

Other and unspecified urticaria

334

2293

1.47

10.12

2.1

2.0

1.31

2.19

ug/l

1.33

283

2044

Mental retardation

351

2.27

10.06

2.0

1.96

2.18

ug/l

0.06

318

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

563

4203

1.34

10.02

1.8

2.1

1.27

2.02

ug/l

1.70

497

3739

Specific development disorders of speech and language

460

2.07

9.99

2.3

2.0

2.74

2.39

ug/l

0.10

399

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

630

4811

1.32

9.97

2.2

2.0

3.90

2.20

ug/l

0.33

549

4259

Vascular syndromes of brain in cerebrovascular disorders

127

693

1.90

9.95

2.0

1.9

1.35

1.85

ug/l

0.25

113

612

Radiculopathy

360

2521

1.45

9.91

2.0

1.9

5.57

2.40

ug/l

0.37

319

2224

Disorders of vestibular function (Vertigo)

1005

8000

1.25

9.87

1.9

1.54

2.21

ug/l

1.98

852

7031

Migraine without aura

238

1529

1.57

9.83

1.9

1.43

1.89

ug/l

0.37

210

1358

Benign neoplasm of other and unspecified endocrine glands

277

1847

1.53

9.83

2.3

2.0

2.39

2.28

ug/l

0.06

244

1650

Other and unspecified injuries of head

153

883

1.77

9.82

1.9

2.1

2.17

2.30

ug/l

0.04

132

779

Migraine with aura and triptan purchases

204

1266

1.63

9.79

2.0

1.08

1.86

ug/l

1.10

174

1133

Myocardial infarction, unclassifiable

611

4158

1.33

9.77

2.0

1.9

1.73

2.40

ug/l

1.26

535

3541

Monoarthritis, not elsewhere classified

485

2.06

9.75

1.9

2.0

2.13

1.44

ug/l

0.30

434

Senility

3.56

9.72

1.9

1.4

1.53

0.96

ug/l

0.27

Complications of other internal prosthetic devices, implants and grafts

493

2.05

9.72

2.2

2.0

1.09

1.49

ug/l

0.45

432

Personal history of other diseases and conditions

139

777

1.80

9.66

2.6

1.8

1.48

2.19

ug/l

0.52

117

685

Crohn disease (strict definition, all UC cases excluded)

102

521

2.01

9.63

1.7

2.0

1.72

1.65

ug/l

0.03

465

Systemic sclerosis

267

2.46

9.61

2.1

1.9

1.20

2.18

ug/l

0.43

242

Arthropathy in Crohn disease

3.79

9.58

1.8

2.0

2.84

1.62

ug/l

0.21

Symptoms and signs involving speech and voice

680

5279

1.30

9.57

2.1

1.9

2.12

2.22

ug/l

0.09

584

4652

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

290

1960

1.50

9.57

2.0

7.33

2.19

ug/l

0.51

258

1759

Toxic effects of substances chiefly nonmedicinal as to source

215

1363

1.60

9.55

2.1

2.0

1.61

2.13

ug/l

0.42

195

1231

Emotional disorders and disorders of social functioning with onset specific to childhood

213

2.57

9.55

2.0

1.8

3.66

1.32

ug/l

0.62

182

Impingement syndrome of shoulder

486

3602

1.36

9.52

2.2

2.0

2.88

2.48

ug/l

0.17

428

3231

Abnormal findings on diagnostic imaging of central nervous system

497

2.02

9.46

2.1

1.9

1.94

1.80

ug/l

0.06

440

140

794

1.80

9.45

2.0

1.8

2.74

3.12

ug/l

0.11

126

654

Mental retardation, wide definition

400

2.14

9.44

2.0

2.12

2.01

ug/l

0.03

359

Heartburn

200

1250

1.62

9.42

1.8

1.9

1.27

2.20

ug/l

0.93

156

1096

Impetigo

390

2.15

9.38

2.0

1.9

2.52

1.95

ug/l

0.15

346

Universal erythroderma, KELA reimbursement

170

2.87

9.35

1.9

2.1

0.93

1.98

ug/l

0.88

153

Hydrocephalus

190

1180

1.65

9.33

2.2

1.9

1.81

2.18

ug/l

0.21

160

1017

Visual field defects

200

1257

1.63

9.33

2.3

1.9

2.21

2.65

ug/l

0.19

163

1106

Alcohol-induced acute pancreatitis

488

2.04

9.32

2.2

2.1

4.32

2.19

ug/l

0.66

443

Impotence

146

848

1.77

9.29

2.2

2.0

5.12

3.07

ug/l

0.32

135

752

Abnormal findings on antenatal screening of mother

390

2.13

9.28

2.1

2.0

2.80

1.65

ug/l

0.19

338

Endocrine disorders, other/unspecified

199

2.68

9.26

1.7

1.8

1.72

2.49

ug/l

0.19

180

Ulcerative colitis (strict definition, require KELA)

299

2047

1.48

9.26

2.0

7.15

2.44

ug/l

0.47

265

1841

Malignant neoplasm of other connective and soft tissue, including Hilmo

482

2.03

9.22

2.1

1.8

1.04

1.59

ug/l

0.52

416

Mixed disorders of conduct and emotions, excluding more controls

3.95

9.18

2.7

1.8

4.34

6.77

ug/l

0.16

Systemic sclerosis, icd10

274

2.40

9.09

2.1

1.9

1.20

2.05

ug/l

0.37

248

Primary coxarthrosis, bilateral

679

5317

1.29

9.03

1.9

2.38

2.19

ug/l

0.11

587

4646

Volvulus

352

2.21

9.02

2.3

1.9

3.43

2.29

ug/l

0.35

301

Mucosal proctocolitis

226

1469

1.56

9.01

2.0

7.25

2.40

ug/l

0.37

206

1320

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

321

2240

1.45

9.00

2.0

6.72

2.35

ug/l

0.47

284

2008

Redundant prepuce, phimosis and paraphimosis

417

3014

1.38

9.00

2.2

2.1

3.22

2.25

ug/l

0.54

370

2709

Disorders of speech understanding and production

350

2.18

8.98

2.6

2.0

3.05

2.66

ug/l

0.09

298

Other benign neoplasms of skin

787

6272

1.27

8.98

2.0

1.9

1.73

2.31

ug/l

1.13

676

5495

Behavioural disorders

128

3.05

8.98

2.1

1.8

3.76

1.11

ug/l

0.46

117

Conduct disorder

128

3.05

8.97

2.1

1.8

3.76

1.07

ug/l

0.47

115

Bacterial, viral and other infectious agents

168

1019

1.68

8.97

2.6

2.0

3.22

1.78

ug/l

0.31

154

916

Excessive earwax

1208

9816

1.21

8.97

1.9

2.0

2.82

2.10

ug/l

0.66

1014

8683

Amyloidosis, other/unspecified

240

2.50

8.92

2.5

1.9

1.14

3.28

ug/l

0.98

212

Fracture at wrist and hand level

636

4931

1.30

8.88

2.1

2.51

2.17

ug/l

0.26

546

4391

Pre-eclampsia or poor fetal growth

351

2483

1.42

8.85

1.9

2.0

1.83

1.88

ug/l

0.03

312

2211

Suppurative and unspecified otitis media

534

3583

1.33

8.83

2.2

2.0

1.34

2.23

ug/l

1.57

472

3170

Otitis externa

415

3040

1.38

8.79

1.9

2.0

2.31

2.22

ug/l

0.06

348

2700

Dementia

1100

6239

1.22

8.77

1.8

1.9

2.94

2.17

ug/l

0.83

858

5490

Open wound of abdomen, lower back and pelvis

316

2.25

8.77

3.0

2.0

0.75

2.35

ug/l

1.03

279

Panniculitis affecting regions of neck and back

409

2.09

8.73

2.5

2.1

2.37

1.97

ug/l

0.11

366

Tuberculosis, wide

190

1200

1.62

8.73

2.1

1.9

3.93

2.11

ug/l

0.39

162

1029

Ankylosing spondylitis

172

1058

1.65

8.71

2.1

2.0

0.99

2.21

ug/l

2.57

154

964

Congenital malformations of the respiratory system

182

2.69

8.67

3.1

2.1

1.72

2.77

ug/l

0.28

169

Cauda equina syndrome

143

2.96

8.66

3.2

2.0

1.44

3.95

ug/l

0.66

132

Malignant neoplasm of other connective and soft tissue

255

2.40

8.64

2.2

1.8

0.99

1.98

ug/l

0.71

222

Primary hyperparathyroidism

230

1519

1.54

8.63

2.0

1.9

1.11

2.10

ug/l

1.78

198

1334

Superficial injury of forearm

177

1099

1.64

8.62

1.7

2.0

1.25

1.78

ug/l

0.53

154

975

Panhypopituitarism

219

2.54

8.62

2.8

2.0

4.91

2.91

ug/l

0.47

197

Dislocation, sprain and strain of joints and ligaments at neck level

238

1582

1.52

8.56

2.0

1.77

2.01

ug/l

0.18

213

1421

Gastrojejunal ulcer

150

2.89

8.52

3.3

2.0

1.86

3.12

ug/l

0.26

133

Viral warts

351

2514

1.41

8.51

2.2

1.9

2.48

2.13

ug/l

0.24

328

2233

Striking against or struck by other objects

584

4510

1.30

8.51

2.1

1.44

2.21

ug/l

1.53

506

4019

Bacterial, viral and other infectious agents

159

965

1.68

8.51

2.6

2.1

3.38

1.84

ug/l

0.31

146

871

Abnormalities of gait and mobility

286

1981

1.47

8.50

2.2

1.9

3.78

2.04

ug/l

0.55

245

1712

Other noninflammatory disorders of uterus, except cervix

412

2025

1.39

8.47

2.1

1.9

1.79

2.09

ug/l

0.28

358

1779

Congenital malformations of trachea and bronchus

102

3.36

8.47

3.6

1.9

1.28

3.60

ug/l

0.41

Other salmonella infections

421

2.05

8.47

2.1

1.9

1.97

2.08

ug/l

0.03

368

Mild mental retardation

214

2.51

8.44

1.8

2.0

2.70

2.50

ug/l

0.04

195

Acne

118

658

1.81

8.41

2.0

2.1

2.08

1.99

ug/l

0.03

107

590

Coeliac disease

220

1446

1.54

8.39

2.1

1.9

2.17

2.22

ug/l

0.02

193

1285

Calculus of kidney and ureter

676

5342

1.28

8.36

2.0

2.82

2.18

ug/l

0.78

602

4722

Maltreatment syndromes

408

2.05

8.35

2.4

2.1

2.77

1.96

ug/l

0.23

364

Benign neoplasm: Descending colon

176

1106

1.63

8.32

2.0

1.52

2.57

ug/l

0.96

160

972

Atopic dermatitis, strict definition with reimbursement

394

2783

1.38

8.31

2.0

1.30

2.23

ug/l

1.51

349

2475

Malignant neoplasm of endocrine gland

114

635

1.83

8.28

2.5

1.9

15.33

1.88

ug/l

0.52

553

Secondary parkinsonism+Parkinsonism in other disease

413

2.07

8.26

2.3

1.8

1.02

1.91

ug/l

0.59

365

Polycystic ovarian syndrome, broad definition

106

576

1.86

8.25

2.0

1.8

2.60

1.50

ug/l

0.27

511

Dementia, including avohilmo

1167

6694

1.21

8.24

1.8

1.9

2.81

2.18

ug/l

0.68

905

5902

Adhesive capsulitis of shoulder

331

2364

1.42

8.23

2.0

2.91

2.44

ug/l

0.16

303

2091

Rash and other nonspecific skin eruption

195

1255

1.58

8.23

2.3

1.9

1.95

2.09

ug/l

0.08

175

1107

Other specified disorders of muscle

352

2.14

8.20

2.3

2.2

2.05

1.35

ug/l

0.33

307

Secondary parkinsonism

408

2.07

8.17

2.1

1.9

1.03

1.94

ug/l

0.58

359

Anoxic brain damage

189

2.64

8.16

2.4

2.0

0.98

1.65

ug/l

0.60

166

Fissure and fistula of anal and rectal regions

440

3293

1.35

8.13

2.1

1.9

1.57

2.18

ug/l

0.82

381

2926

therapeutic use

415

2.05

8.13

1.9

1.42

1.34

ug/l

0.04

371

Perforation of tympanic membrane

202

1316

1.56

8.08

2.0

1.23

2.30

ug/l

1.20

177

1160

Generalized epilepsy

373

2.08

8.07

2.8

1.9

1.08

2.11

ug/l

0.66

329

Sacroiliitis, not elsewhere classified

366

2.09

8.06

2.1

2.2

0.93

2.37

ug/l

0.99

333

Chronic hepatitis, not elsewhere classified

389

2.07

8.01

2.5

2.0

1.16

1.68

ug/l

0.29

345

Other and unspecified hydrocephalus

240

2.40

7.97

2.9

1.9

0.85

2.44

ug/l

0.72

211

conjunctival haemorrhage

181

1157

1.60

7.96

2.0

1.9

3.20

2.45

ug/l

0.22

162

1018

Alzheimer’s disease (Late onset), excluding more controls

352

1660

1.41

7.92

1.7

1.8

3.16

2.71

ug/l

0.13

268

1464

Psoriasis (vulgaris), strict definition

371

2.08

7.87

1.9

2.0

2.56

2.01

ug/l

0.12

336

Chronic laryngitis and laryngotracheitis

290

2042

1.44

7.87

2.0

1.9

1.44

2.35

ug/l

1.15

243

1800

Burns and corrosions of external body surface, specified by site

204

1340

1.55

7.85

2.1

2.20

2.06

ug/l

0.07

178

1199

Malignant neoplasm of anus and anal canal, including Hilmo

134

2.92

7.85

1.9

1.7

5.90

1.75

ug/l

0.90

120

Congenital malformations of the respiratory system

168

2.67

7.83

3.3

2.1

1.42

2.96

ug/l

0.43

156

Assault by unspecified means

162

2.68

7.80

3.0

2.0

5.22

2.52

ug/l

0.42

149

Benign neoplasm: Adrenal gland

172

1093

1.61

7.76

2.1

2.0

2.26

1.94

ug/l

0.16

152

983

Undefined dementia

309

2032

1.42

7.74

1.7

1.8

4.18

2.53

ug/l

0.54

247

1670

Other diseases of hard tissues of teeth

1331

5816

1.19

7.74

2.0

1.9

2.11

2.42

ug/l

0.41

1142

5103

Superficial injury of shoulder and upper arm

224

1507

1.51

7.71

1.9

1.71

2.09

ug/l

0.25

177

1328

Diseases of middle ear and mastoid

967

6529

1.22

7.71

2.1

2.0

1.72

2.14

ug/l

0.77

851

5761

Tuberculosis

164

1034

1.62

7.67

2.1

1.9

1.57

2.51

ug/l

0.50

141

888

Barrett oesophagus

121

706

1.76

7.65

2.6

2.0

2.00

2.61

ug/l

0.29

108

633

Superficial injury of ankle and foot

186

1203

1.56

7.65

2.0

2.20

1.92

ug/l

0.13

168

1075

Other secondary coxarthrosis

438

1.98

7.64

2.6

2.0

2.09

1.91

ug/l

0.04

391

Inflammatory disorders of male genital organs, not elsewhere classified

171

2.65

7.63

2.4

2.1

3.88

0.87

ug/l

0.75

152

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

166

1048

1.62

7.63

2.2

1.8

2.25

2.56

ug/l

0.12

144

920

Contact with and exposure to communicable diseases

389

2874

1.36

7.57

2.2

2.0

1.36

1.89

ug/l

0.88

353

2560

Cerebral aneurysm, nonruptured

175

1122

1.59

7.56

2.0

3.40

2.06

ug/l

0.58

152

1015

Abnormal involuntary movements

269

1883

1.45

7.56

2.0

1.9

1.52

2.10

ug/l

0.70

237

1659

Other specified disorders of kidney and ureter

426

1.99

7.55

2.4

1.9

0.96

1.99

ug/l

0.78

377

Trochanteric bursitis

257

1783

1.46

7.55

2.1

1.9

0.87

2.37

ug/l

4.13

216

1569

Chorioretinal inflammation

337

2.12

7.53

2.3

1.9

2.05

1.40

ug/l

0.22

304

Embolic stroke with flimmer

351

2.09

7.51

1.9

1.7

2.55

2.20

ug/l

0.08

297

Drug-induced hypoglycaemia without coma

209

2.46

7.49

2.3

1.9

4.92

2.95

ug/l

0.33

181

Hypermobility syndrome

356

2.06

7.49

2.0

2.1

0.91

1.98

ug/l

0.66

330

Open wound of wrist and hand

837

6696

1.23

7.48

1.9

2.1

1.82

2.19

ug/l

0.45

735

5984

Disturbances of skin sensation

456

3475

1.32

7.46

2.1

1.9

1.40

2.04

ug/l

0.91

387

3094

Emotional disorders starting during childhood or adolescence

205

2.40

7.45

2.0

1.8

3.99

1.46

ug/l

0.57

176

Nonsuppurative otitis media

331

2072

1.39

7.45

2.1

2.0

2.31

2.28

ug/l

0.02

291

1837

Diseases of inner ear

1147

9366

1.19

7.39

2.0

1.72

2.18

ug/l

1.07

973

8244

Isolated proteinuria

340

2.10

7.37

2.1

2.0

2.43

2.26

ug/l

0.05

303

Foreign body in alimentary tract

121

713

1.74

7.36

2.5

1.9

1.37

2.47

ug/l

0.80

110

635

Inflammatory disease of uterus

178

1150

1.56

7.35

2.1

1.9

3.26

1.68

ug/l

0.90

151

1019

Other disorders of patella

261

1824

1.44

7.34

2.0

1.46

1.92

ug/l

0.55

228

1653

Burns and corrosions

250

1736

1.46

7.32

2.2

2.0

2.57

2.05

ug/l

0.27

219

1557

Heart failure and hypertrophic cardiomyopathy

276

2.25

7.32

2.3

1.9

2.31

2.43

ug/l

0.03

242

Other keratitis

204

1362

1.52

7.30

1.9

2.0

2.71

1.94

ug/l

0.44

183

1214

Alzheimer’s disease (Atypical or mixed)

276

1944

1.44

7.28

1.6

1.8

2.04

2.42

ug/l

0.20

212

1624

Faecal incontinence

171

1100

1.58

7.28

2.0

1.8

1.23

2.00

ug/l

0.70

147

951

Hidradenitis suppurativa

307

2.13

7.27

1.9

2.1

1.50

2.02

ug/l

0.21

280

Other and unspecified intracranial injuries

383

2.02

7.26

2.4

1.9

1.47

2.05

ug/l

0.25

335

Other orthopaedic follow-up care

100

559

1.82

7.26

2.1

1.8

2.84

2.68

ug/l

0.05

493

Coxarthrosis, primary, with hip surgery

1101

8686

1.20

7.25

1.9

1.91

2.13

ug/l

0.28

951

7615

Suggestive for eosinophilic asthma

192

1270

1.54

7.24

1.8

2.0

1.33

2.60

ug/l

1.17

168

1134

Benign neoplasm: Other and unspecified parts of small intestine

213

2.42

7.22

3.0

1.9

5.11

3.14

ug/l

0.29

189

Enthesopathies of lower limb, excluding foot

382

2853

1.35

7.22

2.2

2.0

1.81

2.43

ug/l

0.62

331

2567

Flat foot [pes planus] (acquired)

169

1086

1.58

7.21

2.0

1.9

1.93

1.62

ug/l

0.19

149

984

Other abnormal findings in urine

213

2.42

7.21

2.0

1.9

0.47

3.13

ug/l

1.19

182

Acne vulgaris

472

1.88

7.21

2.2

2.1

2.16

1.92

ug/l

0.08

426

Anuria and oliguria

3.46

7.20

3.0

1.9

0.96

4.69

ug/l

0.54

Corneal ulcer

333

2438

1.38

7.18

2.1

2.0

3.41

2.38

ug/l

0.60

300

2151

Primary biliary cholangitis (PBC)

200

2.43

7.17

2.4

1.8

1.01

1.08

ug/l

0.07

175

Other intracranial haemorrhages

522

1.87

7.13

2.1

1.8

3.18

2.54

ug/l

0.16

462

Postprocedural disorders of nervous system

104

591

1.79

7.11

2.1

2.0

0.64

2.00

ug/l

1.82

536

Other secondary gonarthrosis

123

736

1.71

7.11

2.2

2.0

0.84

1.30

ug/l

0.94

107

658

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

478

1.90

7.10

2.1

1.9

1.90

1.85

ug/l

0.01

417

Fracture of forearm

1028

7897

1.20

7.09

1.9

2.0

2.16

2.39

ug/l

0.25

893

6935

Hyperhidrosis

188

2.44

7.07

1.9

0.57

1.82

ug/l

1.26

170

Social phobias

101

570

1.79

7.04

2.8

2.0

3.32

2.14

ug/l

0.34

511

Abnormal serum enzyme levels

725

5750

1.24

7.00

2.1

2.0

3.30

2.15

ug/l

0.90

670

5088

Other salmonella infections

472

1.89

7.00

2.1

1.9

1.92

2.12

ug/l

0.08

409

Diseases of appendix

1411

10957

1.17

6.99

2.1

2.0

1.86

2.26

ug/l

0.76

1276

9716

Hallux valgus (acquired)

601

3424

1.27

6.99

1.9

2.34

2.66

ug/l

0.17

510

3018

Polyhydramnios

265

2.18

6.98

1.6

1.8

1.12

2.52

ug/l

0.62

229

Viral encephalitis, not elsewhere classified/unspecified

235

2.30

6.96

2.2

2.0

0.68

2.94

ug/l

1.07

204

Other congenital malformations of the digestive system

427

1.93

6.95

2.5

1.9

1.47

2.05

ug/l

0.32

378

Malignant neoplasm of other and ill-defined sites, including Hilmo

179

2.51

6.93

2.0

1.7

3.89

2.17

ug/l

0.29

152

Simple and mucopurulent chronic bronchitis

101

576

1.80

6.93

2.1

1.9

1.77

3.42

ug/l

0.78

502

Chronic myeloid leukaemia [CML], BCR/ABL-positive

121

2.92

6.93

2.6

2.1

1.86

4.46

ug/l

0.48

109

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

589

7166

0.79

6.93

2.0

1.49

2.38

ug/l

1.17

512

6329

Malignant neoplasm of renal pelvis

3.68

6.92

1.7

3.79

2.49

ug/l

0.23

Pure hyperglyceridaemia

268

2.21

6.91

2.5

2.0

3.78

2.38

ug/l

0.30

233

Other disorders of optic [2nd] nerve and visual pathways

129

787

1.67

6.90

2.2

1.9

1.90

2.24

ug/l

0.17

110

698

Lyme disease

341

4565

0.74

6.87

1.9

2.0

1.08

2.21

ug/l

3.09

301

4067

Tuberculosis of other organs

296

2.15

6.87

1.9

8.69

2.11

ug/l

0.49

254

Gingival hyperplasia

426

1.93

6.87

2.0

2.80

1.78

ug/l

0.38

383

Symptoms and signs involving emotional state

281

2.15

6.87

2.0

1.9

2.22

1.46

ug/l

0.36

250

Endovascular or surgical operations to intracerebral aneurysms

130

796

1.67

6.86

2.2

2.0

1.91

1.98

ug/l

0.03

114

713

Other congenital malformations of the digestive system

507

1.84

6.85

2.3

1.9

1.34

1.83

ug/l

0.31

445

Malignant neoplasm of thyroid gland

102

584

1.78

6.84

2.5

1.9

17.03

1.89

ug/l

0.53

508

Acute nasopharyngitis (common cold)

189

1251

1.52

6.82

2.2

1.64

2.18

ug/l

0.37

170

1139

Spirochaetal infections, other/unspecified

345

4598

0.74

6.75

1.9

2.0

1.07

2.22

ug/l

3.27

305

4096

Allergic conjunctivitis

629

7589

0.80

6.72

2.0

1.60

2.31

ug/l

0.83

549

6714

Disorders of vitreous body and globe

1077

8765

1.19

6.72

2.1

2.0

3.42

2.12

ug/l

0.47

959

7738

Pyoderma

213

2.34

6.71

2.4

1.9

2.79

2.88

ug/l

0.01

186

Scleritis and episcleritis

112

663

1.72

6.70

2.4

2.1

1.26

1.91

ug/l

0.53

105

589

Hemiplegia

110

649

1.73

6.69

2.0

1.9

2.76

1.62

ug/l

0.43

569

Appendicitis, broad definition

1393

10885

1.16

6.68

2.1

2.0

1.87

2.26

ug/l

0.72

1261

9657

Ankylosing spondylitis, ICD10

166

1083

1.56

6.68

2.1

0.99

1.83

ug/l

1.57

149

980

Cluster headache, wide

345

2.01

6.67

2.1

2.0

2.74

1.64

ug/l

0.40

310

Malignant neoplasm of tongue, including Hilmo

292

2.12

6.66

2.0

1.8

1.93

1.51

ug/l

0.24

260

Diseases of tongue

129

795

1.65

6.64

1.9

2.0

1.70

2.27

ug/l

0.29

118

709

Sequelae of injuries of upper limb

183

1221

1.52

6.64

2.3

2.1

1.63

1.91

ug/l

0.19

160

1104

Disorders of optic nerve and visual pathways

168

1101

1.55

6.62

2.2

2.0

1.58

2.25

ug/l

0.55

144

980

Injury of unspecified body region

159

1031

1.57

6.61

2.2

2.0

2.36

1.92

ug/l

0.18

135

908

Otitis externa, unspecified

196

1327

1.50

6.60

2.0

2.72

2.16

ug/l

0.29

173

1193

Malignant neoplasm of thyroid gland, including Hilmo

113

673

1.70

6.59

2.4

1.8

15.48

1.76

ug/l

0.54

586

Toxic liver disease

165

2.53

6.59

1.7

1.9

1.53

3.58

ug/l

0.56

150

Other menopausal disorders

243

1936

0.70

6.58

1.7

1.9

1.93

2.01

ug/l

0.04

209

1728

Degenerative macular diseases

282

2047

1.40

6.55

1.9

1.87

2.23

ug/l

0.25

242

1770

Achilles tendinitis

199

1356

1.49

6.51

2.4

2.0

2.58

2.52

ug/l

0.02

177

1236

Ethmoidectomy

237

1669

1.44

6.51

1.9

2.0

2.14

2.53

ug/l

0.14

204

1512

Vascular dementia (undefined)

106

618

1.74

6.50

1.8

1.7

2.34

2.54

ug/l

0.05

509

Other hammer toe(s) (acquired)

339

2332

1.36

6.50

1.9

1.18

2.27

ug/l

2.29

291

2053

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

204

1395

1.47

6.48

2.1

1.9

1.78

1.60

ug/l

0.16

174

1228

Pilonidal cyst

129

799

1.63

6.45

2.0

1.12

1.98

ug/l

0.89

115

724

Other coagulation defects

136

855

1.62

6.45

2.7

1.9

1.58

2.09

ug/l

0.30

115

749

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

230

2.25

6.43

1.9

1.8

1.93

1.70

ug/l

0.10

205

In situ neoplasms

786

6509

1.22

6.40

2.0

1.9

2.19

ug/l

0.00

675

5673

Disorders of parathyroid gland, other and/or unspecified

3.28

6.40

1.8

1.7

11.20

4.96

ug/l

0.26

Other/unspecified enthesopathies, not elsewhere classified

172

1143

1.53

6.39

2.1

2.0

1.14

2.66

ug/l

1.97

149

1003

Other spirochaetal diseases

354

4660

0.75

6.37

1.9

2.0

1.26

2.27

ug/l

2.30

313

4152

Orthopaedic devices associated with adverse incidents

272

2.16

6.36

1.8

1.9

0.49

2.58

ug/l

1.21

236

Cluster headache, strict

317

2.03

6.35

2.2

2.0

2.82

1.57

ug/l

0.43

285

Cardiomyopathy in other diseases

3.67

6.34

2.3

1.6

1.22

7.85

ug/l

0.76

Bullous disorders

132

830

1.63

6.32

2.3

1.8

2.62

2.17

ug/l

0.18

115

720

Melanocytic naevi, other sites/unspecified

150

970

1.57

6.32

2.2

2.0

1.92

1.76

ug/l

0.08

144

863

Other spirochaetal diseases

350

4605

0.75

6.28

1.9

2.0

1.27

2.22

ug/l

2.09

310

4102

Tuberculosis of other organs, strict

348

2.00

6.27

1.8

1.9

7.82

2.34

ug/l

0.44

294

990

7687

1.19

6.26

1.9

2.29

2.23

ug/l

0.05

866

6658

Surgical ablation of atrial fibrillation

3.45

6.26

2.6

2.4

0.53

4.54

ug/l

0.57

Other extrapyramidal and movement disorders in other diseases

482

3801

1.28

6.21

2.0

1.9

1.76

2.29

ug/l

0.59

405

3346

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

227

2.21

6.14

1.9

2.1

1.87

3.15

ug/l

0.56

201

Obstructive hydrocephalus

171

2.44

6.12

2.4

1.8

0.20

3.07

ug/l

1.11

154

Other diseases of lip and oral mucosa

736

6084

1.22

6.11

2.0

1.86

2.16

ug/l

0.45

643

5408

Oter anti-inflammatory and antirheumatic agents, non-steroids

569

2505

1.26

6.10

1.9

2.0

3.30

2.27

ug/l

0.69

493

2235

FESS (DNB20)

225

1591

1.43

6.07

1.9

2.0

2.23

ug/l

0.00

192

1445

Eating disorders

126

787

1.61

6.06

2.1

2.0

2.52

1.83

ug/l

0.32

115

695

Inguinal hernia

1291

7456

1.16

6.05

2.0

2.28

2.14

ug/l

0.14

1134

6618

Oxicams

575

2613

1.26

6.04

1.9

2.1

1.47

2.24

ug/l

1.78

506

2331

Other and unspecified mood [affective] disorders

531

1.75

6.02

2.1

2.20

2.03

ug/l

0.05

475

Salpingitis and oophoritis

258

1869

1.39

6.01

1.8

2.0

2.61

1.80

ug/l

0.56

225

1680

Subjective visual disturbances

459

3612

1.28

6.01

2.1

1.9

2.55

2.21

ug/l

0.12

391

3190

Other disorders of conjunctiva

307

2291

1.36

6.01

2.1

1.9

2.79

2.44

ug/l

0.15

276

2022

Essential (haemorrhagic) thrombocythaemia

410

1.87

5.97

1.7

1.8

0.89

1.76

ug/l

1.32

360

Glaucoma secondary to other eye disorders

588

1.73

5.97

2.1

1.9

2.22

2.36

ug/l

0.04

512

Background retinopathy and retinal vascular changes

285

2.08

5.97

2.2

1.8

3.16

1.45

ug/l

0.70

250

Malignant neoplasm of thymus, including Hilmo

5.33

5.95

1.8

2.0

1.43

1.58

ug/l

0.04

Disturbance of activity and attention

105

618

1.68

5.90

1.8

2.0

1.83

1.71

ug/l

0.05

550

Unspecified event, undetermined intent

259

2.10

5.85

2.4

1.9

1.28

2.59

ug/l

0.55

232

Bell's palsy

225

1603

1.42

5.85

2.4

1.9

5.84

2.21

ug/l

0.88

196

1420

Third [oculomotor] nerve palsy

247

2.15

5.83

1.9

3.02

2.74

ug/l

0.06

218

Benign paroxysmal vertigo

585

4752

1.24

5.83

2.0

1.9

1.35

2.39

ug/l

2.85

506

4183

Superficial injury of wrist and hand

314

2357

1.34

5.83

1.8

2.0

2.33

2.05

ug/l

0.17

267

2103

Cyst of kidney

165

1112

1.51

5.83

2.0

1.9

1.04

2.61

ug/l

1.92

147

985

Injuries involving multiple body regions

406

1.86

5.82

2.7

2.0

3.05

1.99

ug/l

0.31

356

Peritonsillar abscess

326

2461

1.33

5.82

1.9

2.0

2.54

2.18

ug/l

0.18

295

2203

Other and unspecified injuries of ankle and foot

392

1.87

5.78

2.0

1.9

1.09

1.90

ug/l

0.49

350

Papilloedema, unspecified

227

2.18

5.77

1.6

1.9

1.63

2.96

ug/l

0.44

205

Dronedarone medication

344

1.95

5.76

1.9

1.8

1.50

2.73

ug/l

0.54

309

Other and unspecified abdominal hernia

580

1.72

5.73

2.2

1.9

1.19

1.96

ug/l

0.65

514

Injury of urinary and pelvic organs

262

2.10

5.72

2.4

1.9

2.36

2.67

ug/l

0.08

231

Prepatellar bursitis

104

634

1.68

5.69

2.2

2.1

1.05

2.30

ug/l

1.27

574

Malignant neoplasm of vulva, including Hilmo

140

2.54

5.67

2.0

1.6

1.35

1.57

ug/l

0.12

120

Inflammatory diseases of prostate (prostatitis)

286

2133

1.36

5.65

2.0

2.1

1.50

2.36

ug/l

1.21

244

1910

Other strabismus

334

2534

1.32

5.63

2.8

2.0

2.40

2.42

ug/l

0.01

287

2244

Abnormal blood-pressure reading, without diagnosis

454

1.79

5.62

2.3

2.0

1.10

1.25

ug/l

0.10

401

Neovascular glaucoma

583

1.71

5.62

2.1

1.9

2.27

1.78

ug/l

0.17

503

Excessive vomiting in pregnancy

565

1.70

5.61

1.9

2.0

2.13

2.52

ug/l

0.17

508

Procreative management

471

3117

1.27

5.59

2.2

2.1

1.79

2.01

ug/l

0.21

420

2807

Other injuries of spine and trunk, level unspecified

3.04

5.59

1.9

2.0

1.00

4.18

ug/l

0.49

Chondropathies

253

1852

1.38

5.58

1.8

2.0

2.32

1.86

ug/l

0.26

223

1671

Other otitis externa (chronic)

127

816

1.58

5.57

2.0

2.20

2.21

ug/l

0.00

726

Other and unspecified injuries of lower leg

125

799

1.59

5.57

2.0

2.1

0.98

1.75

ug/l

1.00

102

714

Drug-induced acute pancreatitis

7.95

5.57

2.3

2.2

3.61

14.16

ug/l

0.34

Scoliosis

131

846

1.57

5.57

2.2

2.0

3.82

2.35

ug/l

0.34

111

754

Abnormal spermatozoa

314

2387

1.34

5.52

1.8

2.0

2.29

2.33

ug/l

0.01

281

2108

Fall on and from stairs and steps

494

3966

1.26

5.50

2.2

1.9

1.79

2.14

ug/l

0.33

417

3488

Central retinal artery occlusion

351

1.92

5.50

1.8

2.81

1.75

ug/l

0.40

295

Acute nephritic syndrome

246

2.10

5.47

2.7

1.8

5.86

2.50

ug/l

0.63

220

Other peripheral vascular diseases

148

988

1.52

5.45

2.0

1.9

2.57

2.17

ug/l

0.16

134

863

Congenital malformations and deformations of the musculoskeletal system

115

720

1.61

5.44

2.8

2.1

1.75

2.19

ug/l

0.25

105

640

Other and unspecified visual disturbances

187

1308

1.45

5.43

2.0

1.38

2.21

ug/l

0.59

157

1167

Viral meningitis

322

1.93

5.42

1.8

2.1

1.08

2.13

ug/l

0.55

294

Brachial plexus disorders

140

924

1.53

5.40

1.7

2.0

1.57

1.88

ug/l

0.13

125

842

Effects of foreign body entering through natural orifice

438

3476

1.27

5.40

2.2

2.1

2.75

2.36

ug/l

0.17

386

3109

Mixed disorders of conduct and emotions

2.78

5.39

2.7

1.7

4.34

4.39

ug/l

0.00

Allergic purpura

316

1.95

5.39

2.0

1.7

1.52

2.23

ug/l

0.23

277

Early lumbar disc prolapse, operated

117

743

1.59

5.34

2.2

1.74

2.15

ug/l

0.19

104

687

Disorders of vitreous body

1029

8563

1.17

5.33

2.0

3.44

2.10

ug/l

0.46

916

7561

Pemphigoid

413

1.83

5.31

2.2

1.8

1.39

3.15

ug/l

0.69

353

Calculus of lower urinary tract

141

942

1.53

5.28

2.1

1.9

2.59

2.95

ug/l

0.15

123

821

Malignant neoplasm of renal pelvis, including Hilmo

133

2.52

5.27

1.7

1.6

2.69

2.99

ug/l

0.06

112

Other congenital malformations of upper alimentary tract

3.02

5.24

3.3

1.9

1.56

4.59

ug/l

0.44

Other diseases of gallbladder

564

1.68

5.21

2.5

1.9

7.21

1.56

ug/l

0.64

487

Otitis media, unspecified

145

892

1.51

5.21

2.3

2.0

1.41

1.95

ug/l

0.30

126

792

Lesion of radial nerve

451

1.77

5.21

2.0

1.9

2.17

1.94

ug/l

0.08

398

Fibroblastic disorders

482

3887

1.25

5.20

1.9

2.46

2.31

ug/l

0.07

418

3421

Synovial cyst of popliteal space [Baker]

147

991

1.51

5.19

1.9

2.0

1.53

2.54

ug/l

0.71

131

875

Other diseases of peritoneum

558

1.68

5.16

2.1

1.9

2.01

1.72

ug/l

0.09

488

Manic episode

286

1.96

5.13

1.9

2.1

2.55

2.45

ug/l

0.02

254

Retinal vascular disorders

285

2160

1.34

5.11

1.9

1.47

2.22

ug/l

0.97

244

1864

Other disorders of penis

199

1425

1.42

5.10

2.2

2.1

1.20

2.69

ug/l

2.01

164

1262

Allergic contact dermatitis

200

1431

1.41

5.10

2.0

1.9

1.33

2.06

ug/l

1.06

179

1277

Migraine without aura and triptan purchases

183

1288

1.43

5.09

1.9

2.0

1.64

2.01

ug/l

0.20

159

1152

Other noninflammatory disorders of vagina

122

793

1.56

5.08

2.0

1.9

4.01

1.98

ug/l

0.38

708

Occupational exposure to risk-factors

478

1.74

5.08

1.7

2.0

1.56

2.96

ug/l

0.58

434

Other and unspecified follicular disorders

470

1.74

5.06

2.7

2.0

0.48

1.97

ug/l

1.66

422

Brain meningioma

492

1.72

5.06

2.0

1.8

3.04

1.79

ug/l

0.34

424

Infectious mononucleosis

551

1.67

5.05

2.1

2.54

1.67

ug/l

0.31

497

Inflammatory disease of cervix uteri

105

661

1.61

5.05

1.8

2.0

2.48

1.84

ug/l

0.22

577

Varicella [chickenpox]

448

1.75

5.01

2.3

2.1

3.64

1.40

ug/l

0.86

412

Acute appendicitis

1266

10385

1.14

5.01

2.1

2.0

1.96

2.29

ug/l

0.52

1152

9221

Other specified/unspecified soft tissue disorders

601

1.64

5.00

2.3

2.0

1.08

1.42

ug/l

0.37

506

Other appendicitis

154

1058

1.48

4.95

2.4

2.0

1.02

2.09

ug/l

1.60

133

948

Retinal vascular occlusion

280

2128

1.33

4.95

1.9

1.48

2.14

ug/l

0.80

240

1838

Hydrocele

266

2006

1.34

4.93

2.0

4.17

2.46

ug/l

0.53

231

1780

Fall on same level involving ice and snow

1089

9481

1.15

4.93

2.0

2.42

2.09

ug/l

0.37

948

8346

Glaucoma

1268

9589

1.14

4.93

1.9

2.13

2.16

ug/l

0.04

1095

8396

Mucinous and mucinous cystic tumor of rectum

3.54

4.90

2.1

1.8

1.03

1.35

ug/l

0.20

Malignant melanoma, including Hilmo

309

2380

1.31

4.90

1.8

1.59

1.94

ug/l

0.27

264

2063

Viral agents as the cause of diseases classified to other chapters

236

2.05

4.89

2.6

2.0

1.73

2.61

ug/l

0.25

215

Skin changes due to chronic exposure to nonionizing radiation

927

7364

1.17

4.88

1.9

2.41

2.24

ug/l

0.13

806

6372

Mouth breathing

754

6381

1.19

4.88

2.1

2.58

2.12

ug/l

0.32

668

5720

L02BA Anti-estrogens

261

1964

1.34

4.87

1.8

2.0

1.44

1.87

ug/l

0.42

227

1724

Infections with a predominantly sexual mode of transmission

377

2972

1.27

4.85

2.1

2.0

2.04

1.84

ug/l

0.16

326

2652

Injury of muscle and tendon at lower leg level

289

2211

1.32

4.83

2.2

2.0

2.43

2.24

ug/l

0.09

260

1998

Brain meningioma, including Hilmo

515

1.68

4.79

2.1

1.8

2.96

1.83

ug/l

0.32

444

Algoneurodystrophy

279

1.94

4.79

2.1

2.0

2.98

2.11

ug/l

0.15

253

Burn and corrosion of trunk

359

1.83

4.78

1.9

2.0

3.03

2.01

ug/l

0.23

322

Malignant neoplasm of tongue

211

2.10

4.78

1.8

1.46

1.77

ug/l

0.16

192

Other drug-induced secondary parkinsonism

115

2.56

4.77

2.1

0.70

4.46

ug/l

0.92

108

Hyperfunction of pituitary gland

448

1.72

4.74

2.6

2.0

1.41

1.81

ug/l

0.19

395

Benign neoplasm: Ascending colon

303

2344

1.31

4.72

2.1

1.9

1.80

2.27

ug/l

0.53

270

2057

Open wound of shoulder and upper arm

212

2.09

4.71

1.7

1.9

1.85

1.63

ug/l

0.09

189

Unspecified chronic bronchitis

488

1.70

4.70

2.8

1.9

1.51

2.95

ug/l

0.63

419

Vascular dementia

229

1643

1.36

4.67

1.9

1.8

2.76

2.45

ug/l

0.14

171

1386

Eating disorder

524

1.65

4.66

2.2

1.9

2.24

2.10

ug/l

0.05

467

Gestational [pregnancy-induced] hypertension

269

2040

1.32

4.65

1.9

2.0

1.34

1.97

ug/l

0.79

234

1818

Urethritis and urethral syndrome

227

2.03

4.63

2.2

0.53

1.44

ug/l

1.26

203

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

247

1.97

4.62

2.4

1.9

2.08

2.94

ug/l

0.21

218

Metatarsalgia

155

1081

1.45

4.62

2.1

2.0

2.10

2.07

ug/l

0.01

136

967

Haemorrhage in early pregnancy

318

2408

1.29

4.62

1.8

2.0

1.29

2.01

ug/l

0.91

272

2155

Actinic keratosis

906

7250

1.17

4.59

1.8

1.9

2.45

2.25

ug/l

0.14

787

6268

Other disorders of central nervous system

123

2.45

4.58

2.3

2.0

0.88

3.56

ug/l

0.64

113

Viral agents as the cause of diseases classified to other chapters

270

1.94

4.58

2.6

2.0

1.62

2.41

ug/l

0.24

244

Other enthesopathy of foot (+metatarsalgia)

164

1158

1.43

4.57

2.1

2.0

1.99

ug/l

0.00

144

1037

Fracture of neck

135

922

1.49

4.56

2.3

1.9

1.51

1.74

ug/l

0.16

123

808

Coxibs

618

2704

1.21

4.56

1.8

2.0

1.62

2.29

ug/l

1.08

527

2409

Ocular pain

134

913

1.49

4.53

2.1

2.0

1.85

1.63

ug/l

0.12

113

817

Malignant neoplasm of vulva

100

2.62

4.50

2.0

1.6

1.62

1.15

ug/l

0.25

Varicella [chickenpox]

493

1.67

4.48

2.3

2.1

3.45

1.99

ug/l

0.48

452

Atypical facial pain

548

1.63

4.48

1.8

2.0

1.04

1.93

ug/l

0.62

484

Acetic acid derivatives and related substances

623

2695

1.21

4.46

1.8

2.1

2.67

2.29

ug/l

0.20

544

2400

Pustular psoriasis

534

1.64

4.45

2.5

2.0

1.44

1.82

ug/l

0.20

472

Congenital malformations and deformations of the musculoskeletal system

142

977

1.46

4.41

2.5

2.0

1.75

1.96

ug/l

0.13

128

865

Benign neoplasm of meninges

193

1413

1.38

4.40

2.2

1.9

2.32

1.84

ug/l

0.25

154

1239

Malignant neoplasm of gallbladder, including Hilmo

2.93

4.40

1.9

1.6

0.73

1.88

ug/l

1.09

Respiratory tuberculosis, confirmed and not-confirmed

128

873

1.49

4.37

2.0

1.9

1.90

2.29

ug/l

0.14

111

750

Respiratory tuberculosis

128

873

1.49

4.37

2.0

1.9

1.90

2.29

ug/l

0.14

111

750

Disorder of external ear, unspecified

423

1.72

4.34

1.9

2.0

5.85

1.81

ug/l

0.53

389

Family history of malignant neoplasm

140

971

1.45

4.31

2.0

1.9

1.77

2.34

ug/l

0.39

122

871

Nontoxic multinodular goitre

364

2915

1.26

4.28

1.9

2.26

2.47

ug/l

0.10

324

2554

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

2.80

4.27

2.4

1.8

2.58

3.21

ug/l

0.09

Single spontaneous delivery

455

2946

0.81

4.25

1.9

1.39

2.82

ug/l

1.70

404

2562

Malignant neoplasm of other and unspecified parts of tongue

147

2.25

4.24

1.6

1.7

1.90

1.71

ug/l

0.07

131

Colitis due to radiation

155

2.24

4.20

2.3

2.1

3.18

3.92

ug/l

0.11

133

Demyelinating diseases of the central nervous system

121

821

1.49

4.19

1.9

2.1

2.06

1.66

ug/l

0.15

740

Urethral stricture

138

964

1.46

4.19

2.0

1.9

1.86

2.54

ug/l

0.30

115

849

Other congenital malformations

117

788

1.50

4.19

2.3

2.1

1.65

1.69

ug/l

0.02

104

702

Neuroendocrine tumor and carcinoma of small intestine

135

2.30

4.18

1.7

1.8

4.88

1.85

ug/l

0.35

117

Glaucoma suspect

750

6445

1.17

4.18

2.0

2.14

2.28

ug/l

0.13

666

5656

Other benign neoplasms of connective and other soft tissue

180

1315

1.39

4.17

2.0

2.80

2.16

ug/l

0.28

162

1167

Endometriosis of rectovaginal septum and vagina

120

815

1.49

4.15

2.1

1.9

3.26

2.04

ug/l

0.30

105

729

Adenocarcinoma and Papillary adenocarcinoma of kidney

104

2.50

4.15

2.5

1.8

0.38

1.56

ug/l

1.40

Gingivitis and periodontal diseases

2178

10242

1.10

4.15

2.0

2.12

2.18

ug/l

0.07

1895

9037

Other disorders of eyelid

957

7969

1.15

4.14

2.1

1.9

2.64

2.17

ug/l

0.37

837

6947

Ulcerative colitis (strict definition, all Crohn cases excluded)

229

1736

1.33

4.14

2.0

1.20

2.29

ug/l

1.57

202

1552

Bacterial meningitis

406

1.71

4.13

2.7

2.1

1.40

2.00

ug/l

0.31

365

Colonic or urogenital fistula

495

4109

1.21

4.12

2.1

2.0

1.65

2.20

ug/l

0.77

428

3641

Hyperkinetic disorders

106

686

1.52

4.12

1.8

2.0

1.82

1.83

ug/l

0.00

614

Pain and other conditions associated with female genital organs and menstrual cycle

228

1584

1.33

4.11

2.1

1.9

7.22

1.81

ug/l

0.41

200

1428

Sequelae of tuberculosis

274

1.88

4.11

1.8

1.00

2.85

ug/l

0.88

223

Maternal care for known or suspected fetal abnormality and damage

827

0.58

4.08

2.1

3.64

1.77

ug/l

0.23

734

Ulcerative rectosigmoiditis

137

959

1.45

4.07

2.0

2.1

11.13

1.92

ug/l

0.46

129

860

Ehlers-Danlos syndrome

3.02

4.06

2.2

1.6

1.01

1.47

ug/l

0.19

Arthropathy in ulcerative colitis

124

2.33

4.04

2.5

2.0

0.30

1.27

ug/l

1.56

113

Contusion of ankle

370

1.73

4.04

2.3

2.0

2.95

1.93

ug/l

0.23

332

Benign neoplasm: Prostate

113

2.46

4.01

1.8

2.1

1.16

2.23

ug/l

0.45

Chondrocostal junction syndrome [Tietze]

394

1.71

4.01

1.9

2.0

2.07

2.08

ug/l

0.00

348

Malignant melanoma of skin, including Hilmo

253

1955

1.31

4.01

1.8

1.72

1.73

ug/l

0.01

217

1692

Wilms' tumor, including Hilmo

3.04

4.00

2.2

1.8

3.05

2.74

ug/l

0.06

Tongue abnormality

117

800

1.49

3.97

1.7

2.0

1.69

1.71

ug/l

0.01

108

704

Biological medicines for asthma

171

2.10

3.97

1.8

2.0

0.94

2.67

ug/l

0.55

161

Fistulae involving female genital tract

158

2.15

3.95

2.8

2.2

1.06

2.37

ug/l

0.87

139

Pustulosis palmaris et plantaris

465

1.64

3.95

2.3

2.0

1.63

1.99

ug/l

0.16

417

Other inflammation of eyelid

247

1908

1.31

3.94

2.3

1.9

1.55

2.11

ug/l

0.46

215

1680

Thyrotoxicosis

422

3466

1.23

3.93

2.1

1.9

4.72

2.11

ug/l

0.34

367

3054

Trigeminal neuralgia

101

671

1.53

3.93

1.8

2.0

2.53

1.86

ug/l

0.22

592

Congenital malformations of cardiac septa

101

649

1.52

3.91

2.4

2.0

2.40

1.72

ug/l

0.26

574

Malignant neoplasm of cervix uteri

113

2.36

3.90

1.9

1.6

2.78

1.37

ug/l

0.47

Other and unspecified primary disorders of muscles

2.72

3.90

1.7

2.2

2.22

4.03

ug/l

0.20

Mixed conductive and sensorineural hearing loss

248

1921

1.31

3.89

2.1

1.9

1.21

2.53

ug/l

2.09

213

1689

Erectile dysfunction

207

1568

1.34

3.89

2.1

1.9

2.62

2.77

ug/l

0.07

182

1368

Episcleritis

553

1.58

3.88

2.5

2.1

1.35

1.98

ug/l

0.40

491

Toxic effect of ethanol

421

1.67

3.87

2.2

2.1

2.11

1.91

ug/l

0.06

381

Sequelae of other accidents

201

2.00

3.87

3.0

2.0

1.83

2.98

ug/l

0.30

178

Exposure to smoke, fire and flames

294

1.81

3.86

2.2

2.1

4.48

2.58

ug/l

0.33

262

Sixth [abducent] nerve palsy

479

1.62

3.79

1.7

1.9

3.21

1.97

ug/l

0.27

428

Burn and corrosion of hip and lower limb, except ankle and foot

259

1.86

3.79

2.0

2.1

2.30

2.59

ug/l

0.06

227

Torticollis

134

2.22

3.78

1.6

2.0

0.54

3.42

ug/l

0.78

121

Postmenopausal bleeding

471

2078

1.22

3.77

1.9

2.07

2.08

ug/l

0.01

403

1829

Dementia due to Parkinsons disease, excluding more controls

312

1.78

3.75

1.9

1.8

1.58

1.99

ug/l

0.22

268

Other erythematous conditions

418

1.66

3.74

1.9

2.19

1.98

ug/l

0.07

372

Brain glioblastoma and astrocytoma

155

2.12

3.73

1.4

1.7

0.13

1.63

ug/l

3.21

140

Malignant neoplasm of thymus

4.73

3.72

2.0

2.2

0.19

1.79

ug/l

1.03

Golimumab

297

1.78

3.71

1.7

2.2

0.32

1.90

ug/l

1.06

273

Dislocation, sprain and strain of joints and ligaments of thorax

388

1.68

3.71

2.6

2.0

1.88

2.04

ug/l

0.05

340

Haemorrhagic disorder due to circulating anticoagulants

198

2.00

3.69

2.1

1.8

1.91

3.11

ug/l

0.29

168

Sudden idiopathic hearing loss

198

1501

1.33

3.67

2.1

1.9

1.17

2.54

ug/l

1.88

159

1329

Nephropathy induced by other drugs, medicaments and biological substances

5.99

3.66

2.1

1.4

0.46

1.03

ug/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

323

2603

1.25

3.64

2.2

2.0

1.73

2.46

ug/l

0.79

294

2311

Vascular dementia (mixed)

271

1.83

3.63

2.1

1.8

4.05

2.53

ug/l

0.30

228

Memory loss

102

1478

0.68

3.62

2.4

1.9

1.11

2.15

ug/l

1.38

1305

Vertigo of central origin

199

1.97

3.62

1.7

1.9

1.28

3.30

ug/l

0.67

173

Other and unspecified mononeuropathies of upper limb

345

1.72

3.62

2.3

2.1

6.19

2.12

ug/l

0.77

317

Insomnia

1276

10350

0.90

3.61

2.0

1.95

2.32

ug/l

0.64

1122

9144

Benign neoplasm of mouth and pharynx

204

1557

1.32

3.60

2.0

1.08

2.29

ug/l

1.74

171

1380

Dementia in other diseases classified elsewhere

105

719

1.49

3.60

2.3

1.9

2.09

2.30

ug/l

0.09

635

Atrophic disorders of skin

224

1732

1.30

3.57

1.8

1.9

3.19

1.96

ug/l

0.78

203

1532

Other obstetric conditions, not elsewhere classified

252

1246

1.29

3.56

1.7

2.0

0.86

2.02

ug/l

3.02

212

1110

Generalized epilepsy, mode (most common among epilepsy diagnosis)

264

1.81

3.56

2.4

1.9

0.92

2.53

ug/l

0.78

232

Complex cardiac defects

4.03

3.55

2.0

2.7

2.04

2.23

ug/l

0.05

Seborrhoeic keratosis

438

3655

1.21

3.54

2.0

1.9

2.17

2.29

ug/l

0.09

394

3193

Cluster headache, wide,, including avohilmo

534

1.56

3.53

2.0

2.1

2.51

1.95

ug/l

0.20

479

Dislocation, sprain and strain of joint and ligaments of hip

496

1.58

3.52

2.5

1.8

2.40

2.06

ug/l

0.10

440

Carcinoma in situ of other and unspecified digestive organs

521

1.57

3.51

2.2

2.0

1.18

2.06

ug/l

0.71

463

Carcinoma in situ of oral cavity, oesophagus and stomach

2.65

3.49

2.3

2.1

2.53

0.79

ug/l

0.91

Residual foreign body in soft tissue

592

1.52

3.49

1.8

2.2

2.77

1.83

ug/l

0.36

529

Cluster headache, strict, including avohilmo

496

1.57

3.49

2.1

2.55

1.92

ug/l

0.22

446

Dermatophytosis

1127

10068

1.12

3.49

2.0

2.83

2.07

ug/l

0.82

989

8921

Malignant neoplasm of larynx, including Hilmo

246

1.84

3.43

1.8

1.7

0.93

1.81

ug/l

0.72

213

Malignant melanoma

245

1928

1.28

3.43

1.8

1.79

1.68

ug/l

0.06

206

1669

Hypoplasia of dental enamel , including avohilmo

122

2.17

3.43

3.5

1.7

6.33

1.67

ug/l

0.59

107

Autoimmune hyperthyroidism

570

1.53

3.42

2.1

1.9

0.47

1.53

ug/l

2.03

510

Disorders of globe

344

1.70

3.41

2.4

1.8

2.67

2.31

ug/l

0.10

294

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

482

1.57

3.40

2.6

2.0

2.57

1.99

ug/l

0.19

434

Cervicocranial syndrome

174

1309

1.34

3.40

2.1

1.9

1.17

2.10

ug/l

1.61

154

1175

Benign neoplasm: Skin, unspecified

492

1.57

3.40

2.1

1.9

2.70

1.80

ug/l

0.29

439

Calcific tendinitis of shoulder

669

1.48

3.40

2.4

2.1

1.12

2.33

ug/l

1.34

595

Molar incisor enamel hypoplasia

128

2.13

3.39

3.6

1.7

6.38

1.66

ug/l

0.63

112

Inflammatory disorders of breast

507

1.55

3.38

1.9

2.63

2.46

ug/l

0.04

444

Respiratory tuberculosis, clinically confirmed

183

1.98

3.38

1.9

2.0

0.67

3.41

ug/l

0.95

153

Other abnormal findings of blood chemistry

573

1.53

3.38

1.9

2.34

1.96

ug/l

0.13

509

Vascular dementia (other)

2.41

3.37

1.5

1.7

3.65

3.85

ug/l

0.02

Ovarian dysfunction

436

1.59

3.37

2.4

1.8

0.92

2.03

ug/l

0.83

391

Dislocation, sprain and strain of joints and ligaments of knee

961

7857

1.13

3.36

1.9

2.0

1.97

2.17

ug/l

0.26

837

7054

Chronic Coagulation defects

211

1.89

3.35

2.2

1.9

1.99

2.57

ug/l

0.13

193

Ehlers-Danlos syndrome

2.60

3.33

2.1

1.6

0.95

1.23

ug/l

0.12

Infections with a predominantly sexual mode of transmission

465

3651

1.19

3.29

2.1

2.0

2.03

2.10

ug/l

0.05

404

3249

Persistent delusional disorders

135

983

1.39

3.29

2.2

2.0

1.29

1.71

ug/l

0.33

116

858

Otosclerosis

1058

0.64

3.29

2.1

2.0

4.91

2.37

ug/l

0.74

945

Hypertrophic disorders of skin

527

1.54

3.29

1.7

1.9

3.30

2.03

ug/l

0.35

462

Malignant neoplasm of vagina, including Hilmo

4.08

3.28

3.5

1.4

2.89

1.50

ug/l

0.26

Deep endometriosis

129

932

1.40

3.27

2.2

1.9

3.09

2.09

ug/l

0.26

113

819

Dislocation of lens

192

1.93

3.27

1.9

0.64

1.25

ug/l

0.72

164

Toxic effect of corrosive substances

3.69

3.26

2.0

1.9

6.39

0.80

ug/l

0.44

Cushing syndrome

130

2.15

3.26

2.3

1.8

3.74

4.33

ug/l

0.07

118

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

510

4346

1.18

3.25

2.2

2.0

1.25

2.21

ug/l

2.00

438

3864

Follicular cysts of skin and subcutaneous tissue

321

2623

1.23

3.24

2.0

3.89

2.12

ug/l

0.57

288

2336

Delivery

473

2954

0.84

3.22

2.0

1.9

1.20

2.82

ug/l

2.31

419

2569

Thyrotoxicosis, other and/or unspecified

319

2606

1.23

3.22

2.1

1.9

5.76

2.09

ug/l

0.37

278

2312

Acute appendicitis, no complications

914

8079

1.13

3.21

2.0

1.83

2.12

ug/l

0.39

832

7204

Burkitt lymphoma, including Hilmo

9.00

3.21

5.0

1.3

4.05

1.90

ug/l

—

Burkitt lymphoma

9.00

3.21

5.0

1.3

4.05

1.90

ug/l

—

Disorders of refraction and accommodation

376

3109

1.21

3.21

2.0

1.9

3.94

2.08

ug/l

1.04

329

2769

Retinal detachments and breaks

730

6398

1.15

3.21

1.9

2.0

1.31

2.03

ug/l

2.13

638

5645

Other rupture of muscle

2.74

3.20

2.2

1.8

0.81

2.54

ug/l

0.54

Chronic iridocyclitis

588

1.50

3.20

2.5

2.0

2.90

1.77

ug/l

0.34

516

Scabies

499

1.54

3.20

2.3

2.1

2.65

1.90

ug/l

0.23

451

Bullous pemphigoid

336

1.69

3.19

2.5

1.8

0.87

2.56

ug/l

1.05

288

Squamous cell neoplasms and carcinoma of cervix

3.38

3.19

2.1

1.7

4.81

1.24

ug/l

0.65

Superficial injuries involving multiple body regions

282

1.74

3.17

2.1

1.9

4.22

2.43

ug/l

0.34

247

Other demyelinating diseases of the central nervous system

335

1.67

3.16

2.1

2.84

2.41

ug/l

0.07

307

Alcoholic gastritis

202

1.89

3.16

2.0

2.1

5.82

1.48

ug/l

0.83

183

Other and unspecified mononeuropathies, also in other diseases

367

1.64

3.15

2.1

1.9

1.83

2.18

ug/l

0.11

325

Other superficial mycoses

238

1.81

3.15

2.8

1.9

2.79

2.46

ug/l

0.07

221

Causalgia

152

2.02

3.15

1.9

2.0

0.35

2.86

ug/l

0.85

146

Septal defects

609

1.48

3.14

2.4

2.1

2.71

1.71

ug/l

0.37

539

Scabies

177

1354

1.32

3.10

1.9

2.0

1.49

1.94

ug/l

0.33

149

1221

Other disorders of the genitourinary system

225

1781

1.28

3.06

2.2

1.9

1.41

2.00

ug/l

0.59

192

1560

Thyroiditis

107

759

1.43

3.06

1.9

2.0

1.24

2.07

ug/l

0.88

672

Femoral hernia

645

1.47

3.04

2.3

2.0

2.65

2.41

ug/l

0.08

574

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

239

1199

1.27

3.04

1.7

2.0

0.88

2.05

ug/l

2.85

200

1065

Hypertrophic cardiomyopathy

613

1.48

3.03

2.0

3.32

2.01

ug/l

0.51

549

Unspecified/other endometriosis

660

1.45

3.01

2.2

1.9

1.39

1.90

ug/l

0.34

589

Disorders of breast

686

5452

1.15

3.01

1.9

1.97

2.37

ug/l

0.30

590

4767

Medullary carcinoma of thyroid gland, including Hilmo

5.13

3.01

1.9

1.8

166.90

2.95

ug/l

—

Other diseases of blood and blood-forming organs

126

923

1.38

3.00

2.0

1.9

1.65

2.23

ug/l

0.27

109

814

Embedded and impacted teeth

267

1775

1.25

2.99

1.9

2.1

1.81

1.83

ug/l

0.01

241

1579

Pediculosis, acariasis and other infestations

663

1.45

2.98

2.3

2.0

6.01

1.86

ug/l

0.53

598

Early lumbar disc prolapse operation

119

863

1.39

2.97

2.1

2.2

1.71

ug/l

0.00

106

793

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

121

2.11

2.96

2.6

1.8

0.55

3.73

ug/l

0.82

113

Benign neoplasm: Cerebral meninges

167

1279

1.32

2.96

2.1

1.9

2.36

1.91

ug/l

0.20

133

1117

Carcinoma in situ of skin of upper limb, including shoulder

399

1.60

2.94

2.3

1.8

4.10

2.08

ug/l

0.39

342

Atopic dermatitis, strict definition

342

2782

1.21

2.92

2.0

1.36

2.12

ug/l

1.09

305

2492

Vulvovaginal ulceration/inflammation in other diseases

413

1.56

2.91

2.1

2.0

2.06

1.49

ug/l

0.29

366

Other and unspecified pemphigoid

123

2.12

2.91

2.2

1.8

2.83

4.54

ug/l

0.22

101

Lichen planus

227

1814

1.26

2.88

1.9

2.0

2.30

2.07

ug/l

0.12

191

1609

Other nutritional anaemias

130

2.07

2.87

2.8

1.8

1.19

1.25

ug/l

0.03

113

Other predominantly sexually transmitted diseases, not elsewhere classified

221

1758

1.26

2.86

2.2

2.0

2.29

1.76

ug/l

0.32

195

1567

Complications associated with artificial fertilization

2.32

2.86

1.6

2.4

1.11

2.10

ug/l

0.32

Single delivery by forceps and vacuum extractor

617

0.66

2.86

1.5

2.1

2.18

1.96

ug/l

0.05

554

UC patients in KELA-register (code 208), prior to 1994

596

1.47

2.85

2.4

2.0

6.27

2.12

ug/l

0.56

536

Burkitt lymphoma, helper endpoint

7.17

2.84

5.0

2.1

4.05

1.56

ug/l

—

Pediculosis, acariasis and other infestations

221

1763

1.26

2.82

2.0

2.97

2.02

ug/l

0.23

188

1576

Acute appendicitis, with complications

352

2948

1.20

2.82

2.4

1.9

2.27

2.31

ug/l

0.02

320

2603

Viral haemorrhagic fevers, not elsewhere classified/unspecified

280

2294

1.23

2.80

2.2

2.0

1.80

2.44

ug/l

0.57

257

2047

Nontoxic goitre/thyroid nodule

521

4509

1.16

2.79

1.9

2.13

2.17

ug/l

0.02

460

3920

Other specified and unspecified retinal disorders

492

1.51

2.79

2.5

2.0

1.85

1.55

ug/l

0.18

434

Sequelae of injuries of lower limb

152

1159

1.32

2.79

2.2

2.1

2.39

2.01

ug/l

0.18

140

1038

Drug-induced Cushing's syndrome

6.70

2.79

2.0

1.9

0.61

0.41

ug/l

—

Short Achilles tendon (acquired)

270

1.69

2.79

3.1

2.2

1.76

1.47

ug/l

0.14

240

Other degenerative diseases of the basal ganglia

272

1.71

2.77

2.0

1.9

1.22

3.95

ug/l

0.87

240

Retinal haemorrhage

341

1.62

2.77

2.3

1.9

2.41

1.40

ug/l

0.51

304

Juvenile osteochondrosis

278

1.68

2.76

1.5

2.0

2.89

2.35

ug/l

0.10

253

Sleep disorders

1357

10716

0.91

2.75

2.0

1.91

2.33

ug/l

0.80

1196

9465

Other specified/unspecified disorders of bone/cartilage

310

1.64

2.75

2.5

2.0

1.58

2.18

ug/l

0.19

285

Use of other anti-dementia drugs

655

4775

1.14

2.74

1.6

1.8

3.22

2.22

ug/l

0.60

488

4090

Use of memantine

655

4775

1.14

2.74

1.6

1.8

3.22

2.22

ug/l

0.60

488

4090

Trigger finger

231

1860

1.25

2.74

2.1

1.9

3.98

2.47

ug/l

0.34

208

1660

Hordeolum and other deep inflammation of eyelid

650

1.43

2.73

1.8

2.0

2.10

1.38

ug/l

0.31

572

Malignant neoplasm of larynx

190

1.84

2.72

1.7

1.01

2.05

ug/l

0.63

161

Temporomandibular joint disorders, including avohilmo

578

4975

1.15

2.71

2.0

1.07

2.17

ug/l

4.14

516

4424

Pleural plaque without asbestos

671

1.43

2.70

1.8

1.54

3.12

ug/l

0.88

577

Acute alcohol intoxication ICD-9

496

1.50

2.70

2.2

2.0

3.26

1.87

ug/l

0.44

441

Postmenopausal atrophic vaginitis

304

2024

0.82

2.68

1.7

1.9

2.11

2.05

ug/l

0.04

274

1793

Embedded teeth, including avohilmo

686

1.41

2.66

1.9

2.0

2.86

1.90

ug/l

0.35

609

Ménière disease

175

1371

1.29

2.65

1.9

2.0

2.43

2.40

ug/l

0.01

144

1209

Burns and corrosions of multiple and unspecified body regions

259

1.69

2.65

2.4

2.2

5.91

2.14

ug/l

0.49

228

Thyroiditis, unspecified

148

1.94

2.65

1.6

1.8

0.90

2.86

ug/l

0.51

136

Other noninflammatory disorders of cervix uteri

563

1.46

2.65

1.8

1.9

2.61

1.90

ug/l

0.26

505

Respiratory tuberculosis, not confirmed

639

1.43

2.64

2.1

1.9

1.07

1.95

ug/l

0.75

549

Otalgia

117

867

1.36

2.63

2.1

2.0

1.18

2.36

ug/l

1.04

101

774

Carcinoma in situ of skin, other sites/unspecified

216

1.77

2.60

2.0

1.9

1.06

3.00

ug/l

0.72

185

Supervision of normal pregnancy

120

920

0.74

2.60

1.6

2.1

1.68

1.89

ug/l

0.09

111

828

Ebstein's anomaly

7.70

2.60

2.2

2.1

2.86

0.33

ug/l

—

Intermittent heterotropia

498

1.48

2.59

2.4

1.9

2.16

2.24

ug/l

0.02

441

Other peripheral vertigo

171

1341

1.29

2.59

1.9

2.0

1.54

2.34

ug/l

0.61

141

1187

Sequelae of infectious and parasitic diseases

130

982

1.34

2.58

2.1

2.0

1.68

ug/l

0.00

114

856

Benign neoplasm: Brain, supratentorial

164

1.87

2.58

2.7

1.8

1.73

3.63

ug/l

0.47

143

Benign neoplasm of thyroid gland

404

1.54

2.56

2.1

2.0

1.01

2.07

ug/l

0.70

357

Preterm labour and delivery

287

2381

1.21

2.55

1.9

2.0

2.57

1.85

ug/l

0.52

257

2137

Disorders of glossopharyngeal nerve

4.75

2.55

1.0

1.7

0.33

1.73

ug/l

—

Other and unspecified erythematous conditions

381

1.55

2.53

1.8

2.0

2.57

2.08

ug/l

0.15

339

Other disorders of bone density and structure

232

1.71

2.52

2.4

2.0

0.42

2.78

ug/l

1.24

211

Benign neoplasm of middle ear and respiratory system

153

1188

1.30

2.51

1.9

2.0

4.02

2.37

ug/l

0.56

138

1048

Nonspecific lymphadenitis

619

1.42

2.51

2.3

2.1

5.38

2.20

ug/l

0.59

555

Certain conditions originating in the perinatal period

429

1.48

2.51

2.4

2.0

3.83

2.60

ug/l

0.29

385

Congenital malformations of the nervous system

158

1.86

2.50

2.5

2.1

0.35

3.11

ug/l

0.94

143

Anxious personality disorder

144

1.91

2.49

3.3

2.0

4.33

3.23

ug/l

0.14

133

Use of levodopa decarboxylase inhibitor

299

2503

1.21

2.49

1.9

2.17

2.60

ug/l

0.26

243

2169

Impacted teeth

178

1249

1.27

2.49

1.8

2.0

1.45

2.11

ug/l

0.49

165

1116

Use of rotigotine

145

1.93

2.48

1.7

1.9

1.35

4.11

ug/l

0.70

128

Scar conditions and fibrosis of skin

390

1.53

2.48

1.9

2.0

5.09

2.00

ug/l

0.62

351

Atrial septal defect

356

1.55

2.47

2.6

2.0

0.75

2.13

ug/l

0.94

318

Eustachian salpingitis and obstruction

671

1.40

2.47

2.2

2.1

1.29

1.74

ug/l

0.33

608

Parkinson's disease, including avohilmo

343

2909

1.19

2.46

1.8

1.9

2.31

2.46

ug/l

0.08

289

2531

Laparoscopic right hemicolectomy

121

914

1.34

2.46

2.1

1.9

2.07

2.00

ug/l

0.03

109

809

Other benign neoplasms of uterus

674

1.40

2.45

1.9

3.16

1.69

ug/l

0.44

573

Disorders of copper metabolism

6.92

2.44

1.8

2.8

0.37

2.48

ug/l

—

Other neurotic disorders

615

1.42

2.44

2.1

2.0

1.36

1.71

ug/l

0.21

545

Papillary adenocarcinoma of thyroid gland

424

1.50

2.44

2.8

1.9

2.17

1.76

ug/l

0.16

368

MS-disease / Multiple Sclerosis

657

1.40

2.42

1.8

2.1

1.26

1.77

ug/l

0.34

587

505

0.57

2.40

1.6

1.9

0.28

1.46

ug/l

2.87

445

Benign neoplasm: Larynx

443

1.49

2.40

1.8

2.0

2.83

2.00

ug/l

0.25

396

Other and unspecified glaucoma

145

1127

1.30

2.39

1.9

2.79

2.39

ug/l

0.14

126

967

Heterophoria

107

795

1.36

2.39

2.6

2.0

2.39

2.09

ug/l

0.09

704

Medial epicondylitis

394

1.52

2.38

1.7

2.2

0.40

1.60

ug/l

2.13

355

Other secondary gout

2.93

2.35

2.9

2.0

2.55

7.39

ug/l

0.30

Polycystic ovarian syndrome

275

1.61

2.35

2.4

1.7

1.32

1.78

ug/l

0.29

243

Hypertrophic scar

477

1.46

2.35

1.8

2.0

3.70

2.04

ug/l

0.41

422

Other disorders of eye and adnexa

210

1707

1.24

2.34

2.1

2.0

1.49

1.92

ug/l

0.43

178

1515

Autoimmune polyglandular failure

5.06

2.34

1.8

1.2

1.47

0.24

ug/l

—

Maternal care for other conditions predominantly related to pregnancy

179

1400

1.26

2.33

2.0

2.1

1.08

1.89

ug/l

1.58

162

1243

Special screening examination for infectious and parasitic diseases

158

1476

0.79

2.33

1.8

2.0

0.56

2.90

ug/l

5.02

136

1316

Oral lichen planus, including avohilmo , including avohilmo

791

0.66

2.32

1.8

2.0

1.01

1.96

ug/l

0.86

701

Malignant neoplasm of gallbladder

2.67

2.32

1.6

1.5

1.01

2.59

ug/l

0.91

Malignant neoplasm of gum, including Hilmo

2.08

2.31

1.2

1.7

5.66

1.96

ug/l

0.29

Endometriosis

466

2370

1.16

2.31

2.0

1.9

2.27

1.98

ug/l

0.20

405

2086

Injury of eye and orbit

213

1737

1.23

2.31

2.1

2.0

1.82

2.66

ug/l

0.73

180

1563

Disorders of synovium and tendon in diseases classified elsewhere

270

1.63

2.31

2.5

2.1

5.23

1.32

ug/l

0.74

237

Pneumoconiosis due to asbestos and other mineral fibres

391

1.52

2.30

1.7

1.8

0.60

2.63

ug/l

1.20

333

Other bursitis of hip

239

1.66

2.30

2.4

1.9

9.58

1.21

ug/l

0.52

206

Other and unspecified injuries of wrist and hand

398

1.50

2.29

2.2

2.0

3.51

1.83

ug/l

0.44

350

Postpartum care and examination

117

556

1.34

2.28

2.0

2.1

1.08

2.05

ug/l

0.86

102

493

Parkinson's disease

327

2783

1.18

2.28

1.8

1.9

2.41

2.52

ug/l

0.06

273

2425

Other contact dermatitis

122

932

1.32

2.28

2.3

2.0

1.83

2.03

ug/l

0.11

106

820

Other lesions of median nerve

359

1.53

2.27

1.7

1.9

1.40

2.25

ug/l

0.37

310

Palmar fascial fibromatosis [Dupuytren]

321

2730

1.18

2.25

1.8

2.0

3.09

2.46

ug/l

0.23

269

2381

Additional codes for the location of defect, injury or illness

728

1.36

2.23

1.8

1.9

1.84

1.78

ug/l

0.03

642

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

550

1.42

2.23

2.2

2.1

1.84

1.81

ug/l

0.02

495

Mixed specific developmental disorders

2.17

2.22

2.2

2.7

4.73

3.24

ug/l

0.13

Personality and behavioural disorders due to brain disease, damage and dysfunction

188

1.74

2.21

1.9

2.0

3.09

1.85

ug/l

0.27

171

Complications predominantly related to the puerperium

270

2263

1.20

2.21

1.8

2.0

2.03

1.99

ug/l

0.02

241

2013

Kaposi sarcoma, including Hilmo

4.63

2.21

5.7

1.6

0.51

0.62

ug/l

—

Primary open-angle glaucoma

701

6085

1.12

2.20

1.9

2.05

2.37

ug/l

0.31

590

5280

Radial styloid tenosynovitis [de Quervain]

517

1.42

2.20

1.7

2.1

0.84

2.27

ug/l

2.04

457

Embolic stroke

101

756

1.35

2.20

2.1

1.8

2.01

2.44

ug/l

0.14

664

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

492

1.43

2.19

2.2

2.0

1.53

2.20

ug/l

0.28

431

Lesion of sciatic nerve

697

1.37

2.19

2.0

1.8

1.21

2.37

ug/l

0.69

594

Nezelof syndrome

2.74

2.19

2.7

2.1

0.38

7.54

ug/l

0.55

Infections of genitourinary tract in pregnancy

103

772

1.34

2.19

2.0

1.18

2.17

ug/l

0.88

693

Beningn neoplasm: Meninges, unspecified

212

1.69

2.18

2.1

1.8

1.64

2.51

ug/l

0.22

189

Restless leg syndrome

223

1841

1.22

2.18

2.0

0.91

2.05

ug/l

2.73

195

1625

Carcinoma in situ of skin of scalp and neck

446

1.47

2.17

1.8

1.27

3.08

ug/l

0.86

380

Use of ropinirole

546

1.42

2.17

2.0

1.9

1.02

1.88

ug/l

0.73

487

Carcinoma in situ of skin of trunk

538

1.42

2.16

1.9

1.8

1.07

2.67

ug/l

0.90

464

Convergent concomitant strabismus

519

1.42

2.16

3.8

2.1

3.46

2.08

ug/l

0.31

465

Other benign neoplasm of uterus: Other parts/unspecified

546

1.41

2.15

1.9

1.7

3.86

1.76

ug/l

0.51

454

Other specified disorders of external ear

589

1.40

2.15

2.4

2.0

1.92

2.74

ug/l

0.37

536

Corneal scars and opacities

364

1.51

2.14

2.0

2.17

2.16

ug/l

0.00

325

Benign lipomatous neoplasm of other sites/unspecified

164

1314

1.26

2.14

1.9

0.88

2.33

ug/l

2.41

144

1148

Malignant melanoma of skin

179

1448

1.25

2.13

1.8

2.12

1.64

ug/l

0.21

150

1245

Benign neoplasm: Endocrine pancreas

2.11

2.12

2.4

1.9

8.81

5.16

ug/l

0.24

Other and unspecified mononeuropathies of lower limb

324

1.54

2.12

2.5

2.0

1.55

2.32

ug/l

0.30

287

Thyrotoxicosis with diffuse goitre

194

1584

1.23

2.11

2.3

2.0

1.80

1.95

ug/l

0.08

171

1401

Muscle strain

341

1.51

2.09

1.8

2.0

0.66

1.44

ug/l

0.82

302

Ovarian hyperstimulation (induction)

2.10

2.08

1.4

1.9

1.09

1.89

ug/l

0.24

Anankastic personality disorder

333

1.52

2.08

1.7

2.2

2.08

1.90

ug/l

0.04

300

Secondary polycythaemia

294

1.56

2.07

1.9

0.77

2.37

ug/l

0.92

257

Benign neoplasm: Liver/bile ducts

263

1.58

2.03

2.2

2.0

4.34

2.53

ug/l

0.21

236

Myopia

150

1196

1.26

2.03

2.1

2.0

3.07

1.78

ug/l

0.58

138

1069

Migraine, single triptan purchase ok & required. ICD-code if available is included

984

7272

0.91

2.02

2.0

2.1

1.62

2.33

ug/l

1.30

880

6502

Triptan medication for migraine, single purchase ok

984

7272

0.91

2.02

2.0

2.1

1.62

2.33

ug/l

1.30

880

6502

Puerperal sepsis

159

1278

1.25

2.02

2.0

2.71

1.99

ug/l

0.33

145

1158

Benign neoplasm: Rectosigmoid junction

622

1.37

2.01

2.0

1.9

1.55

2.54

ug/l

0.48

551

Voice disturbances

451

3970

1.14

2.01

2.1

1.9

1.67

2.24

ug/l

0.78

396

3506

Bitten or struck by other mammals

147

1172

1.26

2.00

2.2

2.0

1.19

1.80

ug/l

0.64

128

1054

Benign neoplasm: Kidney

487

1.42

1.99

1.9

2.0

3.77

1.82

ug/l

0.45

435

Dislocation, sprain and strain of joints and ligaments of elbow

639

1.36

1.98

1.9

2.1

1.12

1.95

ug/l

0.71

567

Cystic fibrosis, other manifestations/unspecified

4.85

1.98

4.2

1.9

0.57

0.67

ug/l

—

Deviated nasal septum

617

5536

1.12

1.97

2.0

1.61

2.31

ug/l

1.32

523

4938

Diabetes mellitus in pregnancy

257

1382

1.19

1.96

1.7

2.0

1.39

1.61

ug/l

0.23

227

1227

Use of rivastigmine

254

2985

0.84

1.96

1.6

1.8

1.70

2.68

ug/l

1.36

197

2498

Benign neoplasm of urinary organs

676

1.35

1.96

1.8

1.9

3.08

2.36

ug/l

0.17

595

Other and unspecified coagulation defects

496

1.40

1.96

3.3

2.0

1.02

1.82

ug/l

0.61

442

Dermatographic urticaria

641

1.35

1.95

2.0

3.51

1.70

ug/l

0.32

576

Other and unspecified rosacea

133

1053

1.27

1.94

1.9

2.0

1.73

2.00

ug/l

0.14

117

937

Other and unspecified vascular occlusions

197

1631

1.22

1.93

1.9

1.21

2.41

ug/l

1.55

165

1410

Melanocytic naevi

462

4088

1.13

1.91

2.2

1.9

2.24

2.07

ug/l

0.10

416

3613

Contusion of other and unspecified parts of foot

456

1.42

1.91

1.7

2.1

1.92

1.85

ug/l

0.02

411

Antenatal screening

133

943

0.79

1.91

1.9

2.1

1.67

1.86

ug/l

0.09

121

846

Prolonged pregnancy

808

0.72

1.90

1.9

2.1

0.78

1.75

ug/l

1.78

718

Benign neoplasm of male genital organs

334

1.50

1.89

1.9

2.1

1.23

1.38

ug/l

0.11

296

Parkinson's disease, strict definition

302

2600

1.17

1.89

1.8

1.9

2.32

2.59

ug/l

0.15

251

2258

Other congenital malformations of circulatory system

301

1.52

1.88

2.1

1.9

3.31

2.18

ug/l

0.22

277

Other disorders of binocular movement

205

1.63

1.88

3.1

1.9

0.74

3.26

ug/l

1.10

186

Benign neoplasm of other and unspecified female genital organs

442

1.42

1.86

2.1

1.9

4.05

2.25

ug/l

0.37

391

Tooth eruption problems

127

981

1.27

1.83

2.0

2.1

3.64

1.93

ug/l

0.72

102

874

Primary open-angle glaucoma, strict

561

5027

1.12

1.83

1.8

1.9

2.28

2.39

ug/l

0.08

479

4366

Endometriosis diagnosis and infertility diagnosis occurring together

102

787

1.30

1.83

2.2

1.9

2.80

1.66

ug/l

0.27

706

Anorexia (incl.atypical)

485

1.39

1.83

1.8

1.9

2.29

2.12

ug/l

0.05

436

Spinal enthesopathy

393

1.44

1.82

1.7

1.8

0.44

2.49

ug/l

1.81

324

Ulcerative proctitis

685

1.32

1.80

1.9

2.1

20.83

1.67

ug/l

0.58

614

Torsion of ovary, ovarian pedicle and fallopian tube

161

1.70

1.80

1.7

2.2

4.71

2.30

ug/l

0.25

140

Operations for atrial fibrillation

217

1.61

1.78

2.6

2.0

0.47

2.75

ug/l

1.02

192

Other predominantly sexually transmitted diseases, not elsewhere classified

184

1524

1.21

1.78

2.2

2.0

2.02

1.78

ug/l

0.13

162

1360

Disorders of adrenal gland, other and/or unspecified

2.31

1.78

2.0

1.9

0.86

5.76

ug/l

0.48

Carcinoma in situ of other and unspecified sites

663

1.33

1.77

1.9

1.02

2.55

ug/l

1.02

584

Melanoma in situ of scalp and neck

0.00

1.76

0.0

2.1

—

7.15

—

Behavioural syndromes associated with physiological disturbances and physical factors

1462

11066

0.93

1.76

2.0

1.84

2.32

ug/l

1.05

1295

9769

Motorcycle rider injured in other and unspecified transport accidents

575

1.35

1.76

2.4

2.1

3.04

1.58

ug/l

0.53

523

Benign neoplasm: other/unspecified salivary gland

373

1.44

1.75

2.5

1.9

4.41

2.09

ug/l

0.35

334

Medical abortion

894

4447

1.09

1.75

1.9

2.38

2.42

ug/l

0.03

761

3897

Ectropion of eyelid

734

1.31

1.75

2.1

1.8

1.96

2.63

ug/l

0.32

615

Other bursitis, not elsewhere classified

118

1.83

1.74

2.0

5.37

0.97

ug/l

0.43

Other specified/unspecified nutritional deficiencies

2.06

1.73

1.4

1.7

20.77

4.67

ug/l

0.55

Hallux rigidus

230

1953

1.18

1.72

1.9

1.85

2.14

ug/l

0.19

194

1750

Delivery, wide proxy

418

2509

0.88

1.70

1.9

1.12

2.91

ug/l

2.13

367

2153

Erosion and ectropion of cervix uteri

300

1.49

1.70

1.9

2.0

1.79

2.07

ug/l

0.07

270

Use of anticholinesterases

682

5898

0.91

1.70

1.7

1.9

2.42

2.33

ug/l

0.05

521

5084

N06DA Anticholinesterases

682

5898

0.91

1.70

1.7

1.9

2.42

2.33

ug/l

0.05

521

5084

Fourth [trochlear] nerve palsy

309

1.48

1.70

2.6

1.8

5.76

2.26

ug/l

0.31

276

Abnormal findings in secretions and smears from cervix uteri vagina vulva

456

3864

0.89

1.69

2.1

2.0

2.89

2.23

ug/l

0.41

393

3419

Retained placenta and membranes, without haemorrhage

137

1109

1.24

1.68

1.9

1.84

1.79

ug/l

0.02

121

983

Other and unspecified degenerative diseases of nervous system

416

0.61

1.68

2.3

1.8

4.17

2.40

ug/l

0.22

354

Entropion and trichiasis of eyelid

177

1474

1.21

1.68

2.3

1.9

1.50

2.45

ug/l

0.75

151

1258

Tetralogy of Fallot, a congenital heart defect.

3.25

1.68

2.2

2.1

0.35

0.70

ug/l

—

Other disorders of amniotic fluid and membranes

104

796

1.28

1.66

2.4

2.1

1.41

1.72

ug/l

0.21

708

Use of levodopa decarbox-comt-inhibitor

531

1.36

1.66

1.8

1.9

1.54

1.93

ug/l

0.18

468

Endometriosis ASRM stages 3,4

282

2441

1.16

1.66

2.1

1.9

2.38

1.86

ug/l

0.26

249

2144

Burns and corrosions of multiple body regions

1.88

1.65

2.7

2.2

0.62

2.23

ug/l

0.95

Maternal care related to the fetus and amniotic cavity and possible delivery problems

357

2379

0.88

1.60

2.0

1.48

2.03

ug/l

0.69

329

2131

Haemangioma, any site

132

1073

1.24

1.59

2.1

2.0

0.87

2.29

ug/l

2.03

115

956

Benign neoplasm: Liver

231

1.54

1.59

1.8

2.0

5.14

2.83

ug/l

0.23

208

Struck by thrown, projected or falling objec

603

1.32

1.59

1.9

2.0

0.95

2.09

ug/l

1.19

545

Other infective (teno)synovitis

2.36

1.59

1.9

2.3

0.70

1.84

ug/l

—

Dystonia

647

1.31

1.59

2.5

2.0

1.30

1.76

ug/l

0.24

569

Benign neoplasm: Other and unspecified parts of mouth

440

1.38

1.58

2.0

1.15

2.04

ug/l

0.44

394

Other obstructed labour

612

1.32

1.57

1.8

1.9

2.89

1.92

ug/l

0.29

548

Varicose veins of other sites

106

843

1.27

1.56

2.1

2.61

2.03

ug/l

0.20

757

Fat embolism (traumatic)

3.51

1.55

1.8

1.9

0.57

0.33

ug/l

—

Use of antiglaucoma preparations and miotics

160

1332

1.21

1.55

1.7

1.9

2.81

2.45

ug/l

0.12

131

1135

Membranous nephropathy

2.25

1.55

1.3

2.1

0.19

1.28

ug/l

1.38

Benign neoplasm: Other/unspecified site

185

1.60

1.54

2.1

2.0

0.56

3.27

ug/l

1.08

168

Benign neoplasm of major salivary glands

176

1479

1.20

1.54

2.3

1.9

2.55

2.23

ug/l

0.12

156

1302

Communicating hydrocephalus

291

1.47

1.54

2.7

2.0

3.76

2.56

ug/l

0.20

259

Astigmatism

649

1.30

1.53

1.6

1.9

5.55

1.97

ug/l

0.61

577

Congenital deformities of hip

115

1.76

1.53

3.4

1.7

0.60

3.70

ug/l

0.74

107

Contact with heat and hot substances

616

1.31

1.52

1.9

2.1

4.69

1.53

ug/l

0.76

548

Carcinoma in situ, bladder

610

1.32

1.51

1.9

1.09

2.56

ug/l

0.87

543

Bursitis of shoulder

275

1.47

1.51

2.2

2.1

1.08

1.22

ug/l

0.10

237

Chronic rhinitis, nasopharyngitis and pharyngitis

482

4346

1.11

1.51

2.1

2.0

1.25

2.20

ug/l

1.87

426

3866

Divergent concomitant strabismus

105

838

1.26

1.51

2.8

2.0

1.59

1.95

ug/l

0.24

755

Amblyopia ex anopsia

401

1.38

1.50

2.9

1.9

5.24

2.15

ug/l

0.65

353

Pedal cyclist injured in transport accident

330

2913

1.14

1.50

2.0

2.18

2.32

ug/l

0.07

291

2583

Haemangioma and lymphangioma, any site

139

1145

1.22

1.50

2.1

2.0

0.83

2.20

ug/l

2.11

121

1021

Acne conglobata

2.50

1.50

2.0

1.7

3.05

0.77

ug/l

—

Persons encountering health services in circumstances related to reproduction

708

5194

0.92

1.50

2.2

2.07

2.47

ug/l

0.40

633

4709

Noninflammatory disorders of female genital tract

545

2471

1.11

1.49

1.9

1.80

2.02

ug/l

0.15

471

2173

Postpartum haemorrhage

153

1547

0.83

1.49

2.1

2.0

1.07

1.49

ug/l

0.39

140

1373

Congenital malformations of genital organs

693

1.28

1.48

2.5

2.0

2.08

2.26

ug/l

0.06

623

Vasomotor and allergic rhinitis

511

4541

1.11

1.48

2.0

1.25

2.28

ug/l

3.26

445

4035

Hyperaldosteronism

370

1.40

1.46

1.8

2.0

1.32

2.21

ug/l

0.48

334

Inflammation of lacrimal passages (acute and unspecified)

212

1.53

1.46

2.2

1.8

1.46

1.18

ug/l

0.17

184

Exposure to other and unspecified inanimate mechanical forces

107

860

1.25

1.46

2.1

1.83

1.79

ug/l

0.01

770

Whooping cough

2.77

1.44

2.3

1.4

0.92

0.79

ug/l

—

Lateral epicondylitis

186

1580

1.18

1.44

1.9

1.50

2.46

ug/l

0.88

159

1433

Abrasion of teeth

432

4792

0.90

1.42

2.1

2.0

1.95

2.14

ug/l

0.18

381

4290

Pre-eclampsia superimposed on chronic hypertension

2.46

1.40

1.7

1.3

0.53

1.66

ug/l

—

Other/unspecified disorders of vestibular function

546

1.31

1.40

1.7

2.0

0.57

1.80

ug/l

1.38

478

Other sexually transmitted chlamydial diseases

576

0.71

1.40

1.4

2.0

0.84

1.78

ug/l

0.98

516

Benign lipomatous neoplasm

512

4660

1.10

1.38

2.0

2.49

2.13

ug/l

0.22

452

4133

Chronic diseases of tonsils and adenoids

1160

7808

0.94

1.36

2.0

1.82

2.47

ug/l

1.13

1031

6946

Use of donepezil

375

3997

0.89

1.36

1.7

1.8

3.37

2.29

ug/l

0.40

282

3382

Inguinal hernia, unilateral

367

1.38

1.35

2.6

1.8

2.89

2.51

ug/l

0.10

323

Inguinal of femoral hernia, unilateral

367

1.38

1.35

2.6

1.8

2.89

2.51

ug/l

0.10

323

Femoral hernia, unilateral

367

1.38

1.35

2.6

1.8

2.89

2.51

ug/l

0.10

323

Other congenital malformations of tongue, mouth and pharynx

1.80

1.35

2.1

1.8

0.34

1.65

ug/l

1.49

Patent foramen ovale

224

1.49

1.35

2.0

2.2

5.95

2.33

ug/l

0.46

207

Failed induction of labour

298

1.42

1.35

1.4

1.8

0.33

1.45

ug/l

2.43

256

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

752

1.26

1.35

1.9

2.0

0.67

1.69

ug/l

2.76

679

Type 1 diabetes, definitions combined

697

1.26

1.34

2.0

5.12

1.97

ug/l

1.29

624

Exophthalmic conditions

129

1.66

1.32

1.7

1.8

0.44

1.41

ug/l

1.48

117

Benign neoplasm: Tongue

360

1.38

1.32

2.2

1.9

1.76

2.16

ug/l

0.12

321

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

284

1.43

1.32

2.2

2.0

3.43

2.56

ug/l

0.13

255

Disorders of male genital organs in diseases classified elsewhere

1.94

1.31

2.5

2.1

0.52

1.25

ug/l

0.45

Cysts of oral region, not elsewhere classified

747

1.25

1.31

2.1

2.0

3.13

1.85

ug/l

0.52

668

Senile degeneration of the brain, not elsewhere classified

2.08

1.30

2.3

9.18

6.48

ug/l

0.10

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

792

1.24

1.30

1.9

2.0

2.55

2.11

ug/l

0.19

710

Other sexually transmitted chlamydial diseases

379

0.66

1.30

1.5

2.1

1.15

1.36

ug/l

0.09

338

Benign mammary dysplasia

204

1765

1.16

1.29

2.0

1.9

1.18

2.07

ug/l

0.94

169

1543

Recurrent dislocation and subluxation of joint

632

1.27

1.28

1.8

2.0

0.75

1.72

ug/l

2.03

575

Congenital deformities of hip

130

1.63

1.27

3.2

1.8

0.57

3.38

ug/l

0.75

120

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

1.83

1.27

1.6

1.9

2.60

5.67

ug/l

—

Carcinoma in situ of rectum

171

1.56

1.27

2.4

2.1

1.70

3.29

ug/l

0.40

151

Acute poliomyelitis

171

1.55

1.26

1.5

1.8

1.74

2.75

ug/l

0.22

150

Other and unspecified trigeminal disorders

163

1.56

1.25

1.9

3.06

ug/l

0.00

152

Amputation of ankle

2.82

1.25

1.2

1.7

0.95

13.65

ug/l

—

Unspecified threat to breathing

1.80

1.25

3.9

1.9

0.25

4.47

ug/l

—

Cyst of spleen

2.75

1.24

2.2

1.3

9.64

13.77

ug/l

—

Ankyloglossia

1.87

1.23

2.5

2.1

0.30

1.55

ug/l

1.67

Type 1 diabetes, wide definition, subgroup 2

201

0.54

1.22

1.8

1.9

0.71

2.92

ug/l

0.81

166

Postpartum hemorraghe, all women as controls

153

1768

0.85

1.22

2.1

2.0

1.07

1.97

ug/l

1.07

140

1561

Contact with sharp glass

374

1.35

1.21

2.7

2.1

3.10

2.09

ug/l

0.23

340

Conductive hearing loss, unspecified

128

1073

1.20

1.21

2.0

1.31

2.32

ug/l

0.87

109

953

Non-allergic asthma

139

1173

1.19

1.21

2.0

4.25

2.44

ug/l

0.31

127

1040

Other and specified injuries of hip and thigh

298

1.39

1.20

1.9

1.8

4.99

2.39

ug/l

0.34

262

Pigmented purpuric dermatosis

125

1.63

1.20

1.7

2.0

2.13

3.99

ug/l

0.31

117

Meralgia paraesthetica

384

1.34

1.20

2.4

2.1

3.31

1.98

ug/l

0.26

343

Other primary thrombocytopenia

2.11

1.17

1.1

1.7

0.56

8.53

ug/l

—

Pedestrian injured in collision with car, pick-up truck or van

291

1.39

1.17

1.7

1.8

2.66

2.11

ug/l

0.09

258

Other and unspecified injuries of shoulder and upper arm

351

1.35

1.17

2.0

5.58

1.41

ug/l

0.77

309

Type 1 diabetes, strict (exclude DM2)

702

1.24

1.16

2.0

5.18

1.95

ug/l

1.32

630

Injury of muscle and tendon at hip and thigh level

146

1244

1.18

1.16

2.0

1.54

2.45

ug/l

0.59

124

1125

Open bite

334

1.35

1.15

2.9

2.0

3.08

2.18

ug/l

0.28

301

Dementia due to Parkinson's disease

414

1.32

1.15

1.9

1.8

1.58

3.07

ug/l

0.55

352

Carcinoma in situ of skin of ear and external auricular canal

268

1.41

1.14

1.8

3.21

4.68

ug/l

0.26

222

Other vitreous opacities

538

1.28

1.13

2.0

1.28

2.07

ug/l

0.42

468

Other protozoal intestinal diseases

143

1.56

1.13

1.5

1.8

0.80

3.28

ug/l

0.68

128

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

393

3574

1.10

1.13

2.1

2.0

1.92

2.22

ug/l

0.24

329

3200

Anti-inflammatory and antirheumatic products, non-steroids

590

2736

1.09

1.12

1.8

2.0

2.72

2.33

ug/l

0.18

508

2437

Disorders of iron metabolism

176

1.50

1.12

2.3

2.0

2.12

3.07

ug/l

0.20

157

Pedal cyclist injured in other and unspecified transport accidents

161

1388

1.17

1.11

1.9

2.0

2.40

2.14

ug/l

0.10

142

1237

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

147

1259

1.17

1.11

2.1

2.0

0.89

1.91

ug/l

2.30

120

1126

Lichen sclerosus et atrophicus

143

1222

1.18

1.10

1.8

2.0

2.86

1.67

ug/l

0.73

128

1073

Endometriosis of fallopian tube

1.85

1.10

2.2

2.7

0.63

3.92

ug/l

1.20

Tonsillectomy and adenotomy

591

4442

0.92

1.10

1.9

2.1

1.50

2.09

ug/l

1.02

523

3992

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

2.00

1.10

1.9

1.4

8.95

3.25

ug/l

—

Alzheimer disease

734

5016

1.07

1.09

1.7

1.9

2.69

2.24

ug/l

0.27

567

4308

Other maternal disorders predominantly related to pregnancy

639

3717

1.08

1.09

1.9

2.0

1.09

2.43

ug/l

2.54

560

3325

Benign neoplasm of brain and other parts of central nervous system

102

848

1.21

1.08

2.2

2.0

2.22

1.77

ug/l

0.29

755

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

703

1.23

1.08

2.1

2.0

2.54

2.19

ug/l

0.09

618

Postpartum hemorraghe, parous women as controls

153

1511

0.86

1.07

2.1

2.0

1.07

1.76

ug/l

0.77

140

1336

Degenerative diseases of the nervous system

813

5603

1.07

1.06

1.8

1.9

2.81

2.27

ug/l

0.38

638

4841

Acute disseminated encephalitis/encephalomyelitis

2.37

1.05

1.4

1.9

0.16

12.09

ug/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

149

1285

1.17

1.05

2.1

1.9

2.62

2.30

ug/l

0.10

133

1135

Aphakia

187

1.46

1.05

1.5

1.9

1.81

1.37

ug/l

0.11

161

Follicular adenocarcinoma of thyroid gland

1.87

1.04

2.5

1.8

0.30

1.61

ug/l

1.46

Adenocarcinomas of cervix

2.11

1.04

2.0

1.7

1.08

1.38

ug/l

—

Diastasis of muscle

1.76

1.04

2.2

4.61

1.36

ug/l

0.40

Early syphilis

130

1.56

1.04

1.6

2.2

0.70

1.84

ug/l

0.81

116

Burn and corrosion of head and neck

238

1.40

1.04

1.7

2.1

3.50

2.60

ug/l

0.12

218

Benign neoplasm: Skin of ear and external auricular canal

572

1.25

1.04

1.7

1.9

1.38

2.66

ug/l

0.73

493

Contraceptive management

451

3440

0.92

1.03

2.2

2.08

2.55

ug/l

0.34

399

3128

Complications following abortion and ectopic and molar pregnancy

368

1.32

1.03

2.2

1.9

0.61

2.68

ug/l

1.70

329

Glaucoma-related operations

908

0.81

1.03

1.8

1.9

3.83

2.24

ug/l

0.41

783

Intussusception

230

1.41

1.03

1.8

2.1

1.70

0.96

ug/l

0.47

206

Hypertrophy of breast in women and men

244

2179

1.12

1.01

2.0

1.68

2.00

ug/l

0.25

212

1940

Polyp of the female genital tract

432

2274

1.09

1.01

2.0

1.9

1.82

2.02

ug/l

0.11

382

2002

Rosacea

163

1420

1.15

1.00

2.0

2.43

2.26

ug/l

0.05

144

1266

Glaucoma, exfoliation

222

1975

1.13

1.00

1.9

1.8

1.36

2.22

ug/l

1.10

179

1674

Torsion of testis

131

1.54

1.00

1.6

2.2

0.78

1.26

ug/l

0.46

118

Melanocytic naevi of trunk

176

1543

1.15

0.99

2.1

2.0

3.21

2.11

ug/l

0.33

158

1373

Other conjunctival vascular disorders and cysts

292

1.35

0.99

1.9

2.0

2.11

2.44

ug/l

0.08

261

Disorders of orbit

504

1.26

0.98

2.1

2.0

0.67

1.23

ug/l

1.15

442

Other congenital malformations

149

1291

1.16

0.98

2.2

2.0

1.57

1.99

ug/l

0.33

131

1160

Propionic acid derivatives

586

2736

1.08

0.98

1.9

2.0

2.39

2.33

ug/l

0.02

506

2437

Personal history of malignant neoplasm

639

1.23

0.98

2.0

1.9

2.34

ug/l

0.00

573

Alcoholic cardiomyopathy

1.74

0.98

1.9

2.0

5.48

2.59

ug/l

0.34

Other specified/unspecified hearing loss

146

1266

1.16

0.97

2.1

1.9

1.88

2.84

ug/l

0.53

135

1097

Congenital malformations of eye, ear, face and neck

603

1.23

0.97

1.9

2.0

1.15

1.82

ug/l

0.40

535

Disease of hard tissues of teeth, NOS

979

5415

0.94

0.97

1.9

2.0

1.48

2.44

ug/l

3.10

858

4782

Lichen planus, including avohilmo

311

2826

1.10

0.96

1.9

2.16

2.31

ug/l

0.10

265

2504

Hypermetropia

750

1.20

0.95

2.3

2.0

5.79

1.91

ug/l

0.70

665

Benign neoplasm: Pituitary gland, craniopharyngeal duct

615

1.23

0.95

2.5

2.0

2.84

1.71

ug/l

0.48

542

Other and unspecified iridocyclitis

553

1.24

0.93

1.7

2.0

0.48

1.88

ug/l

1.90

491

Nontoxic single thyroid nodule

102

863

1.19

0.93

1.8

2.0

1.51

2.32

ug/l

0.52

772

Other bursitis of elbow

118

1.56

0.93

2.1

2.0

0.89

1.85

ug/l

0.60

100

Amoebiasis

1.70

0.93

1.6

1.8

9.73

4.90

ug/l

0.22

Other acquired deformities of musculoskeletal system and connective tissue

572

1.23

0.92

1.7

2.1

0.87

1.77

ug/l

0.88

509

Motorcycle rider injured in noncollision transport accidents

287

1.33

0.92

3.3

2.2

3.64

1.35

ug/l

0.48

256

Dental pulpitis, including avohilmo

1501

9329

1.05

0.92

2.1

2.0

1.61

2.39

ug/l

2.42

1345

8336

Other and unspecified corneal deformities and disorders

384

1.29

0.92

2.3

2.0

1.58

2.07

ug/l

0.20

341

Benign neoplasm: Parotid gland

132

1143

1.16

0.91

2.2

2.0

2.84

2.32

ug/l

0.15

116

1010

Other osteochondropathies

828

1.19

0.91

1.8

2.1

3.04

1.75

ug/l

0.40

757

Pregnancy examination and test

118

626

1.17

0.90

1.9

2.0

0.94

2.05

ug/l

1.69

108

558

Endometriosis of ovary

201

1751

1.12

0.87

2.1

1.9

1.57

2.01

ug/l

0.33

178

1568

Other congenital malformations of skin

414

1.26

0.87

1.7

2.0

0.69

1.95

ug/l

0.97

370

Glaucoma secondary to eye trauma

1.60

0.86

1.7

2.1

0.80

1.49

ug/l

—

Other deformities of toe(s)

397

1.27

0.86

1.9

2.0

0.43

1.39

ug/l

2.49

361

Shoulder region

162

1.44

0.85

1.6

2.0

1.51

2.73

ug/l

0.28

147

Carcinoma in situ of skin of other and unspecified parts of face

174

1546

1.13

0.85

1.7

1.8

2.55

2.27

ug/l

0.06

147

1316

Ganglion

275

2502

1.10

0.85

2.1

1.9

1.42

2.25

ug/l

0.97

251

2225

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.79

0.84

2.5

1.9

0.86

7.43

ug/l

—

Hydatidiform mole

111

0.54

0.84

1.0

1.8

0.59

3.71

ug/l

—

102

Female infertility

309

1714

1.10

0.82

2.0

2.39

1.81

ug/l

0.36

283

1537

Injury of muscle and tendon at shoulder and upper arm level

672

6341

1.06

0.82

2.1

2.0

1.51

2.14

ug/l

1.29

601

5671

Other, unspecified and serous retinal detachments

436

1.25

0.82

2.4

2.0

0.50

1.67

ug/l

2.46

386

Other congenital malformations of tongue, mouth and pharynx

1.70

0.81

2.5

1.8

0.37

1.49

ug/l

1.37

Unspecified privation

168

1495

1.13

0.80

2.1

2.0

2.09

2.20

ug/l

0.05

149

1315

Mucinous and mucinous cystic tumor

1.85

0.80

1.7

1.5

0.28

2.18

ug/l

—

Other or unspecified paralytic strabismus

1.65

0.79

1.2

2.0

0.80

1.79

ug/l

0.64

Benign neoplasm of bone and articular cartilage

113

980

1.16

0.79

2.0

2.1

0.84

1.65

ug/l

1.30

101

881

Medical treatment for female infertility

149

1308

1.13

0.79

2.0

2.24

1.81

ug/l

0.14

139

1150

Inguinal hernia, bilateral

173

1933

0.89

0.79

1.8

2.0

3.46

2.29

ug/l

0.27

153

1714

Benign neoplasm: Long bones of lower limb

349

1.27

0.78

1.9

2.0

1.06

2.04

ug/l

0.50

315

Effects of heat and light

1.57

0.76

3.4

1.7

2.13

3.92

ug/l

0.24

Monoamine oxidase A inhibitors

174

1558

1.12

0.76

2.1

1.9

1.24

2.08

ug/l

0.82

157

1401

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

468

1.23

0.76

2.2

1.8

1.47

1.86

ug/l

0.18

395

Benign neoplasm: Skin of eyelid, including canthus

263

2408

1.10

0.75

2.0

1.9

2.20

2.24

ug/l

0.02

226

2113

Benign neoplasm: Vulva

219

1.34

0.74

1.8

1.9

6.89

2.37

ug/l

0.50

194

Glaucoma secondary to eye inflammation

100

1.52

0.74

1.8

2.1

1.57

4.95

ug/l

0.53

Other noninflammatory disorders of vulva and perineum

103

893

1.16

0.74

2.2

1.9

4.52

1.90

ug/l

0.44

799

Pedal cyclist injured in collision with motor vehicle

325

1.27

0.74

1.8

2.0

6.05

2.23

ug/l

0.38

289

Severe visual impairment, monocular

117

1.48

0.73

1.8

1.9

4.01

3.44

ug/l

0.06

103

Other specified and unspecified disorders of conjunctiva

117

1.47

0.73

3.3

2.0

7.24

3.67

ug/l

0.32

109

Chronic mastoiditis

362

1.25

0.73

1.8

1.26

2.25

ug/l

0.52

320

Ventricular septal defect, a heart condition

150

1.41

0.73

2.8

2.0

5.62

3.32

ug/l

0.22

132

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

553

1.20

0.72

2.2

2.0

5.81

1.94

ug/l

0.70

491

Benign leiomyoma with endometriosis

176

1953

0.90

0.72

1.8

1.9

0.80

2.04

ug/l

4.39

147

1721

1.96

0.71

1.6

1.8

9.66

1.16

ug/l

—

Female genital prolapse

420

2214

1.07

0.71

1.9

1.89

2.05

ug/l

0.13

339

1948

Other fibroblastic disorders

1.74

0.71

1.7

2.2

0.36

0.94

ug/l

—

Subacute thyroiditis

372

1.24

0.71

2.1

1.9

1.43

2.15

ug/l

0.34

329

Acquired stenosis of external ear canal

145

0.61

0.71

2.1

1.38

3.46

ug/l

—

128

Long labour

162

1546

0.90

0.71

2.0

1.66

1.61

ug/l

0.03

139

1370

Foreign body on external eye

223

2034

1.10

0.70

2.2

2.1

3.97

2.24

ug/l

0.48

198

1841

Migraine with aura, drug-induced

1.52

0.70

2.4

1.9

0.21

1.62

ug/l

1.81

Inguinal or femoral hernia, bilateral

177

1959

0.90

0.70

1.8

2.0

3.40

2.27

ug/l

0.26

156

1739

Carcinoma in situ of cervix uteri

656

1.18

0.70

2.0

1.9

2.65

2.05

ug/l

0.23

575

Deep bite

940

0.86

0.69

2.0

2.1

1.93

2.03

ug/l

0.04

843

Whooping cough

1.65

0.69

2.2

1.4

1.52

5.32

ug/l

—

Fenamates

221

1642

0.91

0.68

1.9

2.0

2.16

2.35

ug/l

0.11

195

1466

Benign neoplasm: Central nervous system, other parts/unspecified

1.66

0.68

2.3

1.9

0.96

7.32

ug/l

—

Systemic atrophies primarily affecting the central nervous system

613

1.18

0.68

2.3

2.0

0.59

2.04

ug/l

2.03

541

Epiphora

294

1.27

0.67

1.7

1.9

0.54

1.50

ug/l

1.64

256

Oral leukoplakia, including avohilmo

357

1.24

0.67

2.1

2.0

0.64

2.08

ug/l

1.01

321

Maternal care for known or suspected abnormality of pelvic organs

165

1248

0.90

0.67

1.6

2.0

1.54

1.93

ug/l

0.22

143

1114

Anisometropia and aniseikonia

348

1.24

0.67

1.8

1.9

0.84

2.25

ug/l

0.80

307

Unspecific neurodegenerative disorder

956

6265

1.04

0.65

1.7

1.9

2.73

2.23

ug/l

0.41

745

5451

Normal-pressure hydrocephalus

840

1.15

0.65

1.8

1.9

1.11

2.72

ug/l

1.35

712

Nontoxic diffuse goitre

359

1.23

0.64

1.6

1.9

0.73

2.08

ug/l

0.95

314

Crowding of teeth, including avohilmo

447

1.19

0.64

2.2

1.9

3.05

2.54

ug/l

0.12

401

Other infective otitis externa

738

1.16

0.63

2.1

2.0

2.00

1.77

ug/l

0.11

656

Carbimazole or st.post thyroidectomy, condition for graves disease

283

2624

1.08

0.63

2.1

1.9

1.10

2.04

ug/l

2.28

243

2326

Disorders of acoustic nerve

342

1.24

0.63

1.9

2.0

2.04

2.25

ug/l

0.06

305

Delayed milestone in childhood

1.61

0.63

5.3

2.5

0.86

2.00

ug/l

—

Use of galantamine

129

1441

0.89

0.63

1.5

1.8

2.57

2.40

ug/l

0.07

1212

Benign neoplasm: Skin of scalp and neck

306

1.25

0.63

2.2

1.9

2.15

2.51

ug/l

0.10

270

Loose body in joint

297

1.26

0.63

1.9

2.0

1.40

1.66

ug/l

0.15

272

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

370

1.22

0.62

1.7

1.9

2.79

2.05

ug/l

0.22

334

Use of rasagiline

380

1.22

0.61

1.7

1.9

1.44

2.05

ug/l

0.28

338

136

1511

0.90

0.61

2.5

1.9

2.65

2.45

ug/l

0.11

122

1343

Hyperkinetic disorders (excl. ADHD)

1.49

0.61

1.5

1.8

5.90

1.29

ug/l

0.39

Benign neoplasm: Skin of lower limb, including hip

353

1.23

0.61

2.5

2.0

2.37

1.94

ug/l

0.10

319

Exposure to other and unspecified animate mechanical forces

263

1.26

0.60

2.0

2.1

0.37

2.49

ug/l

1.26

238

Overjet

130

1.38

0.60

1.9

1.8

0.56

3.59

ug/l

0.82

119

Sequelae of other and unspecified infectious and parasitic diseases

593

1.17

0.59

2.2

2.1

2.23

1.94

ug/l

0.10

541

Foreign body entering into or through eye or natural orifice

115

1025

1.13

0.59

1.9

2.0

0.78

2.16

ug/l

1.85

101

928

Secondary sideroblastic anaemia

1.75

0.59

2.3

1.7

1.42

1.36

ug/l

—

Raynaud syndrome

111

988

1.13

0.59

1.7

2.0

2.58

1.57

ug/l

0.47

884

Conjunctivitis

1113

9629

0.96

0.58

2.0

1.45

2.33

ug/l

2.14

988

8482

Other congenital malformations of face and neck

273

1.25

0.58

1.6

2.0

1.88

2.25

ug/l

0.08

248

Adenomyosis (Endometriosis of uterus)

140

1549

0.90

0.58

2.0

1.9

1.22

2.16

ug/l

1.38

123

1387

Generalized epilepsy, strict definition

184

1.31

0.58

3.5

2.0

0.74

2.55

ug/l

0.62

164

Congenital malformations of uterus and cervix

123

1.39

0.58

3.3

1.8

0.75

0.89

ug/l

0.16

108

Desensitization to allergens

365

0.79

0.58

1.8

2.0

2.42

2.39

ug/l

0.01

328

Routine general health check-up of defined subpopulation

115

0.61

0.58

2.6

2.0

0.56

2.03

ug/l

—

Ptosis of eyelid

193

1772

1.09

0.57

2.1

1.9

1.72

2.10

ug/l

0.17

171

1541

Lesion of femoral nerve

1.53

0.57

2.2

1.8

0.85

5.15

ug/l

0.62

Leiomyoma of uterus

889

4838

1.04

0.57

2.0

1.9

1.80

2.15

ug/l

0.62

752

4242

Injury of muscle and tendon at wrist and hand level

204

1879

1.09

0.56

2.0

1.05

2.38

ug/l

1.64

185

1684

Spermatocele

145

1315

1.11

0.56

1.9

2.0

2.35

2.91

ug/l

0.25

133

1164

Histrionic personality disorder

1.55

0.56

1.8

8.06

6.72

ug/l

—

Sexual dysfunction

168

1.32

0.55

1.8

2.1

0.54

1.54

ug/l

1.04

154

Hypertrophy of breast

184

1688

1.09

0.55

2.0

1.25

1.92

ug/l

0.73

157

1501

Multifocal fibrosclerosis

1.49

0.55

2.5

1.8

1.12

4.74

ug/l

0.50

Diseases of thymus

1.62

0.55

1.3

1.6

7.48

8.81

ug/l

—

Osteomalacia

1.48

0.55

1.6

1.8

3.13

4.87

ug/l

0.16

Hereditary sideroblastic anaemia

1.60

0.55

2.0

1.5

0.20

1.44

ug/l

—

Disorders of tooth development and eruption

196

1459

1.09

0.55

2.3

1.9

1.94

1.92

ug/l

0.01

165

1295

Chronic thyroiditis

1.56

0.53

2.0

1.6

2.37

9.60

ug/l

—

Benign neoplasm: Pharynx, unspecified

1.46

0.52

1.8

1.9

0.44

4.79

ug/l

0.74

Nasal polyp

327

3077

1.07

0.52

1.8

2.0

1.88

2.37

ug/l

0.32

278

2735

Alzheimer’s disease, strict definition

503

4349

0.95

0.52

1.8

3.26

2.32

ug/l

0.45

375

3710

Other infestations

215

1.27

0.51

2.3

1.9

0.47

3.06

ug/l

1.21

189

Benign neoplasm: Skin of trunk

518

1.16

0.51

2.0

0.71

1.74

ug/l

1.01

462

Gonococcal infection

333

1.21

0.51

2.1

2.0

0.55

1.85

ug/l

0.91

302

Gonococcal infection

315

1.21

0.51

2.1

2.0

0.57

1.91

ug/l

0.89

288

Noise effects on inner ear

624

1.14

0.49

1.8

2.0

2.03

1.96

ug/l

0.02

566

Dentofacial anomalies [including malocclusion]

925

7686

0.97

0.49

2.0

1.22

2.36

ug/l

3.32

821

6843

Premature rupture of membranes

135

1060

0.91

0.49

2.1

2.44

2.06

ug/l

0.16

116

940

Alzheimer’s disease (Early onset)

698

0.87

0.47

2.2

1.8

1.36

2.45

ug/l

0.57

582

Poor fetal growth

719

1.13

0.47

1.7

2.0

2.77

1.17

ug/l

0.50

643

Transient global amnesia

156

1439

1.09

0.46

1.8

1.9

3.51

2.27

ug/l

0.45

132

1282

Benign neoplasm of ovary

227

2124

1.07

0.45

1.9

2.37

1.96

ug/l

0.16

201

1874

Oral lichen planus

319

0.81

0.45

1.7

2.0

1.18

2.26

ug/l

0.38

290

Paget disease

1.48

0.45

1.9

1.7

0.19

4.97

ug/l

—

Alzheimer’s disease (Early onset), excluding more controls

494

1.15

0.45

2.3

1.8

1.36

3.00

ug/l

0.92

424

Other complications of labour and delivery, not elsewhere classified

550

0.87

0.45

1.9

0.61

1.17

ug/l

1.02

470

Endometriosis of pelvic peritoneum

159

1400

1.08

0.44

2.1

2.0

1.77

1.87

ug/l

0.05

143

1265

HSIL lesion of the cervix uteri

121

1323

0.91

0.43

2.4

1.9

4.77

1.64

ug/l

0.92

103

1166

Congenital malformations of anterior segment of eye

1.43

0.43

2.3

1.9

0.60

4.11

ug/l

0.50

Benign neoplasm: Choroid

878

1.11

0.43

1.8

2.0

4.13

2.09

ug/l

0.54

778

Delayed puberty

1.62

0.43

3.8

1.7

0.15

1.52

ug/l

—

Maternal care for known or suspected malpresentation of fetus

100

800

0.90

0.43

1.8

2.1

0.49

1.69

ug/l

3.50

712

Chronic suppurative otitis media, including avohilmo

109

993

1.10

0.42

2.3

2.0

1.23

2.11

ug/l

0.57

877

Venous complications and haemorrhoids in the puerperium

0.63

0.42

2.5

1.7

9.20

1.44

ug/l

—

Postdysenteric arthropathy

1.37

0.42

3.5

2.0

0.49

3.98

ug/l

0.66

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

198

1852

1.07

0.42

2.1

2.0

2.93

2.36

ug/l

0.16

176

1662

Cholesteatoma of middle ear

785

1.11

0.41

1.9

1.30

2.64

ug/l

0.87

695

Other superficial mycoses

115

1052

1.10

0.41

2.0

1.38

1.73

ug/l

0.25

941

Postpartum haemorrhage due to anatomy

552

0.87

0.41

2.2

1.9

0.54

1.37

ug/l

1.67

493

LSIL lesion of the cervix uteri

847

0.90

0.41

2.0

1.9

1.34

2.00

ug/l

0.48

754

Intrahepatic Cholestasis of Pregnancy (ICP)

433

0.85

0.40

2.7

2.0

1.87

1.66

ug/l

0.06

395

Vasomotor rhinitis (mode)

100

912

1.10

0.39

2.1

2.0

1.69

1.59

ug/l

0.04

812

Use of selegiline

741

1.11

0.39

1.9

1.17

1.89

ug/l

0.67

646

Caught, crushed, jammed or pinched in or between objects

570

1.13

0.39

2.0

1.56

1.86

ug/l

0.12

513

All dysplastic lesions of the vulva

391

1.16

0.38

2.3

2.0

1.03

2.05

ug/l

0.64

345

Disorders in reading

1.38

0.38

3.0

2.0

0.99

4.54

ug/l

0.54

Other/unspecified enthesopathies of lower limb, excluding foot

789

1.11

0.38

2.1

1.22

2.22

ug/l

0.92

720

Tinnitus

367

3508

1.05

0.38

2.0

1.21

2.14

ug/l

1.77

317

3135

Lesion of plantar nerve

733

1.11

0.38

2.1

1.9

1.11

1.92

ug/l

0.63

648

Transient synovitis

1.31

0.37

1.8

2.0

0.39

0.66

ug/l

—

Other osteochondrodysplasias

1.31

0.37

1.9

2.0

2.08

5.04

ug/l

—

Vestibular neuronitis

136

1262

1.08

0.37

2.1

2.29

2.33

ug/l

0.01

110

1127

Maternal care for other known or suspected fetal problems

157

925

1.08

0.37

1.7

2.1

1.23

1.74

ug/l

0.31

138

826

Congenital malformations of ovaries, fallopian tubes and broad ligaments

402

1.15

0.37

2.2

2.0

0.24

1.97

ug/l

1.73

365

Enterobiasis

116

0.69

0.37

3.3

1.7

0.51

0.85

ug/l

—

105

Polypectomy (DHB20)

996

0.91

0.37

1.9

2.0

1.52

2.02

ug/l

0.24

896

Glucosamine medication

929

7616

0.97

0.36

1.9

2.58

2.22

ug/l

0.31

780

6670

Pedestrian injured in transport accident

850

1.10

0.36

1.6

2.0

2.03

1.75

ug/l

0.10

753

Benign neoplasm: Bone and articular cartilage, unspecified

0.65

0.36

1.6

1.8

1.88

4.79

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

428

0.86

0.36

2.7

2.0

1.87

1.55

ug/l

0.10

389

Other disorders of breast

139

1293

1.08

0.36

1.7

1.9

1.33

2.02

ug/l

0.75

119

1138

Benign neoplasm: Conjunctiva

406

0.86

0.36

1.9

2.17

2.14

ug/l

0.01

357

Carcinoma in situ of cervix uteri, endocervix

0.65

0.36

1.4

1.8

0.13

5.06

ug/l

—

Pregnancy with abortive outcome

890

4512

1.03

0.36

1.9

1.63

2.41

ug/l

1.17

771

3946

Excessive attrition of teeth

835

8118

1.03

0.35

2.0

1.95

2.11

ug/l

0.19

728

7268

Melanoma in situ

701

0.89

0.35

1.9

1.73

2.27

ug/l

0.21

614

Bicornuate uterus

1.40

0.35

1.7

1.4

0.85

1.33

ug/l

—

Other protozoal intestinal diseases

199

1.21

0.35

1.5

1.8

0.73

2.50

ug/l

0.67

181

Other disorders of cornea

138

1286

1.08

0.35

1.8

2.0

1.67

2.05

ug/l

0.30

121

1140

Pneumoconiosis due to dust containing silica

1.35

0.34

2.7

2.0

1.11

1.01

ug/l

—

Contact with nonpowered hand tool

538

1.12

0.34

2.0

2.1

0.70

2.08

ug/l

1.66

486

Postviral fatigue syndrome

1.34

0.34

3.0

1.4

1.93

1.19

ug/l

—

Normotensive glaucoma

131

1404

0.93

0.33

1.8

1.9

4.08

2.28

ug/l

0.47

121

1210

Alzheimer disease, including avohilmo

818

5604

1.03

0.33

1.7

1.9

2.70

2.30

ug/l

0.26

640

4844

Degenerative myopia

1.37

0.33

1.5

1.6

5.07

4.81

ug/l

—

Pedal cyclist injured in noncollision transport accidents

146

1368

1.07

0.32

2.2

2.0

1.45

2.32

ug/l

0.81

132

1230

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.28

0.32

1.5

3.0

0.56

2.11

ug/l

—

All dysplastic lesions of the cervix uteri

187

1962

0.94

0.32

2.3

2.0

3.34

1.86

ug/l

0.60

162

1741

Chalazion

158

1487

1.06

0.31

2.2

2.0

2.92

2.11

ug/l

0.33

136

1321

Other articular cartilage disorders

286

1.16

0.31

1.7

2.1

0.63

1.48

ug/l

1.08

264

Other zoonotic bacterial diseases, not elsewhere classified

1.34

0.31

1.0

1.7

0.70

6.34

ug/l

—

Other and/or unspecified nontoxic goitre

111

1032

1.08

0.31

1.8

1.9

2.86

1.94

ug/l

0.35

910

Stenosis and insufficiency of lacrimal passages

140

1313

1.07

0.31

1.8

1.9

1.36

1.88

ug/l

0.32

125

1150

Dysplasia of cervi uteri

217

1653

0.95

0.30

2.2

2.0

3.24

1.83

ug/l

0.67

190

1475

Macular hole

879

1.08

0.30

1.7

2.0

3.53

2.11

ug/l

0.49

776

Pterygium

473

0.88

0.30

2.0

1.9

1.17

1.89

ug/l

0.35

418

Other congenital malformations of nervous system

1.28

0.30

3.4

1.7

0.45

6.79

ug/l

—

Chronic suppurative otitis media

841

1.08

0.30

2.2

1.9

1.41

1.75

ug/l

0.17

737

Endometriosis ASRM stages 1,2

167

1578

1.06

0.29

2.1

1.9

1.69

1.81

ug/l

0.06

151

1401

Contact with other sharp object(s)

678

1.09

0.29

2.1

1.93

1.95

ug/l

0.00

611

Benign neoplasm: Vagina

139

1.23

0.29

1.8

1.6

1.36

3.41

ug/l

0.45

123

Asymmetry of jaw

106

0.75

0.29

2.4

1.8

0.16

3.77

ug/l

—

101

Benign neoplasm: Testis

1.31

0.28

2.4

1.84

3.07

ug/l

—

Dacryoadenitis

1.29

0.28

2.4

1.9

0.46

1.67

ug/l

1.34

Overexertion and strenuous or repetitive movements

129

1212

1.07

0.28

2.2

2.0

2.84

1.73

ug/l

0.49

116

1090

Benign neoplasm: Brain, unspecified

1.24

0.27

5.0

1.6

4.47

5.15

ug/l

—

Calcaneal spur

128

0.78

0.27

2.0

2.3

1.05

1.53

ug/l

—

113

Primary angle-closure glaucoma

673

1.09

0.27

1.4

2.0

1.24

2.08

ug/l

0.50

579

Obstructed labour due to malposition and malpresentation of fetus

148

1458

0.95

0.26

1.9

2.0

2.51

1.38

ug/l

0.65

132

1291

Other maltreatment syndromes

272

1.14

0.26

2.3

2.1

0.80

1.58

ug/l

0.92

244

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

463

1.10

0.25

1.5

2.0

0.39

1.92

ug/l

1.69

417

Benign neoplasm of breast

144

1364

1.06

0.25

1.7

1.9

2.10

1.92

ug/l

0.10

119

1193

Foreign body in respiratory tract

599

1.09

0.24

2.0

1.94

1.84

ug/l

0.04

534

Mandibular retrognathia

536

0.91

0.24

2.3

2.1

4.41

2.03

ug/l

0.48

489

Complications of labour and delivery

703

4000

0.98

0.24

2.1

2.0

2.09

2.30

ug/l

0.15

642

3523

Alcohol abuse counselling and surveillance

179

0.83

0.23

2.7

2.1

0.92

3.04

ug/l

0.73

166

Supervision of high-risk pregnancy

143

906

0.95

0.23

1.9

2.1

0.89

1.90

ug/l

1.66

131

814

Abnormalities of forces of labour

728

1.07

0.22

2.1

2.0

1.41

1.53

ug/l

0.07

651

Pathological resorption of teeth

410

1.10

0.22

2.3

2.1

1.37

1.97

ug/l

0.31

364

Contact with lifting and transmission devices, not elsewhere classified

231

0.86

0.22

1.9

2.1

5.11

2.93

ug/l

0.33

211

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

0.22

0.0

1.8

—

24.58

—

Toxic effect of other inorganic substances

0.00

0.22

0.0

1.6

—

0.85

—

Exposure to excessive cold of man-made origin

0.00

0.22

0.0

1.9

—

1.60

—

Pityriasis alba

0.00

0.22

0.0

3.0

—

0.22

—

Intentional self-harm by crashing of motor vehicle

0.00

0.22

0.0

2.0

—

22.38

—

Retained (old) intraocular foreign body

0.00

0.21

0.0

2.0

—

0.60

—

Melanoma in situ of upper limb, including shoulder

1.25

0.21

1.5

1.8

2.14

4.49

ug/l

0.31

Contaminated medical or biological substances

0.00

0.21

0.0

2.2

—

0.60

—

Other congenital malformations of skin

853

0.94

0.21

1.7

2.0

0.78

1.75

ug/l

1.48

764

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

935

1.06

0.21

1.9

2.0

3.67

2.06

ug/l

0.42

837

Alzheimer’s disease (Late onset)

478

4118

0.98

0.20

1.7

1.8

3.33

2.36

ug/l

0.44

359

3501

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.25

0.20

1.5

3.0

0.56

2.07

ug/l

—

Varus deformity, not elsewhere classified

108

1.21

0.20

1.4

2.1

1.20

2.27

ug/l

0.51

Other and unspecified disorders of vitreous body

709

7125

0.98

0.20

2.0

3.88

2.10

ug/l

0.41

624

6301

Unspecified parasitic disease

1.22

0.20

2.0

26.71

5.61

ug/l

0.35

Lichen ruber planus, wide definition including periferal and oral lichen planus

340

3309

1.03

0.19

1.9

2.0

2.04

2.32

ug/l

0.21

290

2944

Malignant neoplasm of parotid gland

1.24

0.19

1.6

1.21

2.02

ug/l

—

Bicipital tendinitis

608

1.07

0.19

1.6

2.1

0.81

2.36

ug/l

1.29

546

Benign neoplasm: Cranial nerves

386

1.09

0.18

1.9

2.0

2.20

2.03

ug/l

0.05

345

Labour and delivery complicated by fetal stress [distress]

137

937

0.96

0.18

1.8

2.0

4.07

1.55

ug/l

0.81

124

820

Hair colour and hair shaft abnormalities

1.18

0.18

2.3

2.0

2.47

3.03

ug/l

—

Chondromalacia

319

1.10

0.18

1.6

2.0

0.49

2.27

ug/l

1.24

290

All dysplastic lesions of the cervix uteri, vagina or vulva

235

2389

0.97

0.18

2.3

2.0

2.87

1.73

ug/l

0.57

202

2119

Disorders of pituitary gland, other and/or unspecified

1.17

0.18

4.4

1.6

1.56

5.67

ug/l

—

Disorders of conjunctiva

1367

10832

1.01

0.18

2.0

1.77

2.28

ug/l

0.86

1213

9537

Anogenital herpesviral [herpes simplex] infection

866

0.95

0.17

2.0

1.43

1.87

ug/l

0.23

774

Special screening examination for neoplasms

669

1.06

0.17

1.8

1.9

1.44

3.00

ug/l

1.05

598

Perineal laceration during delivery

844

0.95

0.17

2.0

1.9

0.27

2.00

ug/l

3.93

732

Contact with other specified venomous animals

0.73

0.17

4.6

1.7

2.54

4.93

ug/l

—

Failed attempted abortion

0.74

0.17

1.6

1.9

0.18

1.60

ug/l

—

Other congenital malformations of ear

0.72

0.17

2.8

1.9

0.68

5.22

ug/l

—

Vascular dementia (multiple infarctions)

186

1.13

0.16

2.0

1.7

0.65

2.56

ug/l

0.64

157

Pregnancy, childbirth and the puerperium

422

2254

0.98

0.16

1.8

1.23

3.08

ug/l

1.85

374

1914

Erosion of teeth , including avohilmo

298

2903

1.03

0.16

2.1

2.0

1.75

2.23

ug/l

0.58

269

2596

Increased muscle tone

1.16

0.16

2.1

1.9

0.73

5.04

ug/l

—

Other abnormal products of conception

236

1610

0.97

0.16

1.8

2.1

1.75

1.74

ug/l

0.01

200

1447

Tic disorders

1.16

0.16

2.1

1.8

1.39

5.53

ug/l

—

Carcinoma in situ of breast, intraductal

966

0.95

0.16

2.0

1.9

3.05

1.80

ug/l

0.52

861

Tic and related disorders

1.14

0.16

2.1

1.7

1.39

6.18

ug/l

—

Serous carcinoma of ovary

0.75

0.15

1.3

1.6

0.97

1.72

ug/l

—

Biomechanical lesions, not elsewhere classified

647

0.94

0.15

2.9

2.0

0.95

1.86

ug/l

0.83

567

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

634

1.06

0.15

2.7

2.0

1.05

1.78

ug/l

0.52

570

Clubfoot

1.09

0.14

1.8

2.0

4.78

0.73

ug/l

—

Childhood allergy (age < 16)

595

1.05

0.14

2.1

2.0

1.65

2.11

ug/l

0.31

524

Benign neoplasm: Anus and anal canal

401

1.07

0.14

2.0

1.9

0.61

2.01

ug/l

1.17

352

Carcinoma in situ of skin of lower limb, including hip

316

0.91

0.14

1.6

1.8

0.51

2.39

ug/l

1.25

267

Allergic rhinitis

337

3260

1.02

0.14

2.0

1.16

2.05

ug/l

2.53

294

2922

Triptan medication for migraine, min. 3 purchases

638

4792

1.02

0.14

2.0

2.11

2.05

ug/l

0.05

561

4304

Unspecified lump in breast

184

1786

1.03

0.14

1.9

2.89

2.02

ug/l

0.24

161

1572

Benign neoplasm: Bones of skull and face

103

1.17

0.14

1.8

1.7

0.16

3.96

ug/l

0.82

Tarsal tunnel syndrome

103

1.17

0.14

1.8

1.9

0.89

3.91

ug/l

0.61

Burn and corrosion of wrist and hand

402

1.07

0.14

1.8

2.0

0.91

2.06

ug/l

0.83

358

Blepharochalasis

502

5104

0.98

0.13

2.1

1.9

3.06

2.20

ug/l

0.40

439

4471

Xanthelasma of eyelid

109

0.82

0.13

2.7

1.9

4.69

1.40

ug/l

—

102

Benign neoplasm: Short bones of lower limb

109

0.82

0.13

2.2

2.1

0.28

3.95

ug/l

—

101

Crushed, pushed or stepped on by crowd or human stampede

678

1.05

0.12

2.1

6.89

1.94

ug/l

0.92

606

Injury of nerves at wrist and hand level

424

1.06

0.12

2.1

2.41

1.73

ug/l

0.12

385

Carcinoma in situ of skin

148

1440

1.03

0.11

1.9

1.8

1.80

2.33

ug/l

0.25

127

1239

Plantar fascial fibromatosis

117

1134

1.03

0.11

2.0

0.45

2.53

ug/l

4.88

106

1015

Retinal breaks without detachment

243

2479

0.98

0.10

1.8

2.0

1.45

1.95

ug/l

0.41

202

2211

Exposure to excessive heat of man-made origin

1.15

0.10

6.1

1.9

0.42

4.21

ug/l

0.68

LSIL lesion of the cervix uteri, vagina or vulva

109

1123

0.97

0.10

2.0

1.9

1.05

1.88

ug/l

0.98

988

Accessory breast

1.07

0.09

1.2

1.6

1.02

6.86

ug/l

—

Spontaneous abortion

488

3331

0.99

0.09

2.0

1.66

2.30

ug/l

0.55

431

2973

Gestational diabetes (for exclusion)

260

1841

0.98

0.09

1.9

2.0

1.37

1.83

ug/l

0.59

232

1634

Arnold-Chiari syndrome

1.04

0.09

1.6

0.16

7.82

ug/l

—

Thyrotoxicosis with toxic multinodular goitre

787

0.96

0.09

1.9

2.0

0.66

2.21

ug/l

2.40

682

Other specified/unspecified diseases of inner ear

0.81

0.08

3.4

1.7

2.92

5.44

ug/l

—

Anogenital herpesviral [herpes simplex] infection

491

0.96

0.08

2.0

1.9

1.96

2.17

ug/l

0.05

439

Ectopic pregnancy

168

1647

1.02

0.08

1.9

2.0

2.55

1.95

ug/l

0.22

156

1498

Progressive vascular leukoencephalopathy

622

0.96

0.08

1.8

1.7

0.93

2.87

ug/l

1.72

531

Graves disease, strict definition

101

1037

0.97

0.08

2.1

2.0

0.87

2.02

ug/l

1.76

919

Retinal detachment with retinal break

213

2165

0.98

0.07

1.9

1.09

2.13

ug/l

1.92

192

1906

Tic and related disorders

1.08

0.07

2.1

1.8

1.39

4.93

ug/l

—

Gluteal tendinitis

412

1.04

0.07

2.3

2.1

0.84

2.61

ug/l

1.32

374

Disorders of puberty, all

1.03

0.07

2.8

1.8

0.40

1.58

ug/l

—

Fall on and from ladder

128

1253

1.02

0.07

2.0

1.9

1.05

2.66

ug/l

1.86

114

1115

Benign neoplasm of eye and adnexa

152

1491

1.02

0.07

1.8

1.9

3.89

2.38

ug/l

0.53

121

1317

Antepartum haemorrhage, not elsewhere classified

511

1.04

0.07

2.1

2.0

1.68

1.49

ug/l

0.08

452

Macular cyst

443

1.04

0.06

1.7

2.0

2.89

1.58

ug/l

0.25

387

Benign neoplasm: Scapula and long bones of upper limb

1.11

0.06

2.6

1.9

1.66

1.47

ug/l

0.05

Distal bite

232

0.94

0.06

2.1

2.0

7.18

1.41

ug/l

0.56

209

Contact with machinery

178

1753

1.02

0.06

1.9

2.0

1.59

2.69

ug/l

0.83

168

1565

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

652

1.03

0.05

2.7

2.0

1.05

2.28

ug/l

0.87

587

Prolapse and hernia of ovary and fallopian tube

538

1.03

0.05

1.9

1.7

1.00

1.79

ug/l

0.87

457

Disturbances of smell and taste

514

1.03

0.05

1.8

2.0

4.77

1.24

ug/l

0.61

455

False labour

214

1317

1.01

0.05

1.6

2.1

1.08

1.78

ug/l

0.71

183

1177

Contact with other hot fluids

312

0.96

0.04

1.6

1.9

0.28

2.40

ug/l

1.62

281

Foreign body or object entering through skin

745

0.98

0.04

2.0

2.1

2.54

1.86

ug/l

0.21

673

Melanocytic naevi of other and unspecified parts of face

647

1.02

0.03

1.9

2.0

0.97

1.69

ug/l

0.61

565

Vertical strabismus

389

1.03

0.03

2.0

1.8

2.56

2.02

ug/l

0.10

348

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

819

6462

1.00

0.02

2.0

2.56

2.26

ug/l

0.19

720

5720

Benign neoplasm: Lip

291

1.03

0.02

2.0

1.9

0.85

2.58

ug/l

0.97

257

Crossbite

490

0.98

0.02

2.7

2.0

4.02

2.29

ug/l

0.40

442

HSIL lesion of the cervix uteri, vagina or vulva

154

1527

1.01

0.02

2.4

1.9

4.04

1.90

ug/l

0.76

133

1346

Spirochaetal infections, other/unspecified

120

1212

0.99

0.02

2.2

2.0

1.10

2.19

ug/l

1.41

102

1088

Macular pucker

275

2765

0.99

0.02

1.9

2.0

5.07

2.13

ug/l

0.79

229

2428

Atopic dermatitis

723

5908

1.00

0.02

2.0

1.98

2.20

ug/l

0.20

637

5235

Uterine polyps

106

1050

1.01

0.01

1.7

2.0

0.66

1.93

ug/l

3.74

946

Pollen allergy

157

1560

0.99

0.01

1.8

2.0

1.14

1.98

ug/l

1.58

136

1402

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

104

1048

0.99

0.01

2.0

2.1

1.14

1.88

ug/l

0.69

940

Vascular dementia (subcortical)

533

1.01

0.01

1.6

1.8

0.70

2.71

ug/l

1.65

454

Obstructed labour due to maternal pelvic abnormality

151

1517

1.00

0.00

2.4

2.0

2.81

1.80

ug/l

0.40

135

1356

Melanoma in situ of other and unspecified parts of face

186

0.97

0.00

1.4

1.8

0.51

3.42

ug/l

1.11

159

Presbyopia

754

1.01

0.00

1.8

2.1

4.06

1.95

ug/l

0.32

687

Single delivery by caesarean section

138

793

1.00

0.00

1.8

2.2

1.33

2.20

ug/l

0.57

125

709

Anomalies of dental arch relationship, including avohilmo

199

1797

1.00

0.00

2.3

2.0

2.23

1.99

ug/l

0.15

173

1616

Melanoma in situ of trunk

233

0.99

0.00

2.3

1.9

3.79

2.75

ug/l

0.16

206

Unattended death

132

0.98

0.00

1.5

2.2

5.96

4.48

ug/l

0.12

111

Female infertility, cervical, vaginal, other or unspecified origin

256

1665

1.00

0.00

1.9

2.0

2.03

1.81

ug/l

0.15

234

1493

Other puerperal infections

449

1.00

0.00

1.5

1.9

0.49

1.40

ug/l

1.76

397

Other inflammation of vagina/vulva

249

1.00

0.00

1.9

0.31

1.33

ug/l

1.61

225

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

1.8

—

0.33

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.7

—

0.25

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.8

—

0.54

—

Follicular keratosis (Darier-White)

0.00

0.0

1.3

—

0.30

—

Blindness (ICD-9)

0.00

0.0

2.6

—

0.34

—

Other drug-induced osteomalacia in adults

0.00

0.0

2.2

—

0.37

—

Carcinoma in situ of breast, lobular

1.00

-0.00

2.1

1.5

0.26

4.50

ug/l

—

Fracture of lower limb, level unspecified

0.00

-0.00

0.0

3.0

—

1.18

—

Eosinophilic cellulitis [Wells]

0.00

-0.00

0.0

1.5

—

0.71

—

Other operation for atrial fibrillation

0.93

-0.00

1.6

2.1

0.49

5.56

ug/l

—

Nonscarring hair loss, unspecified, drug-induced

0.00

-0.00

0.0

1.4

—

0.40

—

Other specified air transport accidents

0.00

-0.00

0.0

2.3

—

2.40

—

Bacterial vaccines

0.00

-0.00

0.0

1.4

—

0.46

—

Other and unspecified parapsoriasis

0.92

-0.00

5.7

1.9

1.85

5.52

ug/l

—

Other degenerative disorders of globe

0.00

-0.00

0.0

1.4

—

48.80

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

2.2

—

5.72

—

Familial dysautonomia

0.00

-0.00

0.0

2.3

—

0.56

—

Enophthalmos

0.00

-0.00

0.0

2.7

—

0.27

—

Congenital malformations of posterior segment of eye

0.98

-0.00

1.4

2.0

0.14

7.01

ug/l

—

Acute thyroiditis

0.98

-0.00

1.6

1.7

0.56

1.78

ug/l

—

Miliaria, unspecified

0.00

-0.00

0.0

1.6

—

0.36

—

Other and unspecified nonscarring hair loss

0.91

-0.00

3.2

1.5

0.34

6.86

ug/l

—

Haemorrhagic and haematological disorders of fetus and newborn

0.92

-0.00

5.5

2.4

3.00

1.61

ug/l

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

-0.00

0.0

1.8

—

0.47

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.3

—

0.27

—

Androgenic alopecia

1.01

-0.00

2.8

1.6

2.32

4.70

ug/l

—

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

0.00

-0.00

0.0

1.4

—

0.41

—

Pseudofolliculitis barbae

0.00

-0.00

0.0

3.2

—

1.07

—

Noonan syndrome

0.00

-0.00

0.0

1.8

—

2.88

—

Benign neoplasm: Retina

0.91

-0.00

2.3

1.9

13.80

4.85

ug/l

—

Villonodular synovitis (pigmented)

1.01

-0.00

3.0

1.7

5.41

2.52

ug/l

—

Chondrolysis

0.00

-0.00

0.0

2.4

—

0.60

—

Contact with other specified venomous plants

0.00

-0.00

0.0

1.4

—

27.27

—

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

2.4

—

0.39

—

Exposure to high-pressure jet

0.00

-0.00

0.0

2.2

—

0.51

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

-0.00

0.0

1.2

—

0.33

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.97

-0.00

2.9

1.9

1.88

4.90

ug/l

—

Anhidrosis

0.00

-0.00

0.0

2.2

—

0.30

—

Defect, injury or illness of skull

0.00

-0.00

0.0

2.5

—

2.85

—

Café au lait spots

0.00

-0.00

0.0

5.0

—

29.80

—

Plague

0.00

-0.00

0.0

1.2

—

2.34

—

Mosquito-borne viral encephalitis

0.00

-0.00

0.0

1.6

—

0.28

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

2.3

—

30.71

—

Malignant neoplasm of meninges

0.00

-0.00

0.0

2.8

—

4.22

—

Megavitamin-B6 syndrome

0.00

-0.00

0.0

2.6

—

35.23

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

2.3

—

5.90

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

-0.00

0.0

2.1

—

0.33

—

Disorders of glycoprotein metabolism, other/unspecified

0.00

-0.00

0.0

1.4

—

0.42

—

Reduction defects of unspecified limb

0.00

-0.00

0.0

1.8

—

0.23

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

1.2

—

0.42

—

Crushing injury of neck

0.00

-0.00

0.0

1.5

—

0.44

—

Niacin deficiency [pellagra]

0.00

-0.00

0.0

1.4

—

0.26

—

Disorders of puberty

0.92

-0.00

3.3

1.7

0.47

1.01

ug/l

—

Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.9

—

0.30

—

Hereditary choroidal dystrophy

0.00

-0.00

0.0

2.0

—

0.44

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Procalcitonin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS